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Rh-catalyzed asymmetric hydrogenation has emerged as a powerful tool for the
manufacturing of chiral pharmaceuticals. While the mechanism is well understood,
catalyst design a priori is not yet possible. Supramolecular catalysis, the use of noncovalent forces to affect a catalytic process, can afford the catalyst diversity required to
uncover efficient catalysts and further our understanding. Using a modular design and
self-assembly, a large scale supramolecular catalyst screening in a catalyst scaffold
optimization study of rhodium-catalyzed asymmetric hydrogenation was carried out.
Analyzing the data yields some new insights into the roles of each module making up the
supramolecular catalyst. Perhaps most surprisingly, the presence of a chiral recognition
element positioned remote to the site of catalysis can significantly impact the catalytic
activity and enantioselectivity.

1,1-Disubstituted alkenes are a challenging class of substrates for the asymmetric
hydroboration reaction. Differentiation of the prochiral faces has been met with few
successes from either stoichiometric or catalytic approaches. Takacs et al. revealed
amide and ester groups direct the -selective Rh-catalyzed hydroboration of 1,1-

disubstituted-,-unsaturated alkenes. In the work described herein, analogous oximedirecting groups were used in an attempt to diversify the substrate scope. Unlike the
amide- or ester-directed examples, we find oxime-directed hydroboration proceeds
through an unusual C-H activation/metallation that proves crucial to turnover of
borylated products. Whereas it was previously presumed that certain reduced byproducts
were derived from adventitious H2 reduction, deuterium-labeling experiments suggest
competing pathways from a common intermediate leading to both borylated and reduced
products.

In 1993, the World Health Organization (WHO) declared tuberculosis (TB) a global
public emergency. Current drug treatments have reduced the mortality rate 40% since
1990, but increasing numbers of drug-resistant tuberculosis strains have been reported.
D-Cyloserine (DCS) is a second line drug for the treatment of TB. In a collaborative
effort with Professors Robert Powers (UNL-Chemistry) and Raul Barletta (UNL
Veterinary and Biomedical Sciences), experiments with an isotopically-labeled DCS
were proposed to elucidate the mechanism. Previously reported routes were not
amenable to the milligram quantities available for isotopically labeled serine starting
material. The synthetic route that will be described was used to produce both labeled and
unlabeled DCS.
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PREFACE

The introductory chapter of this dissertation serves as a review of supramolecular
catalysts in which a metal structurally assembles the catalyst. In contrast to previously
published reviews, a direct analysis from the contribution of the supramolecular
interactions on the catalytic reaction will be highlighted. This chapter represents a subset
of our investigation on supramolecular catalysts for a review in preparation. The
subsequent chapters cover research related to asymmetric synthesis, specifically,
asymmetric catalysis and isotopically labeled-compound synthesis for a collaborative
project. The second chapter is a summary of our findings from the catalyst scaffold
optimization of a supramolecular asymmetric hydrogenation catalyst; its focus is on
catalyst structure-activity relationships. The third chapter is an ongoing mechanistic
investigation into an unusual C-H activation found during the oxime-directed rhodiumcatalyzed hydroboration. The fourth chapter describes an asymmetric synthesis of an
isotopically-labeled tuberculosis drug D-cycloserine to support a collaborative project
with Professors Robert Powers (UNL-Chemistry) and Raul Barletta (UNL Veterinary and
Biomedical Sciences.
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CHAPTER ONE: SUPRAMOLECULAR CATALYSIS
1.1 Introduction
The macromolecular frameworks which direct the three-dimensional assembly of
enzymes commonly incorporate structural motifs such as hydrogen-bonding and metal
complexation. The active site of these enzymes must be somewhat rigid to selectively
accommodate a complex substrate yet flexible enough to distort it as needed to
accommodate the transition-state structure.1 The study of the interactions which govern
the assembly of these macromolecules has been broadly named supramolecular
chemistry. Synthetic methodologies for supramolecular chemistry generally focus on the
construction of macromolecules via non-covalent interactions including metal-ligand
coordination, hydrogen-bonding, and dipole-dipole or ionic interactions, although van der
Waals attractions and the avoidance of hydrophobic interactions likely also play
important but less well-defined roles. When these reversible intermolecular forces are
used to optimize a catalyst in effecting its reaction, this field is known as supramolecular
catalysis.
A supramolecular approach to catalyst design has some potential advantages over
traditional methods. While monodentate ligands have been used very effectively in
applications requiring the use of two or more equivalents of ligand, fine-tuning the
catalyst from steric and electronic substituents effects alone by combinatorial strategies is
often a challenge. Bidentate ligands offer more control to precisely define the chiral
space, but building large ligand libraries for screening by one ligand at a time synthesis
can be very tedious. Supramolecular approaches hope to offer the opportunity to control
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the chiral space and provide the opportunity to construct large ligand libraries through
self-assembly. The three common approaches to self-assembled supramolecular catalysts
via non-covalent interactions: metal-ligand coordination, hydrogen-bonding, and dipoledipole or ionic interaction, are illustrated in (Figure 1A). Metal-directed self-assembly
forms the basis for the work described in Chapter 2 of this thesis, and therefore this
introductory chapter will focus on similar approaches.
Typical architectural assemblies of a metal-directed self-assembled supramolecular
catalyst are shown below (Figure 1B). Bifunctional ligands with two binding sites can be
used in an orthogonal binding approach. A metal ion, participating in a structural role,
binds preferentially to the primary binding site assembling the bidentate ligand. The
secondary binding site would then be available for chelation to a catalytically active
metal ion. Alternatively, addition of chelating bridging ligands to coordinating metal
ions form discrete or networked metal-organic frameworks (MOFs). These catalysts
could participate in host-guest chemistry wherein a substrate’s conformation inside the
cavity can lead to a chemo-, regio-, or stereoselective chemical transformation. A
catalytic active site(s) introduced to the inside of the cavity might successfully exploit the
cavity to effect a size- or shape- selective reaction. Lastly, self-assembling polymers may
be formed with two orthogonally-binding ligands in an appropriately designed
monomeric unit. Addition of a structural metal and catalytically active metal selfassembles the heterogeneous polymeric catalyst.

3

Figure 1 Design of a supramolecular catalyst. A) Traditional approaches versus
supramolecular approaches. B) Architectures common in metal-organized supramolecular
catalyst systems.

This chapter will review progress in the design of asymmetric supramolecular
catalysis via metal-directed self-assembly. Its organization features a different type of
analysis from traditional reviews of the young, but rapidly developing, field.2-14 The
focus of this brief review is to summarize the influence of the supramolecular catalyst
scaffold/framework with, where possible, the direct comparison to the corresponding
combination of monomeric ligands. Included in this discussion is a brief review over the
development of some metal-organic frameworks that have been used for asymmetric
catalysis. MOFs are often excluded from reviews on asymmetric supramolecular
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catalysis; we argue that their synthesis via self-assembly and potential secondary
interactions with substrates warrants their inclusion. While organocatalysts are outside
the scope of this review and not incorporated in this discussion, remarkable
enhancements from supramolecular interactions have been observed in asymmetric
organocatalytic MOF catalysis.15-23

1.2 Homogeneous Organometallic catalysis – Neutral and anionic ligand-metal
coordination to form supramolecular chelating ligands
Van Leeuwen and Reek, two of the major players in this field, jointly published one of
the earliest examples using a Lewis acid-Lewis base interaction to assemble a chiral
bidentate ligand (Figure 2).24 Zinc-porphyrins were used as templates to coordinate with
a series of pyridyl-substituted BINOL-phosphite ligands. Following the titration of the
pyridyl-substituted ligands with bis-porphyrin template B by UV-Vis confirmed the
expected ratio of 2 ligands to 1 template B. The coordination behavior of the rhodiumchelated ligands was further studied with high-pressure NMR spectroscopy under syn gas
(20 bars 1:1 H2/CO, toluene-d8). Upon addition of template B, the rhodium-hydride
shifted from  = -9.5 to -11.1 ppm; this is believed to be a shielding effect of the
porphyrin to rhodium. Monodentate ligand L1 and the L1-(mono-porphyrin)template A,
gave similar very low enantioselectivity (6-7% ee) in the rhodium-catalyzed asymmetric
hydroformylation reaction. Use of the bis-zinc porphyrin (template B) with two
equivalents of pyridyl phosphite gave a modest increase in enantioselectivity up to 33%
ee. Since the combination of template A + L1 and L1 gave similar results, the increase in
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enantioselectivity when using the combination of template B + L1 is construed to arise
from supramolecular organization.

Figure 2 Metal-porphyrin templates organize pyridyl phosphorus ligating groups.
Adapted from Ref 24 with permission from The Royal Society of Chemistry

Van Leeuwen and Reek designed a new template by covalently linking one phosphite
ligating group to the zinc-porphyrin. Addition of a series of phosphine substituted
pyridines generates a series of supramolecular catalyst scaffolds in situ. These catalysts,
named SUPRAPhos, have been successfully used for asymmetric hydroformylation,25,26
asymmetric hydrogenation,27 and palladium catalyzed alkylation.28,29 Van Leeuwen and
Reek demonstrated the asymmetric hydrogenation of a tri-substituted cyclic enamide in
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one of the more remarkable examples of the influence of the supramolecular scaffold
(Figure 3).27 This particular alkene substrate had proven notoriously difficult to reduce
with high enantioselectivity via rhodium catalyzed asymmetric hydrogenation (RhCAH).30 The monodentate control ligand, (BINOL)PO-Ph, was reactive but gave no
asymmetric induction. The chiral (BINOL)P-functionalized porphyrin C in combination
with PPh3 also failed to afford high enantioselectivity. However, the chiral (BINOL)Pfunctionalized zinc porphyrin C in combination with ortho, meta- and paradiphenylphosphine-substituted pyridines gave interesting results. While the ortho- and
para-substituted pyridylphosphines (L2 and L4, respectively) furnished low conversion
and low enantioselectivity (44-62% yields, 27-47% ee), the metapyridyldiphenylphosphine ligand (L3) afforded quantitative yield and high
enantioselectivity (94% ee). The 31P NMR of a 1:1 mixture of BINOL-zinc porphyrin C
and L3 with Rh(cod)2BF4 confirmed formation of the desired 1:1 bidentate ligand to
rhodium chelate. Coupling constants were JP-P = 41 Hz, JRh-P = 263 Hz for the BINOL
phosphite and JP-P = 41 Hz, JRh-P = 146 Hz for the phosphine.

7

Figure 3 SUPRAPhos library finds an effective asymmetric hydrogenation catalyst.
Adapted from Ref 27 with permission from John Wiley and Sons.

In trying to assess the role of the supramolecular scaffold in his supramolecular
catalysts, Reek reported a supramolecular hydroformylation catalyst in which the Lewis
acid-Lewis base interaction changed the preferred coordination geometry at rhodium
(Figure 4).31 UV-Vis spectra confirmed the expected binding of the two porphyrin
moieties to the 4-pyridyl substituted phosphoramidite. Using high pressure NMR, the
authors determined the rhodium hydride was cis to the bulky monodentate ligand. After
coordination of the two zinc porphyrins, the H-coupling is consistent with a trans-
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coordination of hydride with respect to the phosphorus ligand. This example illustrates
how supramolecular organization may influence the preferred confirmation of rhodium
species. Asymmetric hydroformylation of 2-octene with monodentate phosphoramidite
ligand L6 gave low conversion and low selectivity. Use of phosphoramidite ligand L6
coordinated to two equivalents of zinc porphyrin A, afforded the 2- and 3-branched
isomers in 29% and 27% yields. The selectivity was increased modestly as well.
.

Figure 4 Zinc template influences geometry of hydride and its implications in
asymmetric hydroformylation of styrene. Adapted from Ref 31with permission from John
Wiley and Sons.
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Takacs and coworkers were next publishing in this field and with a new approach of
using a structural metal to bring two ligating groups together.33-35 Bisoxazolines of
complementary chirality combine with Zn(II) to form the thermodynamically favored
heteroleptic complex nearly exclusively as judged by NMR (Figure 5A). 32 When
bisoxazolines with substituted tethers and ligating groups are used, the resulting
heteroleptic complex constitutes a chiral bidentate catalyst that has been generated by in
situ metal-directed self-assembly. These catalysts have been used effectively in
palladium-catalyzed asymmetric allylic amination,33 rhodium-catalyzed asymmetric
hydroboration,34,35 and rhodium-catalyzed asymmetric hydrogenation.36,37 Selected
examples are shown in Figure 5.
For the Pd-catalyzed asymmetric allylic amination (Figure 5B), carrying out the
corresponding reaction using the reference monodentate phosphite, (TADDOL)POPh
afforded the substituted product with moderate enantioselectivity, 48% ee. Screening the
reaction with a series of identically (TADDOL)P-functionalized scaffolds of
incrementally varied structure afforded a range of selectivity from racemic to 82% ee.33
The variation in selectivity noted for a large group of ligands with the same ligating
groups gave rise to the idea of ligand (or catalyst) scaffold optimization. In analyzing the
data, we find that scaffolds bearing two ArCH2O- tethers generally afforded higher
selectivity than tethers in which the (TADDOL)P-ligating groups were appended via
ArO-linkages. In contrast, asymmetric hydroborations of styrene derivatives found ArOlinked tethers generally gave the higher enantioselectivity.34,35 Again, as perhaps inferred
by the term “ligand/catalyst scaffold optimization”, we found that a different catalyst
scaffold was required for optimum results with each ortho-substituted styrene suggesting
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each substrate requires a slightly different catalyst pocket (or perhaps in analogy to
biocatalysts, active site) for optimum results. Consider the following selected examples
for the hydroborations of ortho-methoxystyrene and ortho-fluorostyrene: catalyst L8
gives 99% ee for ortho-methoxystyrene but only 76% ee for ortho-fluorostyrene; catalyst
L9 gives 66% ee for ortho-methoxystyrene and 91% ee for ortho-fluorostyrene. The
results indicate that very subtle changes to the substrate can significantly alter
requirements for an effective catalyst structure.
The results obtained in the asymmetric hydrogenation studies (the subject of the
studies reported in Chapter 2 of this thesis) revealed that like the Pd-catalyzed allylic
aminations, use of ArCH2O-linked tethers increases the efficiency and selectivity of a
catalyst.36,37 However, this study also uncovered that use of these tethers comes with a
cost; the catalyst becomes too flexible and fail to respond to incremental catalyst scaffold
optimizations (i.e., are difficult to optimize) when two ArCH2O-linked phosphites are
combined in the same scaffold. In those studies we find that catalyst scaffolds bearing
one ArO- and one ArCH2O-linked chiral phosphite provided a better balance between
rigidity and flexibility (vide infra).
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Figure 5 Selected examples of catalysis using Takacs supramolecular catalysts. A) Selfassembly of heteroleptic bisoxazoline-zinc complex affords heteroleptic complex.; B) Pdcatalyzed allylic alkylation affords product in increased selectivity.; C) Substrate tailored
Rh-catalyzed asymmetric hydroboration of ortho-substituted styrenes.; D) Rh-catalzyed
asymmetric hydrogenation of two substrates with a mixed ArO- and ArCH2O- linked
scaffold gives highest selectivity.
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While the Takacs group has thus far been unable to obtain a crystal structure of their
supramolecular catalyst, several studies to obtain some structural information of these
supramolecular catalysts were conducted.35

Circular dichroism (CD), an experiment

which detects the differential absorption of left and right circularly polarized light was
used to determine if any noticeable structural changes occurred with the addition of
rhodium. The CD spectrum for a zinc-chelated self-assembled ligand shows a large
bisignate curve with a zero-crossing around 316 nm (Figure 6A). Upon addition of
rhodium, this bisignate curve is lost, suggesting a significant conformational change upon
binding. High resolution fast atom bombardment (FAB) mass spectrometry found a peak
consistent with the expected hetero-bimetallic complex.

31

P NMR data confirmed the

data with expected JRh-P couplings of 249 and 254 Hz and JP-P coupling of 38.8 Hz. DFT
calculations using mixed basis sets (B3LYP/6-31G for non-metal atoms and
B3LYP/LanL2DZ for metal atoms) were carried out to study the preliminary topography
around rhodium. The models suggest that a chiral pocket may be formed around the
catalytic center (Figure 6B).
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Figure 6 Structural characterization of Takacs’ supramolecular catalyst. A) CD spectra
indicates a structural change occurs from addition of rhodium to zinc-chelated selfassembled ligand. B) DFT model (B3LYP/6-31G for non-metal atoms and
B3LYP/LanL2DZ for metal atoms) of supramolecular catalyst suggests a chiral pocket
may form around catalytic site. Reproduced from Ref. 35 with permission from the
Royal Society of Chemistry.

Van Leeuwen developed a new strategy using supramolecular interactions to relay
chirality through an organizational metal to two achiral ditopic ligands. (Figure 7).38
Combinations of phosphine-substituted Schiff bases and chiral diols self-assemble around
titanium forming chiral bidentate ligands. The chiral TADDOL diol combined with
achiral phosphine L11 alone gave poor selectivity in the rhodium-catalyzed asymmetric
hydrogenation reaction. In contrast, the titanium-assembled L12 and L13 afforded 8187% ee. 1H NMR characterization of the heterobimetallic complex [Rh(L12)(nbd)]BF4
complex found distinct chemical shifts in equal intensities for the two imine and methoxy
hydrogens; this suggests [Rh(L12)(nbd)]BF4 exists as a single diastereomer (Figure 8).
31

P NMR data confirmed this conclusion with expected JRh-P couplings of 159 and 151 Hz

and JP-P coupling of 30.8 Hz. Furthermore, matrix-assisted laser desorption/ionization
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(MALDI) mass spectrometry identified a peak corresponding to the expected mass of the
[Rh(L12)(nbd)]BF4.

Figure 7 Rh-catalyzed asymmetric hydrogenation with a catalyst relying on transfer of
chirality from a remote diol. Adapted with permission from J. Am. Chem. Soc. 2011,
133, 18562-18565. Copyright 2014 American Chemical Society
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Figure 8 Supramolecular catalyst L13 selectively forms one diastereomer upon chelation
to rhodium as evidenced by H NMR and 31P NMR. Reprinted with permission from J.
Am. Chem. Soc. 2011, 133, 18562-18565. Copyright 2014 American Chemical Society

1.3 Homogeneous Organometallic catalysis – Supramolecular capsules and boxes
with enclosed catalytically active site
Hupp and Nguyen designed a supramolecular “box” with an encapusultated or
enclosed site for catalysis inside the box (Figure 9).39 Zinc porphyrin templates (T or T’)
bearing tin porphyrin bridging ligands (A or C) were used to form the outer walls that
enclose a catalytically-active manganese porphyrin (M). Tin porphyrins were ligated by
chiral N-acetyl protected phenylalanine to create a chiral environment around the
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manganese active site. Conditions were reported under which the encapsulated catalyst
could be assembled via a one-pot synthesis. Fluorescence spectroscopy was used to
confirm the location of the manganese porphyrin as inside the assembly. The addition of
manganese porphyrin to a solution of AAT4 results in fluorescence quenching from the
surrounding zinc porphyrin; nearly complete quenching was observed at a 1:1
stoichiometry of AAT4 : M. While chiral assemblies CMCT4 and CMCT’4 gave only
12-14% ee for the asymmetric sulfur oxidation of methyl p-tolyl sulfide, the control
reaction of manganese porphyrin M with N-acetyl-D-phenylalanine afforded completely
racemic product. This supramolecular system is reportedly the first example of remote
asymmetric induction from the surrounding environment of an achiral abiotic
homogeneous catalyst.
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Figure 9 Enantioselective sulfoxidation reactions catalyzed by supramolecular porphyrin
boxes. *Reactions were stopped <25% yields to compare reaction rates of oxidizing
subunit M alone compared to when it is enclosed in supramolecular box. Reprinted with
permission from J. Am. Chem. Soc. 2008, 130, 16828-16829. Copyright 2014 American
Chemical Society
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Reek devised a system to encapsulate a chiral bidentate phosphoramidite ligand inside
a molecular “box” (Figure 10).40 The zinc-salphen D was used as a template to
coordinate with bispyridyl-substituted phosphoramidite ligand L14. Reek had previously
reported a similar approach using an achiral catalyst to affect the regioselective
hydroformylation of unfunctionalized alkenes. 41 Circular dichroism (CD) was used to
monitor complexation of L14 as titrated with zinc salphen D. A single inflection point in
the series of CD spectra was observed after a 1:1 stoichiometry was reached; this
suggests the formation of a discrete assembly that does not undergo any significant
structural changes after the molecular box assembles. Diffusion-ordered NMR
(DOSY),42 an NMR technique used to approximate the hydrodynamic radius of a
molecule in solution, was used to estimate a hydrodynamic radius of 1 nm; the result
closely matches the dimension expected from the computational model for L15-Rh(acac)
as determined using Spartan© PM3. The addition of rhodium acac affords the L15Rh(acac) complex. Its 31P NMR spectrum shows the expected doublet (JP-Rh = 290 Hz),
and electrospray ionization mass spectrometry found a peak corresponding to the L15Rh(acac) species.
L15-Rh(acac) catalyzed the asymmetric hydroformylation reaction of 2-octene
demonstrating that the unusual catalyst systems could be used for the asymmetric
hydroformylation reaction of an non-functionalized (i.e., lacking a strong directing
groups) internal alkene. Due to alkene isomerization, obtaining high yields is challenging
for these troublesome hydroformylation substrates.41 Interactions with the
supramolecular catalyst scaffold had little or no effect on the regioselectivity for trans 2-
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octene, although an increase in enantioselectivity was observed for the reaction with the
supramolecular catalyst compared to that with the chiral phosphoramidite L15 alone (i.e.,
72% to 22% ee). Cis 2-octene afforded more dramatic effects. The encapsulated catalyst
L15-Rh(acac) favored formation of the 3-substituted carboxaldehyde isomer with a
concurrent substantial increase in enantiomeric excess from 4% to 86% ee; however, the
yields were low for the reasons stated above. When the reaction times were extended in
an attempt to obtain more practical yields, a slight drop in regioselectivity and
enantioselectivity was accompanied by the increase in yield. Starting from cis-2-octene,
(S)-2-ethylheptanal was formed in 57% yield and 76% ee.
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Figure 10 Self-assembly of a confined chiral rhodium catalyst for the asymmetric
hydroformylation of unfunctionalized alkenes. aAt 40°C for 5 days. Adapted with
permission from J. Am. Chem. Soc. 2012, 134, 2860-2863. Copyright 2014 American
Chemical Society
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1.4 Homogeneous Organometallic catalysis – Self-assembly of supramolecular
nanovessels for asymmetric catalysis

A number of research groups have pursued the idea that supramolecular assemblies
could also function as a “nanovessel” or “molecular flask.” Encapsulated guests might be
forced to adopt a preferred reactive confirmation once confined inside the vessel. If the
nanovessel is chiral, it might promote enantioselective catalysis inside the vessel;
Bergman and Raymond have reported the only two examples of using host-assemblies to
catalyze an enantioselective transformation (Figure 11).43,44

44

It should be noted that

Fujita also reported a [2+2] cycloaddition promoted by a chiral supramolecular assembly,
but a stoichiometric equivalent of catalyst was required.45 Bergman and Raymond’s
supramolecular assemblies possess a well-defined cavity for guest recognition and
encapsulation and function well in aqueous environments.46-53 The clusters are
assembled via coordination of six bis(catecholate)-functionalized ligands with four
gallium metals; three catecholate groups coordinate to each gallium ion in an octahedral
arrangement possessing either a right(Δ)- or left(Λ)-handed helicity at the metal center
(Figure 11A).54 Racemic L16 was resolved with (S)-N-methylnicotinium iodide. Ion
exchange chromatography with tetramethyl ammonium and potassium iodide salts
affords the “empty” resolved host rendering it capable of exchange with a cationic
substrate.55 CD spectra of the resolved hosts show the expected two mirrored images.
ΔΔΔΔ-L16 was shown to promote a simple, but quite remarkable, aza-cope
rearrangement in up to 64% ee and up to 74% yield (Figure 11A). This was an especially
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significant conceptual advance since the cavity bears no specific identifiable coordinating
groups to influence the selectivity; yet the reaction shows some selectivity.
Bergman, Toste, and Raymond recently reported a more robust nanovessel for
asymmetric catalytic rearrangements with neutral substrates (Figure 11B).44 Modifying
the vertices of the bis(catecholate) ligand with chiral amide directing groups
accomplishes two purposes: 1) The hydrogen-bonding interaction between the amide NH and the catecholate oxygen gives the structure more strength; and 2) The chiral amide
is capable of promoting chiral self-assembly eliminating the need for classical resolution.
Using the tether derived from (R)-(-)-3,3-dimethyl-2-butyl amine affords the ΔΔΔΔ-L17
host, while its antipode gives the ΛΛΛΛ -L17 host. The CD-spectrum of ΔΔΔΔ-L17 and
ΛΛΛΛ -L17 were mirror images of one another. The absolute configuration of ΔΔΔΔL17 was determined by X-ray crystallography which clearly indicated the presence of
hydrogen-bonding between the amide NH and catecholate at the vertices. The pure
enantiomers incorporate 12 potassium ions capable of rapidly exchanging with guest
molecules. Stereochemical analysis by 1HNMR after the addition of a chiral ammonium
guest molecule further confirmed the enantiomeric purity of the capsules. Inclusion of an
enantiopure guest molecule to each enantiomer of L17 afforded two different complexes
as judged from their distinctly different 1HNMR spectra due to diastereomeric
interactions.
The catalyzed carbonyl-ene cyclization of a simple monoterpenoid substrate was
examined with chiral hosts L16 and L17. Chiral host L16, which had been designed for
a cationic guest molecule, did not catalyze the carbonyl-ene cyclization of the
monoterpenoid substrate. This suggests no reaction occurs outside or on the surface of the
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nanovessels; the latter point can be problematic and difficult to assess. The two
enantiomers of L17, ΔΔΔΔ-L17 and ΛΛΛΛ -L17, afforded products in similarly high
yield (92-94%) and matching diastereoselectivity and enantiopurity, but opposite
configuration.

Figure 11 Chiral supramolecular host chemistry and its application to enantioselective
catalysis of charged and neutral substrates. A) Space filling model of L17 and the first
reported example of a chiral host used in catalytic amounts catalyzing an asymmetric
reaction (the Aza-Cope rearrangement) Adapted with permission from J. Am. Chem. Soc.
2009, 131, 17530-17531. Copyright 2014 American Chemical Society; B) Crystal
structure of L18 and application in enantioselective monoterpene-like cyclization of
neutral substrates. Adapted with permission from J. Am. Chem. Soc. 2013, 135, 1880218805. Copyright 2014 American Chemical Society
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1.5 Heterogeneous Organometallic catalysis – metal-organic frameworks (MOFs)
Metal-organic frameworks (MOFs) are porous three-dimensional coordination
polymers composed of organic bridging ligands and inorganic connecting points; while
MOF catalysts are often considered separately from supramolecular catalyst systems, it
seems more fitting to include them in this summary of recent advances in supramolecular
asymmetric catalysts. Incorporating chirality and a catalytically active site in the bridging
ligands transforms the MOF into a (supramolecular) heterogeneous asymmetric catalyst.
These pores inside the MOF are capable of enzyme-like shape- and size- selectivity
altered by modifying the bridging ligands, often done in a combinatorial fashion. A pore
too large often fails induce chirality to the catalytic reaction, while a pore too narrow or
small limits substrate access. Some benefits to using MOFs for asymmetric catalysis
over traditional homogenous catalysts are their reusability, often lower tendency toward
catalyst deactivation, and in ideal cases enzyme-like substrate size selectivity. Although
the first report of MOFs use as asymmetric catalysts was less than 20 years ago, the
burgeoning field has advanced significantly for both organocatalyzed and metalcatalyzed reactions.56-58
The first generation of asymmetric MOF catalysts tried to exploit induction from an
inorganic coordination sphere to a remote achiral catalytic site (Figure 12A).
Independently, Kim 59 and Lin60 reported similar strategies in 2000-2001. In Kim’s
report, the chiral MOF D-POST-1 was synthesized from tartaric acid-derived ligands
with zinc at the connecting points (Figure 12B). X-ray crystallography revealed the void
volume of the channels makes up 47% of the total volume, and 47 water molecules were
found in each unit cell. The use of D-POST-1 to catalyze the esterification of racemic 1-
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phenyl-2-propanol afforded the esterified product in 8% ee. Although the enantiomeric
excess was low, this publication demonstrated for the first time the use of a chiral MOF
in an asymmetric transformation.

Eight years after Kim’s first report, Tanaka reported modest selectivity could be
obtained with a chiral MOF catalyst using the strategy of chiral relay.61 Slow diffusion of
the chiral bridging ligand 2,2’-dihydroxyl-1,1’-binaphthalene-1,1’-dicarboxylic acid
(L18) with Cu(NO3)2 formed the chiral MOF [Cu2(L18)2(H2O)2] • MeOH • 2H2O (Figure
12C). Single crystal X-ray diffraction found that the four carboxylate oxygen atoms are
each coordinated to the Cu(II) ion. Thermogravimetric analysis (TGA) found 19% of its
mass was lost upon heating from 25-to-120 °C; this is attributed to loss of entrapped
solvent molecules. Removal of the guest solvent molecules in vacuo converted the
crystalline MOF into an amorphous solid as shown by X-Ray powder diffraction;
however, crystallinity could be regained upon exposure to solvent vapor. The MOF was
used in the asymmetric epoxide ring-opening of cyclohexene and cyclopentene oxides
with aromatic amines. In a neat solution of amine and epoxide, MOF [Cu2(L18)2(H2O)2]
catalyzed the reaction giving the product in 51% yield and 51% ee. Hydrogen-bond
donors such as BINOL have been shown to participate in organocatalyzed epoxide
openings.62 As a control experiment, the authors found that, while addition of (S)BINOL to a mixture of amine and epoxide afforded ring-opened product, the 3% yield of
product obtained was nearly racemic. The poor selectivity from the BINOL control
reaction was interpreted as indicating that chirality form the BINOL subunits was relayed
to the copper paddlewheels which were the sites responsible for catalyzing the
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enantioselective epoxide opening. An alternative explanation is cooperative participation
from the BINOL chiral hydrogen-bond donor and the Lewis acidic Cu center. To
distinguish whether the catalysis was occurring inside the pores or on the surface, bulky
arylamine nucleophiles, reactants that presumably cannot access the MOF pore interiors,
were examined; aromatic amines with an ortho-methyl or para-methyl gave nearly
racemic products and in much lower yield (i.e., 3-13%).
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Figure 12 First generation of metal-organic frameworks use as asymmetric catalyst. A)
General strategy using chiral relay to remote catalytically active site. B) Kim’s tartratederived MOF and its use in the resolution of racemic alcohols. Reproduced from Ref 59
with permission from Nature Publishing Group C) Tanaka’s BINOL derived bridging
ligand forms MOFs and its use in the asymmetric ring-opening of meso-epoxides.
Reproduced from Ref 61 with permission from Royal Society of Chemistry
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In the second generation of MOF catalysts, the bridging ligand was used to
immobilize a successful homogenous catalyst asking the question, how does
incorporation inside a MOF influence catalyst reactivity (Figure 13A). Lin and coworkers immobilized ruthenium BINAP-derived catalysts on a porous zirconium
amorphous surface with great success (Figure 13B).63

X-ray powder diffraction

confirmed L19-Ru-Zr was amorphous. IR spectra exhibit O-H stretching vibrations
consistent the presence of MeOH solvates, and thermogravimetric analysis (TGA)
confirmed the presence of solvates resulting in a ca. 20% loss of mass from when heated
from 20-to-200 °C. Ru-BINAP-DPEN, the homogeneous analogue of L19-Ru-Zr, gives
80% ee in the hydrogenation of acetophenone.64,65 Under similar conditions, L19-Ru-Zr
affords the product in 96% ee; a series of ketones were studied and all afforded >90% ee
(see reference 63). To examine the durability of this heterogeneous catalyst, L19-Ru-Zr
was recycled; the catalyst was reused eight times with no decrease in selectivity, although
after the sixth recycle, the reaction did not go to completion. Similar strategies in
homogeneous catalyst immobilization were reported by Hupp for immobilizing a
manganese epoxidation catalyst.66
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Figure 13 Second generation of metal-organic frameworks use as asymmetric catalyst.
A) General strategy immobilizing chiral ligating groups into scaffold of MOFs. B) Lin’s
immobilization of Ru-BINAP-DPEN in a porous zirconium solid affords higher
selectivity than homogeneous analogue. Reproduced from Ref 63 with permission from
John Wiley and Sons.

Post-synthetic modification of a chiral MOF is a powerful new strategy that relies on
incorporating orthogonally bifunctional groups bridging ligands (Figure 14A). Lin
demonstrated this idea in a MOF assembled from pyridine-substituted BINOL derivative
L20 and Cd(II) ions (Figure 14B).67 Single crystal x-ray crystallography found three
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Cd(II) ions, six chloride ions, and three L20 ligands in the unit cell. The diameter of the
channels inside the MOF were large (1.6 x 1.8 nm across); PLATON calculations found
54% void space accessible to guests. Two-thirds of the BINOL ligands were found Hbonding with neighboring unit cells limiting their availability for post-synthetic
modification. Nonetheless, added Ti(OiPr)4 was found to react with the one-third of
available chiral diols. This strategy was studied further with a series of MOFs composed
of tetra-substituted BINOL derivatives.68 The BINOL derivatives were functionalized
with carboxylate-terminated tethers of varying lengths. Carboxylate-bridged copper
paddlewheels were formed upon addition of copper(II) leaving the diols available for
sequential Ti(OiPr)4 addition. Crystal structures of a series of model MOFs (that is,
methyl ether derivatives of diols) found the approximate void space to vary 69-90%
dependent on tether length. To evaluate effectiveness of these functionalized MOFs in
catalysis, the Lewis acid catalyzed addition of alkyl zincs to aldehydes was explored.
The homogeneous catalyst derived from BINOL afforded the product in 88% ee. MOFs
derived from L20 and L22-24 afforded 82-84% ee with similar conversions to the
homogenous catalyst. Only the MOF derived from L21 gave poor selectivity; this was
attributed to the pore size being too small resulting only in non-selective surface
catalysis. Similar results were found when substrates larger than acetophenone were
used; they gave low selectivity and low yields.
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Figure 14 Tunable MOFs for asymmetric catalysis. Adapted with permission from J.
Am. Chem. Soc. 2005, 127, 8940-8041. Copyright 2014 American Chemical Society.
Reproduced from Ref 68 with permission from Nature Publishing Group.
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Due to the crystalline nature of many MOFs, some details of their active sites are more
accessible by crystallography than typically is obtained for homogeneous catalysts. In
the course of their structure-activity studies, Lin and co-workers analyzed a MOF catalyst
that gave low selectivity (ca 30% ee) in the titanium-catalyzed addition of alkyl zinc to
aldehydes (Figure 15).69 X-ray diffraction studies revealed substantial intermolecular
BINOL-chelation that seems to account for the poorly selective catalyst.

Figure 15 Interpenetrated networks form non-selective catalysts. Reproduced from Ref
69 with permission from John Wiley and Sons.
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1.6 Heterogeneous Organometallic catalysis – Heterobimetallic polymers
Supramolecular polymers are chains of monomeric units held together by nonbonding forces.71 When catalytically active functional groups are built into the
monomeric subunits, the supramolecular polymer affords a heterogeneous catalyst. Ding
and co-workers recently reported a series of heterobimetallic polymeric catalysts that
show promise for rhodium-catalyzed asymmetric hydrogenation (Figure 16A).75
MonoPhos (i.e., (BINOL)PNMe2) and a 2,2’:6’,2”-terpyridine unit were connected by an
alkyne linker. Upon the addition of Fe2+ salts, the Fe-bridged bis(MonoPhos) ligand
structures were formed. Their structures were characterized by UV/Vis, IR, elemental
analysis, and high resolution mass spectrometry. When cationic rhodium(I) was added to
a solution of iron complex in dichloromethane, a solid precipitated from solution. Its
analysis by powder x-ray diffraction showed the particles to be amorphous and by
scanning electron microscope to be micron-sized. A series of heterogeneous catalysts
with varying counterions were similarly prepared and isolated. As a model reaction these
heterobimetallic oligomer or polymer catalysts were screened in heterogeneous
asymmetric hydrogenation (Figure 16B). For the substrates examined, L25 was found to
be both remarkably reactive and selective, proving superior to even the homogeneous
rhodium catalyst prepared with the chiral monodentate MonoPhos ligand. Furthermore,
L25 could be recycled more than ten times with no loss in catalytic activity or selectivity.
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Figure 16 Formation of a heterobimetallic heterogeneous catalyst. A) Preparation via
sequential addition; B) Asymmetric hydrogenation using heterogeneous catalyst gives
excellent selectivity compared to monodentate ligand. Adapted from Ref 75 with
permission from John Wiley and Sons.
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1.7 Conclusions and future outlook

Computational modeling has yet to reach the point where it is feasible to design a
priori an efficient tailor-made asymmetric catalyst. Thus catalyst development still
requires novel discovery strategies and some luck to find successful hits. Supramolecular
approaches to catalyst discovery is still a young field, but the results reported to date
demonstrate some benefits through combinatorial synthesis and control of the active site
topography that remains difficult using the traditional approaches involving monodentate
or covalently-linked ligands.
Where does the field of supramolecular asymmetric catalysis go next? Cragg,
Grothaus, and Newman analyzed the sources of new drugs (for human consumption) for
the treatment of diseases from 1998-2008, a total of 1024 compounds.76 Remarkably,
while 57% of the drugs were either synthetically modified or inspired from the structures
of natural products, only 6% were the actual isolated natural product itself. The ability to
modify a polyfunctional natural product, that is, the post-synthetic modification of a
natural product, is one direction for developing chemical transformations by
supramolecular catalysis. The challenge lies in building enzyme-like site-specific
selectivity at a targeted site in a polyfunctional molecule.77 Scott Miller and co-workers
have reported a series of small peptide catalysts for site-selective transformations on
challenging natural product substrates.78-82 Exploiting the control of active site
topography and/or binding pocket accessibility to successfully target site-selective
reactions on a complex natural product would add significant value to supramolecular
catalysis.
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A second area, identifying new reaction pathways, could be productively addressed
with the right supramolecular catalyst. For example, David MacMillan recently
discovered conditions for a new -amino C-H arylation reaction from “reaction discovery
screening.”83 Using the reaction discovery approach in a controlled supramolecular
combinatorial screen for new reactions seems a likely and exciting future direction for the
field.
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CHAPTER TWO: OPTIMIZATION OF A SUPRAMOLECULAR HYDROGENATION
CATALYST

2.1 Rhodium-catalyzed asymmetric hydrogenation
Rhodium-catalyzed asymmetric hydrogenation (Rh-CAH) is one of the most useful
reactions in asymmetric catalysis. The addition of H2 to a prochiral alkene is atom
economical and generates a minimal amount of waste. The substrate scope is diverse,
and there has been a substantial amount of research into the mechanism of the reaction
over the last 30 years. Historically, these traits have made the asymmetric hydrogenation
one of the most studied reactions of asymmetric catalysis. The origin of asymmetric
hydrogenation date back to early studies by 2001 Nobel laureate William Knowles, who
sought an efficient route to synthesize the rare amino acid L-DOPA for the treatment of
Parkinson’s disease (Figure 1).1 The then practiced route utilized a Pd/C promoted
hydrogenation followed by a chiral resolution. While this route was effective in
preparation of the desired L-isomer, it also generated a large amount of waste from the
undesired D-isomer. Wilkinson hypothesized it might be possible to bypass this
resolution by producing only the L-isomer through an asymmetric hydrogenation.
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Figure 1 Preparation of the Parkinson's drug (L)-DOPA with a chiral resolution step

In the mid 1960’s, Wilkinson developed the homogeneous catalyst, Rh(PPh3)3Cl, that
proved quite reactive toward the hydrogenation of unhindered olefins. 2 A short time
later, Horner and Mislow developed a chiral resolution for the preparation of chiral
phosphines.2 The chiral phosphines were found to be stable to racemization under mild
conditions and could be used to prepare a chiral variant of Rh(PPh3)3Cl. As a model
substrate for the (L)-DOPA precursor, the asymmetric hydrogenation of an N-acetyl
protected dehydrophenylalanine derivative was explored (Figure 2). Horner and
Mislow’s chiral phosphines gave the reduced product in 28% ee. The first generation
substituted a propyl group for a cyclohexyl which increased the enantioselectivity only
slightly. Further modification resulted in the development of PAMP and CAMP which
gave the products in 58% ee and 88% ee.
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Figure 2 Evolution of monodentate phosphine ligands for the Rh-CAH

Bidentate phosphine catalysts started being explored in the early 1970’s. It was
believed the bidentate phosphine ligands would give a more rigid organized chiral space
than the monodentate phosphines could achieve. Kagan developed the chiral bidentate
ligand DIOP derived from chiral sugars.3 DIOP was remarkable because the chirality
was not on the phosphine itself, but on the backbone of the ligand. Using DIOP the
product was obtained in 83% ee (Figure 3). Knowles connected two PAMP phosphine
ligands with an ethylene bridge and named this ligand DIPAMP. DIPAMP gave the
highest levels of enantioselectivity achieved up to that point in time, 95% ee.
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Figure 3 Evolution of chiral bidentate ligands for Rh-CAH

After being largely ignored in preference to chiral bidentate ligands, it was reported by
Feringa and deVries in 2002 that certain monodentate BINOL phosphoramidites were
very effective for the Rh-CAH of dehydroamino acid derivatives (Figure 4).4 Despite not
having the added rigidity from a linker, these ligands can be equally effective as bidentate
ligands. Enantioselectivities of 92-99% ee were reported for both (E)- and (Z)dehydroamino acid derivatives. A big advantage of these monodentate phosphoramidite
ligands was their simple preparation from chiral diols enabling access to large libraries of
chiral ligands for combinatorial screenings. Since the initial report, phosphite and
phosphoramidite monodentate ligands have been shown to be very effective for the RhCAH of a wide variety of substrates.5-12
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Figure 4 First report of effective BINOL phosphoramidite ligands in the Rh CAH

The mechanism of the rhodium-catalyzed asymmetric hydrogenation has been
extensively studied over the last 30 years.13-19 Experimental evidence suggests two
distinct pathways leading to the hydrogenated product (Figure 5). If substrate
coordination to rhodium occurs before oxidation addition of H2, the mechanism is known
as the Halpern-Brown unsaturated pathway.14,17,19 If the order of addition is reversed and
oxidative addition of H2 precedes substrate coordination, this is known as the dihydride
pathway.20-23 While both have a common octahedral dihydride intermediate, the
difference lies in whether stereoselection occurs from a square planar rhodium(I) or
octahedral rhodium(III) complex. Thus far, evidence for the dihydride pathway has only
been observed when electron rich phosphine ligands were used.
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Figure 5 Stereoselection in the rhodium-catalyzed hydrogenation can occur through one
of two pathways

In the Halpern-Brown unsaturated mechanism, the stereoselection is first determined
from the addition of H2 to the substrate-bound rhodium. The mechanism is summarized
below (Figure 6). A doubly-solvated chiral rhodium(I) complex coordinates to the
prochiral substrate affording two diastereomeric complexes differing in energy (Figure 6,
A and A’). Oxidative addition of H2 gives the octahedral Rh(III) complex through an
“anti-lock and key” mechanism (Figure 6, C and C’). That is, the minor diastereomer
reacts more quickly than the major diastereomer.14,17,19 Landis and co-workers evaluated
the different approaches of H2 to rhodium using DFT and ONIOM calculations finding
significant energy differences between the different transition states.24-26 Labeling
studies suggest the oxidative addition is irreversible when isotopic scrambling was not
observed in presence of a D2 atmosphere.16,17 Migratory insertion of the alkene affords
an alkyl metal hydride species (Figure 6, D and D’). Reductive elimination gives the
chiral reduced product while regenerating the Rh(I) catalyst (Figure 6, E and E’). The
mechanism is very well understood; the enantioselectivity can even be predicted using a
quantum mechanics-guided molecular mechanics method (Q2MM). For example,
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building upon their previous mechanistic studies,27 Wiest and co-workers were able to
corroborate experimental data for a series of widely used chiral bidentate phosphine
ligands with predicted enantioselectivities.28 The overall agreement between
experimental and predicted selectivity for all examples had an average unsigned error of
0.8 kcal/mol.

Figure 6 Halpern-Brown unsaturated mechanism for Rh-CAH

Conversely, the Rh(III) dihydride mechanism suggests oxidative addition to
rhodium(I) occurs first, and the prochiral substrate’s coordination is the stereoselective
step.20-23 Key evidence is observation of dihydride intermediates by H NMR at low
temperatures. Thus far, dihydride intermediates have only been observed when electron-
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rich P*-stereogenic phosphine ligands were used. The dihydride intermediates have
never been observed with substrate pre-coordinated, because the migratory insertion
occurs too quickly. This mechanism also provides stereochemical models where the
predicted enantiomer from substrate precomplexation is not formed.29
Asymmetric hydrogenation is widely used in pharmaceutical applications today.30
Because of this, many research groups are still pursuing this reaction for catalysts that are
selective towards an ever growing library of compounds. Their ultimate goal is to find a
“privileged” catalyst generally reactive and selective for many substrates. A
supramolecular catalyst has the advantage of more chemical space to tailor the chiral
pocket for the substrate.
Supramolecular chemistry has a long history, but as described in Chapter 1, the use of
supramolecular catalysts for asymmetric catalysis is still at an early stage. The Takacs
group has reported effective self-assembled supramolecular catalysts for reactions such as
asymmetric allylic amination,31 hydrogenation,32 and hydroboration.33,34 The studies
described in this chapter are those carried out for Rh-CAH; herein we describe the first
in-depth investigation into the significance of each component of a self-assembled
supramolecular hydrogenation catalyst.35
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Figure 7 Pharmaceutical drugs synthesized with Rh-CAH as a key step. Asymmetric
reduction marked by red bond.

2.2 Key components of a supramolecular catalyst
The Takacs supramolecular heterobimetallic catalyst can be divided into four
customizable modules (Figure 8).35 The active site can be modified with different
catalytically active metals such as Pd, Rh, or Ir (Figure 8, I). The ligating group can be
substituted with electronically different phosphorus ligands or nitrogen-based ligands
(Figure 8, II). The scaffold building tether can vary the connectivity pattern of either
mono- or bi-aryl tethers while controlling the connectivity to the ligating group through
either a benzylic or phenolic linkage (Figure 8, III). Chirality-directed self-assembly
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serves as the recognition elements which bring the complimentary bidentate ligand
(Figure 8, IV).

Figure 8 Strategy for optimization of a supramolecular catalyst. Reprinted with
permission from ACS Catal. 2012, 2, 2743-2752. ©2014 American Chemical Society

Combination of equimolar equivalents of a remote phosphorus bearing (S,S)bisoxazoline with a phosphorus bearing (R,R)-bisoxazoline in the presence of Zn(II)
affords near exclusively the neutral heteroleptic complex SAL Zn(STRT). The
heteroleptic complex binds with nearly perfect tetrahedral geometry around zinc while
the homoleptic complex is distorted to avoid unfavorable steric interactions between the
phenyl substituents.36,37 The difference in stability between the heteroleptic and
homoleptic complexes, such as those whose crystals structures are shown (Figure 9,
below) is estimated to be 4 kcal/mol or greater based on thermodynamic equilibria. In
the example illustrated below, if ST = RT and both P(OR)2 substituents are either (i)
enantiomeric or (ii) achiral and otherwise identical on both subunits the zinc complex is
meso by inversion symmetry. However, if ST ≠ RT, the zinc complex lacks inversion
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symmetry and is chiral. In section 2.9, the impact of this will be described with respect to
the asymmetric hydrogenation reaction.
.

Figure 9 Chirality directed self-assembly affords heteroleptic bimetallic complex

Scaffold optimization involves varying the substitution patterns of the tethers
attached to the bisoxazoline. The tethers were varied within a series of aryl and biaryl
subunits of ortho-, meta-, or para-substitution (Figure 10). Typically, it has been found
that the optimal catalyst bears a scaffold that varies from substrate to substrate, and
similarly for different reactions. While some may see this as a disadvantage, we note the
nature exploits the substrate selectivity as a hallmark of many biocatalysts (i.e.,
enzymes). The power of scaffold optimization lies in the rather unique ability to tailor
the catalytic pocket for each substrate. In the course of the studies described below, one
key feature will be that the flexibility of the catalyst can be tuned (or at least subtly
varied) by changing the scaffold building tether subunit with either a benzylic or phenolic
linkage to the ligating group. While this difference results in only 1 or 2 additional or
fewer of degrees of conformational freedom in a structurally large (ca 2 kD)
supramolecular catalyst, the impact on a catalyst’s performance can be great. This will
be described in further detail in section 2.7.
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Figure 10 Library of tethers used in SAL synthesis

2.3 Ligating group and catalytic metal selection for catalyst scaffold optimization
studies
The first step was selection of the ligating group. A series of chiral monodentate
ligands were used to screen for candidates. Chiral phosphite ligands have been reported
to be effective for the Rh-CAH.5,6,10,12 The chiral diols BINOL, BIPHEP, and TADDOL
were selected based upon their prior utility in asymmetric catalysis. To ascertain a sense
of a chiral ligating group’s effectiveness, two monodentate phosphite ligands modeling
ultimate the tether backbone were synthesized with phenol (OPh) or benzylic (OBn)
linkages.
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Figure 11 Strategy for selecting monodentate ligands for hydrogenation catalyst
screening of substrates

Two prototypical enamides substrates were selected for this study, the dehydro
phenylalanine derivative S1 and 1,1-disubstituted eneacetamide S2. The substrates were
screened with the TADDOL, BIPHEP, and BINOL derived phosphites with cationic
Rh(nbd)2BF4 at 1 mol percent catalyst loading (Table 1). After the reaction, yields were
determined with N-benzyl acetamide as internal standard on GC. Catalysts with
TADDOL ligands L1 and L2 were active but non-selective in the hydrogenation of S1
and S2. Biaryl backbones BIPHEP (L3, L4) and BINOL (L5, L6) gave higher
selectivities than TADDOL. BINOL was chosen as the ligating group for this study,
because the selectivity was good yet had some room for improvement by catalyst scaffold
optimization, especially considering the energetics of enantioselective reactions. This
was of course a risky proposal given that the previous hydrogenation study of BIPHEPSALs showed only incrementally increases over the monodentate ligands. As a
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benchmark for the scaffold optimization study, that is, a model system for the effect of
mixed ArO- and ArCH2O- phosphite linkages, the combination of (BINOL)POPh with
(BINOL)POBn was also run. The effective use of mixtures of chiral monodentate
ligands was first reported by Reetz38 and since that report has been exploited for its
versatility in identifying new catalysts.39 In our hands, the L5/L6 combination of chiral
monodentate ligands were no more effective than L5 or L6 alone. This could suggest the
an increase in selectivity from mixed scaffolds (something that we ultimately find, vide
infra) results from supramolecular catalyst scaffold optimization rather than simply a
mixed ligand effect.
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Table 1 Ligating group selecting based on monodentate ligand screeninga

S1
Entry
1
2
3
4
5
6
7

Monodentate ligand
(R)-(TADDOL)POPh L1
(R)-(TADDOL)POBn L2
(R)-(BIPHEP)POPh L3
(R)-(BIPHEP)POBn L4
(R)-(BINOL)POPh L5
(R)-(BINOL)POBn L6
L5 + L6c

ee (%)b
4
30
67
53
69
78
78

yield (%)
97
99
99
65
99
99
99

S2
ee (%)b
10
15
67
53
86
92
92

yield (%)
99
99
99
99
99
99
99

a

Reaction conditons: 1 mol% Rh(nbd)2BF4, 2.1 mol% monophosphite, DCE, rt, 16 h.
Yields and enantioselectivity determined by chiral GC using N-benzyl acetamide as an
internal standard. bUnless otherwise noted, the (S)-enantiomer predominates the reaction.
c
Equimolar amounts of each ligand.

The selection of metal precursor to be used in the catalyst scaffold optimization study
was determined next. Alternate diene precursors, counterions, and metals to
Rh(nbd)2BF4 were examined under a standard set of hydrogenation conditions (i.e,
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substrate S1 or S2, 1 mol% catalyst loading, BINOL phosphite L6, 30 psi H2, DCE, 16
h). Rh(cod)2BF4 gave comparable results as Rh(nbd)2BF4, which indicates that the diene
precursor has little or no effect on the reaction. (We had assumed at the onset, as others
do, that diene would simple be reduced under the reaction conditions.) A “neutral”
rhodium catalyst, [Rh(nbd)Cl]2 did not show any catalytic activity as one would expect
for rhodium with a covalently bound counterion and the need for two-point binding of the
substrate with the catalyst. Substituting the [BF4]- counterion with [TfO]- or [B(C6F5)4](i.e., BArF) in the Rh(nbd)2X catalyst precursor gives catalysts that exhibit comparable
reactivity and selectivity. Consider the results summarized above and given its favorable
solubility properties and commercial availability, Rh(nbd)2BF4 was used in the scaffold
optimization studies.
Iridium-catalyzed hydrogenation has been effective for the enantioselective
hydrogenation of substrates lacking strong directing groups, and we also briefly
considered catalysts based on iridium as an alternative to rhodium for the catalyst
scaffold optimization studies.40,41 However, Ir(cod)2BF4 is ineffective as a catalyst
precursor under our stand reaction conditions with the selected chiral monophosphite
ligands. This is perhaps not surprising. Effective iridium-catalysts typically employ P,Nligands. Catalyst deactivation is believed to result from formation of bridged iridiumhydride complexes. Use of a non-coordinating counterion is important as strong
coordination of the counterion inhibits olefin coordination and subsequent migratory
insertion of an iridium di-hydride species.42 High concentrations of iridium-dihydride
lead to the catalyst deactivation.
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2.4 SAL screening of dehydrophenylalanine derivative S1
BINOL-derived monodentate phosphites proved to be both reaction and reasonably
enantioselectivity for the Rh-CAH of prototypical substrates S1 and S2 under our
prescribed reaction conditions. The BINOL phosphite ligating group was appended to a
series of SAL tethers. Among the set of possible tethers shown in Figure 10, all of the
monoaryl and biaryl tethers bearing a benzylic linkage to the ligating group were
synthesized and included in the study. Their inclusion reflects the preliminary evidence
from the BIPHEP SALs and monodentate screening suggesting that ArCH2O-linked
phosphites were generally more successful than the corresponding the ArO-linked series.
For the ArO-linked series, the monoaryl tethers were excluded based on unpublished gel
permeation chromatography (GPC) results suggesting that the ArO-linked tethers do not
quantitatively form the desired bidentate chelate due to distance between restricted P-P
distance between ligating groups.
BINOL-bisphosphite SALs were prepared by adding an equivalent of Zn(Et2) to
combinations of appropriately (S,S) or (R,R)-bisoxazoline coupled tethers. Rh(nbd)2BF4
was then added to the resulting Zn complex providing a series of in situ generated
supramolecular catalysts. Initial screening of the pseudo-C2-symmetric SALs, scaffolds
comprised of (R,R) and (S,S)-bisoxazline coupled to identical tethers, were used to
determine whether all of the catalyst combinations should be examined. Hydrogenation
of S1 revealed a range of enantioselectivity from racemic to 93% ee with yields ranging
from no reaction to quantitative (Figure 12). While the large spread in the data looks
promising in terms of scaffold optimization, only a couple catalysts give low
enantioselectivity while the bulk of them give results within a relatively narrow range,
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that is, 68–93% ee. This is not what one would hope to see in a large scale scaffold

Enantiomeric excess (%)

optimization study.
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Figure 12 Hydrogenation of dehydrophenylalanine derivative S1 with BINOL SALs

Figure 13 summarizes the full data set from screening the BINOL-SAL derived catalysts with

S1. Tethers labeled C-G are ArO-linked phosphites, while those labeled I-P are ArOCH2linked phosphites. Catalysts bearing two ArO-linked tethers on the bidentate ligand are
generally not reactive; see Figure 14 upper left quadrant. Interestingly, while these
ArO,ArO-linked scaffolds are not reactive, they are still more selective than the
corresponding monodentate ligands which gave only 69% ee for (BINOL)POPh L5. In

62

contrast, the ArCH2O,ArCH2O-linked scaffolds, that is, prepared from tethers I-P on both
sides, are generally very reactive. The mixed ArO,ArCH2O-linked scaffolds, with one
tether selected from among tethers C-G and the other from among I-P, gave yields that
had a exhibited wide variance from very low to quantitative. Based upon these initial
results, it was decided not to screen the remaining untested pseudoC2-symmetric ligands
(i.e., the diastereomers of the ligands already screened) under the assumption that the box
complex, the element that would differ in the diastereomer, was too far from the site of
reaction and rather highly symmetric; the implication being that it the diastereomeric
series of catalysts simply would behave similarly.
.
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Figure 13 Full data set from BINOL SAL hydrogenation screening of
dehydropheylalanine derivative S1

LEGEND
0-29
30-69
70-89
90-94
95-100

63

2.5 Comparing supramolecular scaffolds with similar ligating groups (BINOL-SALs
vs BIPHEP-SALs)
The chiral backbones of BINOL and BIPHEP are similar, but the question remains,
how does a supramolecular catalyst with a particular scaffold and BINOL ligating groups
compare to that with BIPHEP ligating groups on that same scaffold?32 More specifically,
if a non-selective catalyst with a BIPHEP ligating group is compared to a SAL with
BINOL ligating groups, will their results correlate? Out of the 93 BINOL scaffolds
screened with substrate S1, 39 could be directly compared under the same reaction
conditions to the BIPHEP ligands screened in the previous study. When the data was
sorted according to the ascending enantioselectivity from the BIPHEP SALs, it was very
surprising to find only modest correlation between the two series of catalysts given the
similarity of the ligating groups appended to the identical scaffold (Figure 14).
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Figure 14 Comparison of BIPHEP SALs vs BINOL SALs in the hydrogenation of S1
(sorted by BIPHEP SALs)

Sorting by tether connectivity to the ligating group, a trend was discovered
amongst the data (Figure 15). The ArO,ArO-linked scaffolds (i.e., C-GT, C-GT) exhibited
markedly lower enantioselectivity for BIPHEP-SALs (9-58% ee) than the BINOL-SALs
(68-84% ee). The ArCH2O,ArO scaffolds (I-PT,C-GT) occupied the mid-range of
selectivity within each series: BIPHEP-SALs (35-79% ee); BINOL-SALs (70-90% ee).
ArCH2O,ArCH2O-linked SALs (I-PT, I-PT) were on average the most selective within each
series: BIPHEP-SALs (76-82% ee); BINOL-SALs (83-92% ee).
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Figure 15 Comparison of BIPHEP vs BINOL SALs with respect to benzyl vs phenyl
connectivity to ligating group in the hydrogenation of S1 (sorted by BIPHEP)

The data might be consistent with a measure of catalyst scaffold flexibility. With each
ArCH2O-linked tethers (I-PT), the scaffold has an additional degree of rotational freedom
relative to the corresponding ArO,ArO-linked scaffolds (C-GT, C-GT). The ArO,ArOlinked scaffolds are perhaps too rigid which results in less effective catalysts. As the
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degree of flexibility is increased to the other extreme in this study, that is,
ArCH2O,ArCH2O-linked scaffolds, the extent to which catalyst scaffold optimization
impacts the level of enantioselectivity is generally minimal. These data suggest that the
delicate balance between flexibility and rigidity required for an effective catalyst. Why
this effect is observed more clearly with the BIPHEP-SALs than the BINOL-SALs is not
understood at this point.

2.6 Catalyst scaffold optimization study for enacetamide S2
When a similar screening of catalysts was carried out for the para-chloro
eneacetamide S2, the results spanned a wide range of enantioselectivity, racemic to 96%
ee (Figure 16). The data are arranged from lowest to highest enantioselectivity and colorcoded by tether type (ArCH2O- and/or ArO-linked) in Figure 17. Catalysts comprised of
only ArO-linked tethers (C-GT) afforded a range of selectivity from racemic to 90% ee.
The mixed ArCH2O,ArO-linked tethers (I-PT, C-GT) gave the widest range of
anantioselectivity, ranging from racemic to 96% ee. The ArCH2O,ArCH2O-linked
tethers (I-PT, I-PT) afforded the highest average level of enantiomeric excess and relatively
narrow range of enantioselectivity, 74% to 94% ee.
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Figure 16 Hydrogenation of S2 with BINOL SAL Zn (STRT) series

The full data on yields and enantioselectivity are summarized in Figure 17. The yield
data also show wide variations among the catalysts. In spite of the close similarities
among the catalysts screened, yields range from no reaction to quantitative. Since all
reactions were run under a standard set of reaction conditions for a standard reaction
time, low yields (i.e., low catalyst turnover numbers) may reflect catalyst decomposition
and/or a slow catalyst (i.e., low catalyst turnover frequency). In either case the result is
of significance from the standpoint of catalyst scaffold optimization.
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Figure 17 Full data set from BINOL SAL hydrogenation screening of S2

(BINOL)SAL Zn(IC) was identified as the best scaffold among the supramolecular
catalysts screened giving 96% ee and quantitative conversion for substrate S2. As a side
note, (BINOL)SAL Zn(IC) also gave the highest selectivity for substrate S1 as well. In
order to further assess catalyst efficiency, the screening results were analyzed with
respect by comparing to percent yield against the percent enantiomeric excess. Figure 18
shows the percent yield plotted on the x-axis, and the percent enantiomeric excess on the
y-axis; the values closest to the origin are not reactive and not selective. The ArO,ArOlinked scaffolds are predominantly found in this region. The upper-quadrant represents
catalysts which are both highly reactive and highly enantioselective. This region is
occupied mostly by scaffolds possessing at least one ArCH2O-linked tether.
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Figure 18 Plot of catalyst performance (% ee vs % yield) in the catalyzed asymmetric
hydrogenation of S2 coded by tether combination

Note that some data points in Figure 18 overlap. Surface plots examining the heavily
occupied high yield-high enantioselectivity quadrant of Figure 19 better displays the
number of redundant catalyst results. In a system where catalyst scaffold optimization is
effective, small modifications to the tether structures are expected to affect catalyst
performance. At the time this study was carried out, little thought had been given to how
best to make use of catalyst scaffold optimization. That is, although usage of the term
catalyst scaffold optimization was introduced into the literature by Takacs, others whose
research fit into its description had given little strategic thought as how to productively
apply the concept or even systematically evaluate its application beyond making a series
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of random changes to the scaffold. Based on the study described here, we suggest that if
changing the tethers has little effect on catalyst effectiveness, then the catalyst may be too
flexible and unlikely to be optimized by such a study. In this context, Graph A highlights
the hydrogenation results from scaffolds with ArCH2O,ArCH2O-linkages, while graph B
corresponds to results from mixed scaffolds (i.e., ArCH2O,ArO-linkages) (Figure 19).
These plots reveal that, in general, the extra methylene linkage makes catalysts (in this
case) more effective but less amenable to favorable scaffold optimization; in short,
scaffolds that are too flexible, in this case, behave similarly to having no connected
catalyst scaffold (i.e., similar to catalysts using two monophosphite ligands). Mixed
ArCH2O,ArO-linked scaffolds, which may be intermediate in terms of scaffold
flexibility, give catalysts which exhibit a very broad range of selectivity and reactivity.
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Figure 19 Surface plots highlighting relative abundance of hydrogenation catalysts with
closely-related scaffolds that are selective and efficient. A) Scaffolds with two ArCH2O
tethers. B) Scaffolds with mixed ArO linkage and ArCH2O linkage.
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2.7 Examining the effect of small changes to the most efficient catalyst
(BINOL)SAL Zn(IC) was found to be the best catalyst scaffold in this study, giving
the highest selectivity for both substrates with near quantitative conversion. The catalyst
scaffold contains both an ArO-linked and an ArCH2O-linked tether suggesting the need
for a balance between flexibility and rigidity as discussed in previous sections. In this
section, we drill down through the data to analyze how small changes to this optimal
scaffold affect reactivity and selectivity. Is this a sharply unique optimum where any
subtle change seriously erodes performance, or is this the best among a broad array of
similar structures that differ incrementally in their performance?
The results obtained for several small systematic changes in the structure are
summarized in Figure 20. Overall, the structural changes mostly led to noticeable but
only incremental, changes in performance. For example, when the results obtained for
catalysts wherein the phosphite ligating group on the ArO-linked tether varies from the
ortho- to meta- to para-position, that is, (BINOL)SAL Zn(IE) and (BINOL)SAL Zn(IG)
respectively, the enantioselectivity decreases from 93% to 89% to 88% ee for S1 and
from 96% to 91% to 88% ee for S2; all reactions proceed in high yield under the standard
reaction conditions. Modifying to the biaryl in the (R)-bisoxazoline subunit, that is, from
the meta- to para-linked biaryls as in (BINOL)SAL Zn(ID), affords a catalyst giving
lower enantioselectivity for S1 (86% ee) and both lower enantioselectivity (85% ee) and
yield (76%) for substrate S2. Replacing the ArO-linked phosphite by an ArCH2O-linked
phosphite (i.e., (BINOL)SAL Zn (IK)) or moving the monoaryl ArCH2O-linkage from
meta to para (i.e., (BINOL)SAL Zn(JC)) had surprisingly little impact on the catalyst
efficiency, 90-94% ee and quantitative yield for both substrates.
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Figure 20 Incremental effect of varying the structure of an empirically determined
optimal catalyst scaffold

An interesting question arose at this point during this study. Is the optimum scaffold
identified in this study also optimal for other ligating groups? The corresponding
(BIPHEP)SAL Zn(IC) and (TADDOL)SAL Zn(IC) catalysts were prepared and
evaluated in comparison to (BINOL)SAL Zn(IC) and the corresponding monophosphites
(Figure 21). Remarkably, the structurally similar (BIPHEP)SAL Zn(IC) was a poor
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catalyst giving low reactivity and enantioselectivity. Furthermore, (TADDOL)SAL
Zn(IC) was ineffective as well. Unlike (BINOL)SAL Zn(IC), both analogues were less
efficient than their corresponding monophosphites. With the exception of
(BIPHEP)POPh, BINOL, BIPHEP, and TADDOL monophosphites all gave near
quantitative conversion. This is not to say that another catalyst scaffold could be found
for BIPHEP and TADDOL, we might argue that would indeed be the case. The scaffold
and ligating group are not independent contributors to catalyst efficient; they are
intimately coupled.

Figure 21 Influence of the ligating group on the performance of SAL Scaffold Zn(IC)
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2.8 Influence of the chiral recognition element (BINOL) SAL Zn
If identical achiral substituents are appended to (R)-box and (S)-box, the heterochiral
Zn complex is meso (achiral) as a consequence of inversion symmetry. However, when
the two substituents attached to (R)-box and (S)-box differ and are not enantiomers, the
heterochiral zinc complex lacks a center of inversion and is chiral. For example, a large
optical rotation was observed for the mixed cyano/benzyl complexes.36

Figure 22 Complexation of a chiral pseudo-racemic Zn complex. Reproduced from Ref
36 with permission from the Centre de la Recherche Scientifique (CNRS) and the Royal
Society of Chemistry

A subtle stereochemical feature of the catalysts examined raised the question of how
the chiral recognition subunit impacts catalyst performance, if at all. Of the 169
supramolecular catalysts studied with S2, all with the same (BINOL)PO-ligating group,
13 have two identical tethers ; the remaining 156 are comprised of non-identical tethers.
Consider the two complexes (BINOL)SAL Zn (IC) and (BINOL)SAL Zn(CI) (Figure
23). These scaffolds differ only by the interchange of the two tether subunits appended to
the zinc core. Since the two different tethers have chiral ligating groups of matching
handedness but differ in the configuration of the chiral recognition subunit, the two
ligands (and the derived supramolecular catalyst) are diastereomers. Diastereomeric
catalysts are not required to have similar reactivity and selectivity, but since the
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recognition subunit is located quite far from the site of catalysis, it was not expected that
a large difference in catalyst performance would be observed. Nonetheless, the two
diastereomeric catalysts exhibit a marked difference in enantioselectivity from 96% ee to
87% ee for S2.

Figure 23 Diastereomeric catalysts have different performances

When comparing enantioselectivity achieved via selective diastereomeric reaction
pathways, it is important to consider the logarithmic relationship between enantiomeric
excess and the differences in activation energies leading to (S)- and (R)-products. For
example, comparing the ΔΔGǂ (R/S) values of 96% ee and 87% ee translates to a
difference in enantioselectivity (Δes) of 0. 73 kcal/mol for the diastereomeric
(BINOL)SAL Zn(IC) and (BINOL)SAL Zn(CI) catalysts. It seems quite remarkable that
the bisoxazoline Zn complex, positioned far from the catalytically active site, has such a
significant influence. Since it is believed that H2 association and oxidative addition are
the enantiodetermining steps, it seems reasonable to presume that the catalyst scaffold
folds in such a way that the box complex impedes the approach of H2 for one of the
diastereomers creating a matched/mismatched is relationship between the chiral elements
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% ee

(i.e., recognition subunit and ligating groups) within the catalyst.
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Figure 24 Theoretical relationship between enantioselectivity and ΔΔGǂ

Is difference in performance between the diastereomeric (BINOL)SAL Zn(IC) and
(BINOL)SAL Zn(CI) catalysts typical or an exception? In total, 78 pairs of
diastereomeric catalysts were identified in the screening set and compared for catalytic
efficiency. The tethers were sorted by their composition of ArO-linked and ArCH2Olinked tethers. To simplify the data, the Δes values were plotted unsigned (i.e., their
absolute values) against the observed difference in reactivity (as judged by the yield
obtained under the standard reaction conditions) (Figure 25). As expected, most catalysts
were not strongly influenced from the presence of the chiral box moiety and exhibited
minimal changes in reactivity and/or Δes; see the data points clustered about the origin in
Figure 25. Generally, catalyst pairs that exhibited a substantial difference in
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enantioselectivity also exhibited a large difference in reactivity as well; see the upper and
lower right regions of the plot.

The data in Figure 25 are color-coded by type of linkage to the two ligating groups.
Scaffolds composed of two ArCH2O-linkages, the most flexible catalysts, were impacted
the least from the chiral recognition element. The most rigid scaffolds, that is, those with
only ArO-linkages had a significant number of catalysts that exhibited large differences
in yield under standard reaction conditions. The differences might be attributed to
differing turnover frequency (i.e., reaction rates) and/or turnover numbers and catalyst
deactivation; the data collected cannot distinguish between the two possibilities. The
scaffolds with mixed linkages of one ArO-linked and one ArCH2O-linked phosphite
exhibited the largest influence from the chiral recognition element. This is perhaps not
unexpected as these catalysts were the most receptive to the scaffold optimization.
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Figure 25 Differences in yield and enantioselectivity between 78 pairs of diastereomeric
catalysts in the CAH of S2 with (BINOL)SAL Zn(STRT). Yellow circle points represent
scaffolds with only tethers C-G, the blue squares only I-P, and the green diamonds are for
mixed combinations of C-G and I-P

A few specific examples of matched/mismatched catalytic performances are
highlighted in Table 2 to illustrate the wide range of effects found. Examples were found
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for the scaffolds with mixed tethers C-G and I-P(entries 1-7) and those comprised of
only ArCH2O tethers I-P (entries 8-9) and ArO tethers C-G (10-11). As a representative
of catalysts which had little difference between reactivity or selectivity with the
diastereomeric catalysts, (BINOL)SAL Zn(OG) (entry 1) and its complimentary
diastereomer were both quite effective in the Rh-CAH of S2. (BINOL)SAL Zn(LC)
(entry 3) and (BINOL)SAL Zn(CL) gave similar reactivity but a significant difference in
selectivity. Not all diastereomeric catalysts efficiency comparisons result in changes in
both selectivity and reactivity. (BINOL)SAL Zn(NG) (entry 4) and its diastereomeric
scaffold (BINOL)SAL Zn(GN) both gave high selectivity, yet one diastereomer was less
reactive. There were some striking examples where one diastereomer was quite effective
while the other was unreactive and non-selective (entries 5-7). While most of the flexible
doubly ArCH2O-linked scaffolds showed no influence by the chiral recognition subunit,
several examples were identified where significant differences in selectivity and/or
reactivity were observed (entries 8-9). The more rigid scaffolds containing only ArOlinkages were less selective and reactive as a whole, several examples that were
moderately selective were identified where their diastereomeric partners gave less
effective catalytic performances (entries 10-11).

Table 2 Selected examples where diastereomeric catalysts exhibit matched/mismatched
reactivity and/or selectivity in the CAH of S2.a

Entry
1
2

Zn
( T T)
OG
IC
S R

% yield (% ee)
99 (94)
99 (96)

Zn
( T T)
GO
CI
S R

yield (% ee)
99 (93)
99 (87)

Δes (kcal/mol)
0.09
0.73
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3
4
5
6
7
8
9
10
11
a

LC
NG
LD
FP
JF
KL
KM
EG
EC

99 (94)
99 (90)
96 (92)
85 (90)
98 (92)
94 (94)
87 (92)
99 (84)
94 (84)

CL
GN
DL
PF
FJ
LK
MK
GE
CE

93 (86)
58 (90)
23 (0)
nr
10 (37)
99 (86)
99 (74)
28 (68)
85 (75)

0.53
0
1.88
1.42
0.58
0.55
0.46
0.29

All examples gave predominantly the (S) enantiomer

To further illustrate the importance of the chiral recognition element, the bisoxazoline
zinc complex was eliminated and replaced with a relatively unstructured straight chain
alkyl linker. This approach was effective for Reetz and co-workers when used for the
screening of simple to prepare bidentate ligands for the Rh-CAH of a series of prochiral
substrates.43 In their report, reactivity and selectivity was affected varying the chain
length between the two ligating groups. In our case, the bidentate ligands were prepared
from 1,n-diols (Table 3). While reactivity for the ligands was generally high, selectivity
varied wildly for S1 and S2. The 1,4-butane diol derived bisphosphite was slightly more
selective in the CAH than the monodentate ligands L5 or L6 for S1, but nowhere near as
selective as (BINOL)SAL Zn(IC); the tether structure is important.
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Table 3 Alkyl chain linked phosphites in the Rh-CAH of S1 and S2

S1
Entry
1
2
3
4

Bidentate ligand
L7
L8
L9
L10

ee (%)
20
87
71
13

yield (%)
99
99
99
90

S2
ee (%)
26
68
64
53

yield (%)
93
90
87
99

2.9 Characterization of Rh[BINOL(SAL) Zn(IC)](nbd)]BF4
A question that often arises is whether these supramolecular catalysts are (in all cases)
monomeric or perhaps di- or oligomeric in these reactions (Figure 26). The “in all cases”
variant is of course not possible to answer definitively. The first approach we tried,
attempts to grow a crystal of Rh[(BINOL)SAL Zn(IC)(nbd)]BF4 suitable for X-ray
analysis, were unsuccessful.
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Figure 26 Catalytic species possible in solution for (BINOL)SAL Zn(STRT)

Another common technique used to characterize bidentate ligands is NMR. By
comparing literature values for P-Rh-P coupling constants, the catalyst structure can be
inferred. The flexible nature of these supramolecular catalysts increases the difficulty in
obtaining reliable structural information via NMR. Dr. Shin Moteki was able to
characterize a related (TADDOL)SAL bound to rhodium(I) with a triflate counterion.44
The data was consistent for cis-chelation of the bidentate ligant to rhodium. Rhodium
complexes with biaryl-type phosphorus based ligands often have more complicated
spectra from a reversible dimerization process wherein η-arene coordinated dirhodium
complexes may be formed. These interactions have been well characterized in Rh-
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BINOL phosphinite45 and Rh-BINAP complexes.46 η6-Arene coordinated rhodium
complexes to the related diphenylphosphine ligands have also been observed in Rh-dppe
complexes.47 When 2 equivalents of (BINOL)POBn or (BINOL)POPh were added to 1
equivalent of Rh(nbd)2BF4 in CDCl3, 2 sets of doublets corresponding to the bidentate
rhodium complex and the η-arene coordinated dirhodium complex (Figure 27). The
upfield doublet corresponds to the η-arene complex; addition of MeOH disrupts the picomplexation and results in only the downfield doublet remaining.
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Figure 27 31P NMR study showing dynamic behavior of BINOL phosphite-Rh
complexes.
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(BINOL)SAL Zn(IC) gives two singlets in the 31P for two chemically distinct
phosphite ligands (Figure 28). However, upon addition of Rh(nbd)2BF4, a broad peak
was formed. Lowering the temperature to slow dynamic behavior in the catalyst did not
resolve the broad peak. The addition of MeOH or substrates S1 or S2 did not help either.

Figure 28 31P NMR of (BINOL)SAL Zn(IC)

High-resolution mass spectrometry is another common technique for obtaining
structural information. However, methods such as fast atom bombardment (FAB) or the
more mild matrix-assisted laser desorption/ionization (MALDI) technique were
unsuccessful in characterizing the (BINOL)SAL scaffold; a parent ion was not found. It
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is not uncommon to have difficulty in characterization of an effective catalyst. Catalysts
may owe their efficiency due to their relative instability of their chemical intermediates.
Joost Reek and co-workers recently reported the stability of a catalytic intermediate in the
Pd-catalyzed allylic alkylation reaction had an inverse relationship to reactivity of the
catalyst.48 That is, ineffective catalysts were more easily characterized from their added
stability, while effective catalysts were difficult to detect.

Yet another technique of structural characterization typically used for polymers is gelpermeation chromatography (GPC). This technique uses a size-exclusion matrix to
differentiate different sizes (i.e., the hydrodynamic radius of the structure) of molecules
in solution (Figure 29). The differentiation occurs as smaller molecules penetrate the
stationary porous phase which slows their elution time from the column. Larger
molecules not able to pass into and then through the stationary phase will elute more
quickly since they have fewer interactions inside the column. This technique is
commonly applied to polymers where polystyrene standards of large molecular weights
can be used to determine the relative size of a synthesized polymer.
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Figure 29 In size exclusion chromatography, smaller molecules spend more time
interacting with the porous column, while larger molecules are able to pass through more
quickly.

It should be possible to get some structural information if the retention times vary as a
function of structural changes in going subunit to SAL to supramolecular catalyst.
Ligands before and after zinc and rhodium addition were injected on a GPC column (4.6
mm Jordi Gel DVB (cross-lined divinylbenzene stationary phase) column, Pore size 100
Å, CHCl3 as the eluent). No significant change was observed upon addition of zinc to the
tethers (Table 4, entries 1-3). The lack of a change in retention time is likely a result of
the structural change not being significant enough to have the retention time effected.
However, upon addition of rhodium, the complex exhibited a longer retention time (Table
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4, entry 4). We interpret this change in the following way; as rhodium chelates to the
bidentate ligand, the structure is made more compact explaining the longer retention time.

Table 4 GPC studies on BINOL catalysts

Entry
1
2
3
4

ligand
BINOL tether I
BINOL tether C
(BINOL)SAL Zn(IC)
[(BINOL)SAL Zn(IC)Rh(nbd)]BF4

Retention
Time (min)
7.5
7.4
7.4
8.1

Conditions: 4.6 mm Jordi Gel DVB column, Pore size 100 Å, flow rate = 0.7 mL/min,
mobile phase (CHCl3)
Scaffolds which bear only one ligating group are monodentate ligands and must form
a dimer upon addition of rhodium. Thus, these catalysts serve as excellent controls for
effectively doubling the size of (BINOL)SAL Zn(IC) catalyst. Because the truncated
ligands only have one large BINOL phosphite, they are smaller than the bidentate
scaffold and thus have longer retention times than the free (BINOL)SAL Zn(IC) scaffold
(Table 5, entries 1 and 3). Upon addition of rhodium, both of the catalysts eluted with
shorter retention times suggesting an increase in the size of the catalyst (Table 5, entries 2
and 4). Since the rhodium-chelated truncated ligands had shorter retention times than
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[(BINOL)SAL Zn(IC)]Rh(nbd)BF4, this result gives some evidence the desired 1:1
catalyst rhodium complex is forming

Table 5 GPC data on truncated BINOL catalysts

Entry
1

ligand
(BINOL)SAL-Zn(I-truncated)

Retention
Time (min)
8.4

2
3

[(BINOL)SAL-Zn(I-truncated)]2Rh(nbd)BF4
(BINOL)SAL-Zn(C-truncated)

7.6
8.2

4

[(BINOL)SAL-Zn(C-truncated)]2Rh(nbd)BF4

6.5

Conditions: 4.6 mm Jordi Gel DVB column, Pore size 100 Å, flow rate = 0.7 mL/min,
mobile phase (CHCl3)
These truncated ligands can also be used as hydrogenation catalysts to compare their
reactivity. The (BINOL)SAL Zn(I-truncated) and (BINOL)POPh are both phenol linked
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phosphites (Table 6, entries 1-2). Their reactivity however is significantly different under
identical reaction conditions which may be a result of the truncated ligand being too
bulky for effective catalysis. The phenol ligating group keeps the bulky substituent
nearby. (BINOL)SAL Zn(C-truncated) and (BINOL)POBn are ArCH2O-linked
phosphites (Table 6, entries 3-4). These two catalysts gave comparable performance to
one another. The bulkiness of the truncated ligand may not be a factor from the increased
degree of freedom in the benzylic linkage to the phosphite. Since neither of the truncated
ligands outperformed the bidentate (BINOL)SAL Zn(IC), this further supports the
catalytically active species to be the bidentate catalyst.

Table 6 Truncated monophosphite ligands do not out perform s(BINOL)SAL Zn(IC)
S1
Entry
1
2
3
4
5c

ligand
BINOL-POPh
(BINOL)SAL-Zn(I-truncated)
BINOL-POBn
(BINOL)SAL-Zn(C-truncated)
(BINOL)SAL Zn(IC)

ee (%)
69
30
82
85
93

yield (%)
99
2
99
99
96

S2
ee (%)
yield (%)
86
99
65
13
92
99
92
99
96
99

Reaction conditons: 1 mol% Rh(nbd)2BF4, 2.1 mol% monophosphite, DCE, rt, 16 h.
Yields and enantioselectivity determined by chiral GC using N-benzyl acetamide as an
internal standard. bUnless otherwise noted, the (S)-enantiomer predominates the reaction.
c
1 mol% of bisphosphite was used.

2.10 Conclusions and future directions
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Structure-activity studies are commonly undertaken to determine which structural
elements are important factors in the success of a catalyst system. Small molecule
catalysts, while often effective, omit some of the key structural features of enzymes due
to their limited chiral space. Supramolecular catalyst systems are being pursued with the
hope to organize the topography around a catalytic pocket and thus more closely mimic
enzyme-like structures. However, much less is known about strategies for optimizing the
performance of supramolecular catalyst systems. Understanding which factors are
important in a supramolecular catalyst will be crucial to design effective enzyme-like
catalysts. Among the more surprising aspects of this study is that the remotely positioned
chiral recognition element can have a significant influence the effectiveness of the
catalyst system in a matched/mismatched relationship with the chiral ligating groups.

Thus far, these supramolecular systems have only explored the hydroboration of
styrenes, hydrogenation of prochiral enamides (present study), and asymmetric allylic
amination. In unpublished work, some striking success has been realized in finding
catalysts that can distinguish between closely related sites for reaction, that is, site
selective catalysts. It is expected that future studies will be directed along these lines
focusing on complex transformations involving substrates with multiple potential sites of
reaction. The post-synthetic modification of natural products is a vastly underdeveloped
aspect of organic synthesis. Enzyme-like supramolecular catalysts hold promise for such
transformations and should complement other approaches. For example, Scott Miller has
reported some small peptide catalysts capable of post-synthetic modifications via a
variety of transformations on polyfunctionized natural products.49-55 However, while the
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use of synthetic peptide catalysts requires their de novo synthesis and are limited to
solvents that promote hydrogen-bonding to preserve catalyst structural integrity, the
bisoxazoline-zinc chiral recognition element exploits combinatorial diversification. Their
utility may in part reflect the fact that their facile self-assembly by chiral discrimination is
reminiscent of a “click” reaction, one that occurs rapidly and in near-quantitative yields.56
As supramolecular catalysis is developed, it is intriguing to think of the possibilities of
substituting zinc for a metal which may participate in redox chemistry. Ruthenium
catalysts have been exploited by McMillan and co-workers for their redox properties and
their compatibility with organocatalysts.57

Not only would substitution of zinc for

ruthenium add another catalytic metal, it would also change the geometry around the
metal from tetrahedral to octahedral. Bonnet, Collin, and Sauvage reported the stepwise
synthesis of an octahedral ruthenium complex with three different substituents.58
Conditions may be found that allow for three complimentary groups, each with a role in
the catalysis, to organize around the ruthenium center giving way to a diverse new family
of self-assembled supramolecular catalysts.

2.11 Experimental
Reactions were carried out in a dry atmosphere (N2). Dichloromethane (DCM),
tetrahydrofuran (THF), and methanol (MeOH) were freshly distilled under the following
conditions: DCM from calcium hydride, THF from sodium metal and benzophenone,
and MeOH from Mg. All synthesized compounds were purified with flash
chromatography with the indicated solvents using EMD Silica Gel 60 Geduran ®. Thin
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layer chromatography analyses were performed on Analtech Silica Gel HLF (0.25 m)
precoated analytical plates and visualized with use of handheld short wavelength UV
light, vanillin stain (ethanol, H2SO4, and vanillin), and Ninhydrin stain (ethanol, acetic
acid, and ninhydrin). All reactions were performed in a chemical fume hood or in a
glovebox with a nitrogen environment. NMR spectra were recorded on either a 400
MHz or a 300 MHz Bruker Advance NMR spectrometer using CHCl3 ( 7.27 ppm),
CDCl3 ( 77.0 ppm), or CH2Cl2 ( 5.30 ppm) for reference. Gas chromatography
analysis was performed with a CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a
temperature program of 140-200 oC at 1 oC/min). Peaks are expressed as m (unresolved
multiplet), q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet). IR spectra
were recorded using an Avatar 360 FT-IR. Optical rotations were measured in solutions,
1.0 g/100 mL CH3Cl unless indicated otherwise, and recorded using an Autopol III
automatic polarimeter. HRMS analyses were performed by the Nebraska Center for
Mass Spectrometry. All phenolic tethers were prepared using procedures described in the
literature.
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Screening protocols and compilation of screening data for SAL hydrogenation
studies
Screening protocol procedures for SAL hydrogenation screening

Chamber A

Chamber B

Supporting Information Figure 1: Hydrogenation chambers used for the hydrogenation
screenings; Chamber A is used for up to 24 small scale screenings, and Chamber B can
be used for up to 72 small scale screenings or can accommodate sixteen 20 mL vials for
large scale vials for screening.

Stock solutions BINOL tether ((S,S)-I) (3.0 mg, 4.0 μmol) in 2.3 mL CH2Cl2 and
BINOL tether ((R,R)-C) (3.4 mg, 4.2 μmol) in 2.2 mL CH2Cl2 were prepared. An aliquot
of each of the tether stock solutions (0.10 mL, .18 mmol SAL) was transferred to a vial
containing three glass beads (added to aid with stirring). A stock solution of ZnEt2 (2.0
μmol/mL in CH2Cl2) was prepared from ZnEt2 (1.0 M in hexanes). Approximately 0.10
mL (.20 μmol ZnEt2) of the freshly prepared ZnEt2 stock solution was added to the
hydrogenation vials and the vials were stirred on an orbital shaker (ca 125
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revolutions/min) over a 30 minute period. The CH2Cl2 was removed under reduced
pressure (ca 30 min) and the catalysts were redissolved in dichloroethane (0.20 mL). A
stock solution of Rh(nbd)2BF4 (3.0 mg, 8.0 μmol) in dichloroethane (4.4 mL) was
prepared and an aliquot of the Rh(nbd)2BF4 stock solution (0.10 mL, .18 μmol Rh) was
added to each vial. The resulting metal-ligand complex was stirred on an orbital shaker
shaker (ca 30 min at 125 revolutions/min.)

A stock solution of N-(1-(4-

chlorophenyl)vinyl)acetamide (3.6 x 101 mg, 0.18 mmol) in dichloroethane (1.0 mL) was
prepared and an aliquot (0.10 mL, 1.8 x 10-2 mmol) was added to each reaction vial. The
vials were loaded into the hydrogenation chamber. The chamber was purged with H 2 (5
X 30 psi). The chamber was charged with H2 (30 psi) and lightly shaken (ca 125
revolutions/min) at ambient temperature for 16 h, at which point the hydrogen pressure
was released. A stock solution of an internal standard, N-benzyl acetamide, was prepared
(82 mg in 3.0 mL ethyl acetate). An aliquot (0.10 mL, 1.8 x 10-2 mmol) was added to
each of the reaction vials. The organics were filtered through a small plug of silica gel.
Ethyl acetate (1 mL) was used to rinse the vial and silica plug. An additional wash (ethyl
acetate, 0.5 mL) was used to rinse the silica plug. Combined organics were then analyzed
via gas chromatography CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a
temperature program of 140-200oC at 1 oC/min). The (S)-enantiomer eluted at 22.2 min
(97.9%) and the (R)-enantiomer at 23.2 min (2.1%); []D = -154 (c = 0.5, EtOH); 1H
NMR (400 MHz, CDCl3)  7.33-7.25 (4H, m), 5.76 (1H, bs), 5.11 (1H, m), 2.00 (3H, s),
1.48 (3H, d, J = 6.9 Hz); 13C NMR (100 MHz)  169.11, 141.79, 133.06, 128.77, 127.58,
48.20, 23.41, 21.69
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Compilation of p-Cl screening with self-assembling ligands (SALs) with p-Cl
eneacetamide

97
(R,R)-Bisoxazoline linked tethers
C
D

(S,S)-Bisoxazoline linked tethers

E
F
G
I
J
K
L
M
N
O
P

ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)

C

D

E

F

G

I

J

K

L

M

N

O

P

57
16
69
35
84
94
82
32
60
22
96
100
94
100
94
100
94
100
70
43
91
100
70
100
93
100

65
37
67
13
64
14
90
10
60
3
85
76
92
100
86
79
92
100
0
0
78
34
20
33
40
80

75
85
68
93
80
100
0
0
68
28
91
100
91
100
86
100
91
100
89
100
89
100
87
100
91
100

80
70
22
11
27
9
70
12
68
16
80
56
92
98
57
19
87
67
87
14
87
52
82
39
90
85

65
63
0
0
84
100
0
0
67
95
89
100
90
100
87
100
92
100
88
100
90
100
93
100
91
100

87
100
77
11
87
100
92
92
86
30
87
100
92
100
90
100
90
100
88
100
92
100
94
100
91
100

92
100
80
74
90
100
37
10
85
96
91
100
91
100
91
100
92
100
92
100
93
100
93
100
93
100

93
100
88
23
92
100
83
24
85
90
93
100
93
100
91
100
94
94
87
92
92
100
89
88
94
100

86
93
0
23
65
85
0
0
85
73
92
100
91
100
86
100
88
100
80
100
87
100
87
58
89
100

80
53
0
0
90
100
0
0
82
88
88
100
90
100
74
100
88
100
91
100
84
100
89
78
92
63

93
100
0
0
86
100
86
20
90
58
90
100
91
100
88
100
90
100
86
75
89
100
90
100
93
100

89
73
87
11
92
100
86
25
94
100
92
100
92
100
90
100
92
100
91
100
91
100
93
100
94
100

94
97
0
0
92
100
0
0
92
100
93
100
87
100
91
100
93
100
94
100
93
100
94
100
94
100

Phenol-linked tethers are C-G.
Benzyl-linked tethers are I-P.

LEGEND
0-29
30-69
70-89
90-94
95-100
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Compilation of Diastereomeric data

Legend
Yellow = phenol tethers = C-G
Blue = benzylic tethers = I-P
Green = mixed benzyl-phenol tethers (C-G) + (I-P)
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Diastereomeric SALs Set A
(S,S) (R,R)
%ee
Entry Tether Tether product XS1
1
C
D
65
2
C
E
75
3
C
F
80
4
C
G
65
5
D
E
68
6
D
F
22
7
D
G
0
8
E
F
27
9
E
G
84
10
F
G
0
11
I
J
91
12
I
K
93
13
I
L
92
14
I
M
88
15
I
N
90
16
I
O
92
17
I
P
93
18
J
K
93
19
J
L
91
20
J
M
90
21
J
N
91
22
J
O
92
23
J
P
87
24
K
L
86
25
K
M
74
26
K
N
88
27
K
O
90
28
K
P
91
29
L
M
88
30
L
N
90
31
L
O
92
32
L
P
93
33
M
N
86
34
M
O
91
35
M
P
94
36
N
O
91
37
N
P
93
38
O
P
94
39
I
C
96
40
I
D
85
41
I
E
91
42
I
F
80
43
I
G
89
44
J
C
94
45
J
D
92
46
J
E
91
47
J
F
92
48
J
G
90
49
C
K
93
50
C
L
86
51
C
M
80
52
C
N
93
53
C
O
89
54
C
P
94
55
K
D
86
56
K
E
86
57
K
F
57
58
K
G
87
59
D
L
0
60
D
M
0
61
D
N
0
62
D
O
87
63
D
P
0
64
L
E
91
65
L
F
87
66
L
G
92
67
E
M
90
68
E
N
86
69
E
O
92
70
E
P
92
71
M
F
87
72
M
G
88
73
F
N
86
74
F
O
86
75
F
P
0
76
N
G
90
77
G
O
94
78
G
P
92

Diastereomeric SALs Set B
DDG‡

%R
17.5
12.5
10
17.5
16
39
50
36.5
8
50
4.5
3.5
4
6
5
4
3.5
3.5
4.5
5
4.5
4
6.5
7
13
6
5
4.5
6
5
4
3.5
7
4.5
3
4.5
3.5
3
2
7.5
4.5
10
5.5
3
4
4.5
4
5
3.5
7
10
3.5
5.5
3
7
7
21.5
6.5
50
50
50
6.5
50
4.5
6.5
4
5
7
4
4
6.5
6
7
7
50
5
3
4

(S,S) (R,R)
%ee
%S (kcal/mol) Yield (%) Tether Tether product XS1
82.5
-0.92
37
D
C
69
87.5
-1.15
85
E
C
84
90
-1.30
70
F
C
82
82.5
-0.92
63
G
C
60
84
-0.98
93
E
D
64
61
-0.26
11
F
D
90
50
0.00
0
G
D
60
63.5
-0.33
9
F
E
0
92
-1.45
100
G
E
68
50
0.00
0
G
F
68
95.5
-1.81
100
J
I
92
96.5
-1.96
100
K
I
90
96
-1.88
100
L
I
90
94
-1.63
100
M
I
88
95
-1.74
100
N
I
92
96
-1.88
100
O
I
94
96.5
-1.96
100
P
I
91
96.5
-1.96
100
K
J
91
95.5
-1.81
100
L
J
92
95
-1.74
100
M
J
92
95.5
-1.81
100
N
J
93
96
-1.88
100
O
J
93
93.5
-1.58
100
P
J
93
93
-1.53
100
L
K
94
87
-1.13
100
M
K
87
94
-1.63
100
N
K
92
95
-1.74
100
O
K
89
95.5
-1.81
100
P
K
94
94
-1.63
100
M
L
80
95
-1.74
100
N
L
87
96
-1.88
100
O
L
87
96.5
-1.96
100
P
L
89
93
-1.53
75
N
M
84
95.5
-1.81
100
O
M
89
97
-2.06
100
P
M
92
95.5
-1.81
100
O
N
90
96.5
-1.96
100
P
N
93
97
-2.06
100
P
O
94
98
-2.31
100
C
I
87
92.5
-1.49
76
D
I
77
95.5
-1.81
100
E
I
87
90
-1.30
56
F
I
92
94.5
-1.68
100
G
I
86
97
-2.06
100
C
J
92
96
-1.88
100
D
J
80
95.5
-1.81
100
E
J
90
96
-1.88
98
F
J
37
95
-1.74
100
G
J
85
96.5
-1.96
100
K
C
94
93
-1.53
93
L
C
94
90
-1.30
53
M
C
70
96.5
-1.96
100
N
C
91
94.5
-1.68
73
O
C
70
97
-2.06
97
P
C
93
93
-1.53
79
D
K
88
93
-1.53
100
E
K
92
78.5
-0.77
19
F
K
83
93.5
-1.58
100
G
K
85
50
0.00
23
L
D
92
50
0.00
0
M
D
0
50
0.00
0
N
D
78
93.5
-1.58
11
O
D
20
50
0.00
0
P
D
40
95.5
-1.81
100
E
L
65
93.5
-1.58
67
F
L
0
96
-1.88
100
G
L
85
95
-1.74
100
M
E
89
93
-1.53
100
N
E
89
96
-1.88
100
O
E
87
96
-1.88
100
P
E
91
93.5
-1.58
14
F
M
0
94
-1.63
100
G
M
82
93
-1.53
20
N
F
87
93
-1.53
25
O
F
82
50
0.00
0
P
F
90
95
-1.74
100
G
N
90
97
-2.06
100
O
G
93
96
-1.88
100
P
G
91

DDG‡
%R
15.5
8
9
20
18
5
20
50
16
16
4
5
5
6
4
3
4.5
4.5
4
4
3.5
3.5
3.5
3
6.5
4
5.5
3
10
6.5
6.5
5.5
8
5.5
4
5
3.5
3
6.5
11.5
6.5
4
7
4
10
5
31.5
7.5
3
3
15
4.5
15
3.5
6
4
8.5
7.5
4
50
11
40
30
17.5
50
7.5
5.5
5.5
6.5
4.5
50
9
6.5
9
5
5
3.5
4.5

%S (kcal/mol) Yield (%)
84.5
-1.00
35
92
-1.45
94
91
-1.37
32
80
-0.82
22
82
-0.90
14
95
-1.74
10
80
-0.82
3
50
0.00
0
84
-0.98
28
84
-0.98
16
96
-1.88
100
95
-1.74
100
95
-1.74
100
94
-1.63
100
96
-1.88
100
97
-2.06
100
95.5
-1.81
100
95.5
-1.81
100
96
-1.88
100
96
-1.88
100
96.5
-1.96
100
96.5
-1.96
100
96.5
-1.96
100
97
-2.06
94
93.5
-1.58
92
96
-1.88
100
94.5
-1.68
88
97
-2.06
100
90
-1.30
100
93.5
-1.58
100
93.5
-1.58
58
94.5
-1.68
100
92
-1.45
100
94.5
-1.68
78
96
-1.88
63
95
-1.74
100
96.5
-1.96
100
97
-2.06
100
93.5
-1.58
100
88.5
-1.21
11
93.5
-1.58
100
96
-1.88
92
93
-1.53
30
96
-1.88
100
90
-1.30
74
95
-1.74
100
68.5
-0.46
10
92.5
-1.49
96
97
-2.06
100
97
-2.06
100
85
-1.03
43
95.5
-1.81
100
85
-1.03
100
96.5
-1.96
100
94
-1.63
23
96
-1.88
100
91.5
-1.41
24
92.5
-1.49
90
96
-1.88
100
50
0.00
0
89
-1.24
34
60
-0.24
33
70
-0.50
80
82.5
-0.92
85
50
0.00
0
92.5
-1.49
73
94.5
-1.68
100
94.5
-1.68
100
93.5
-1.58
100
95.5
-1.81
100
50
0.00
0
91
-1.37
88
93.5
-1.58
52
91
-1.37
39
95
-1.74
85
95
-1.74
58
96.5
-1.96
100
95.5
-1.81
100

‡

D(DDG )
Abs D(DDG‡)
Set A - Set B D es (kcal/mol) D (% Yield)
0.09
0.09
2
0.29
0.29
-9
0.07
0.07
38
-0.10
0.10
41
-0.08
0.08
79
1.48
1.48
1
0.82
0.82
-3
-0.33
0.33
9
-0.46
0.46
72
0.98
0.98
-16
0.07
0.07
0
-0.22
0.22
0
-0.14
0.14
0
0.00
0.00
0
0.14
0.14
0
0.18
0.18
0
-0.16
0.16
0
-0.16
0.16
0
0.07
0.07
0
0.14
0.14
0
0.16
0.16
0
0.08
0.08
0
0.39
0.39
0
0.53
0.53
6
0.45
0.45
8
0.25
0.25
0
-0.06
0.06
12
0.25
0.25
0
-0.33
0.33
0
-0.16
0.16
0
-0.30
0.30
42
-0.28
0.28
0
-0.09
0.09
-25
-0.13
0.13
22
-0.18
0.18
37
-0.07
0.07
0
0.00
0.00
0
0.00
0.00
0
-0.73
0.73
0
-0.28
0.28
65
-0.23
0.23
0
0.58
0.58
-36
-0.15
0.15
70
-0.18
0.18
0
-0.58
0.58
26
-0.07
0.07
0
-1.42
1.42
88
-0.26
0.26
4
0.09
0.09
0
0.53
0.53
-7
-0.27
0.27
10
-0.16
0.16
0
-0.66
0.66
-27
-0.09
0.09
-3
0.10
0.10
56
0.35
0.35
0
0.64
0.64
-5
-0.09
0.09
10
1.88
1.88
-77
0.00
0.00
0
1.24
1.24
-34
-1.34
1.34
-22
0.50
0.50
-80
-0.89
0.89
15
-1.58
1.58
67
-0.39
0.39
27
-0.06
0.06
0
0.15
0.15
0
-0.30
0.30
0
-0.07
0.07
0
-1.58
1.58
14
-0.26
0.26
12
0.05
0.05
-32
-0.16
0.16
-14
1.74
1.74
-85
0.00
0.00
42
-0.09
0.09
0
-0.07
0.07
0

100

(R,R)-Bisoxazoline linked tethers
C

(S,S)-Bisoxazoline linked tethers

D
E
F
G
I
J
K
L
M
N
O
P

ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)
ee (%)
yield (%)

C

D

E

F

G

73
2

68
6
74
9

80
8
86
36
89
38

84
11
75
5
84
5
85
13

72
2
0
0
92
96
85
4
0
0
88
100
89
100
91
100
90
100
91
100
90
7

93
96
91
100

86
100
87
85
90
95

89
100
91
100
88
100
89
92

88
100
88
70
83
7
88
54
70
5

I

87
100

J

89
100
90
100

K

L

M

N

O

P

89
100

86
21
82
48

88
24
88
17
92
73

83
7
86
3
85
95
86
11

80
5
86
2
90
100
84
7
93
18
89
100
91
100
88
100
91
100
88
100
86
7
92
10

77
4
87
3
89
100
88
6
80
30
88
93
89
100
86
100
86
100
84
20
84
30
83
36
83
50

90
100
91
100
91
100

87
100
88
100
87
90
89
100

89
80
91
100
80
16
88
27
86
100

87
100
89
100
87
100
88
100
86
89
84
16

LEGEND

Screening protocol procedures scale-up reaction
The following procedure is typical. To a solution of BINOL tether ((S,S)-I) (3.7 mg, 5.1
μmol) and BINOL tether ((R,R)-C) (3.8 mg, 5.1 μmol) in dicloromethane (DCM, 1.0 mL)
was added a solution of diethyl zinc (0.10 mL, 5.6 μmol) dropwise and 3 2 mm glass
beads. The resulting mixture was stirred on an orbital shaker (ca 125 revolutions/min)
for 30 minutes and then concentrated in vacuo to afford (BINOL)SAL Zn(IC) which was
diluted with dichloroethane (DCE, 2.0 mL) and used without further purification. A
solution of Rh(nbd)2BF4 (1.9 mg, 5.1 μmol) in DCM (0.20 mL) was added dropwise and

0-29
30-69
70-89
90-94
95-100
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the resulting mixture was stirred for 30 minutes at ambient temperature under N2. A
solution of N-(1-(4-chlorophenyl)vinyl)acetamide (1.0 x 102 mg, 5.1 x 102 mmol) in DCE
was then added and the vial was placed into a hydrogenated chamber. The chamber was
purged with hydrogen gas (5 x 20 psi) and then pressurized to 30 psi H2 and lightly
shaken (ca 125 revolutions/minute) at ambient temperature for 16 hours. The hydrogen
pressure was released, and the crude reaction mixture was concentrated and purified by
flash chromatography on silica gel using EtOAc/Hexanes (1:5) as the eluent yielding (S)N-(1-(4-chlorophenyl)ethyl)acetamide (98% yield) as a white solid: gas chromatography
on a CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a temperature program of 140200oC at 1oC/min) show 95% ee; []D = -152 (c = 0.5, EtOH)[The configurations were
assigned from comparing optical rotations with the reported values]; 1H NMR (400 MHz,
CDCl3)  7.33-7.25 (4H, m), 5.76 (1H, bs), 5.11 (1H, m), 2.00 (3H, s), 1.48 (3H, d, J =
6.92 Hz); 13C NMR (100 MHz)  169.11, 141.79, 133.06, 128.77, 127.58, 48.20, 23.41,
21.69.
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Synthesis of key compounds
Synthetic route for S2-BINOL

Preparation of IX

To 1,3-benzene dimethanol (10.0 g, 72.4 mmol) and imidazole (19.7 g, 289 mmol) was
added DMF (150 mL) under N2. The reaction mixture was stirred (15 minutes) at room
temperature then cooled (0oC) and TBDPS-Cl (21.4 mL, 72.4 mmol) was added dropwise
over 5 minutes. The reaction mixture was allowed to warm to room temperature
overnight. NaHCO3 (satd.) was added (100 mL) and the mixture was extracted with
diethyl ether (3 x 100 mL). The organic extracts were combined, dried with magnesium
sulfate, filtered, and concentrated. Flash chromatography on silica gel (25:75 ethyl
acetate:hexanes) affords IX (19.7 g, 72.3 %) as a white solid. TLC: Rf 0.30 (25:75 ethyl
acetate:hexanes); 1H NMR (400 MHz, d-CHCl3)  7.81-7.78 (4H, m), 7.53-7.32 (10H,
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m), 4.87 (1H, s), 4.71 (1H, s), 2.10 (1H, s), 1.20 (9H, s); 13C NMR (100 MHz, d-CHCl3)
 141.44, 140.88, 135.68, 133.52, 129.82, 128.58, 127.83, 125.64, 125.41, 124.70, 65.52,
65.38, 26.95, 19.41 IR (neat) 3330, 3064, 2856, 1600-1500, 1107 cm-1; HRMS (ESI):
Calcd. For C24H28O2Si (M+Na)+: 399.1756, found 399.1769 m/z.

Preparation of X

IX (10.0 g, 26.7 mmol) and PPh3 (6.98g, 26.7 mmol) was dissolved in THF (150 mL) ,
stirred (15 minutes), then cooled (0oC). A solution of CBr4 (8.81 g, 26.7 mmol) in THF
(15 mL) was added dropwise. The reaction mixture was allowed to warm to room
temperature overnight (16 h). The precipitate was removed by filtration through celite,
washed with THF (2 x 50 mL), and the combined organic washes were concentrated.
Flash chromatography on silica gel (5:95 ethyl acetate:hexanes) affords X (8.90 g, 76%)
as a colorless oil. TLC: Rf 0.70 (5:95 ethyl acetate:hexanes); 1H NMR (400 MHz, dCHCl3)  7.87-7.85 (4H, m), 7.58-7.38 (10H, m), 4.92 (2H, s), 4.60 (2H, s), 1.27 (9H, s);
C NMR (100 MHz, d-CHCl3)  141.88, 137.80, 135.73, 133.48, 129.93, 128.86,
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127.94, 127.71, 126.820, 126.23, 65.35, 33.85, 27.04, 19.49; IR (neat) 2958, 2852, 1103,
1070 cm-1; HRMS (ESI): Calcd. For C24H27OSiBr (M+H): 461.0912, found 461.0912
m/z.
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Preparation of (S,S)-XI

To a cooled solution (-78oC) of (S,S)-bisoxazoline [(S)-BOX] (5.0 g, 16.3 mmol) in THF
(150 mL), NaHMDS (1M in THF, 17.1 mL) was added dropwise over the course of 1 h,
and stirred at -78oC for 2 hours. A solution of X (7.17g, 16.3 mmol) in THF (15 mL) was
added dropwise to the reaction mixture and slowly allowed to warm to room temperature
overnight. The reaction was quenched with the addition of NH4Cl (satd) and extracted
with CH2Cl2 (3 x 100 mL). The combined organic extracts were dried with MgSO4,
filtered, and concentrated. Flash chromatography on silica gel (33:33:33 ethyl acetate:
hexanes: CH2Cl2) afforded (S,S)-XI (6.94 g, 64%) as a light yellow oil. TLC: Rf 0.85
(6:94 methanol:dichloromethane); Optical rotation: []D20 = -17.1o (c 0.5, CH3Cl); 1H
NMR (400 MHz, d-CHCl3)  7.80-7.78 (4H, m), 7.52-7.27 (18H, m), 7.05-7.03 (2H, m),
5.28 (2H, t, J = 8.52 Hz), 4.85 (2H, s), 4.72 and 4.71 (2H, overlapping t, J = 8.12, 8.12
Hz), 4.24-4.21 (1H, m), 4.20-4.11 (2H, m), 3.60-3.48 (2H, m), 1.21 (9H, s) ppm; 13C
NMR (100 MHz, d-CHCl3)  165.55, 165.52, 142.18, 142.13, 141.47, 137.99, 135.66,
135.55, 129.81, 128.80, 128.76, 128.70, 128.66, 127.84, 127.78, 127.65, 127.55, 126.87,
126.74, 126.70, 126.52, 124.52, 41.51, 36.02, 26.99, 19.43 ppm.; IR (neat) 2951, 2849,
1653, 1108, 1067 cm-1; HRMS (ESI): Calcd. For C43H44N2O3Si (M+Na): 665.3199,
found 665.3208 m/z.
Preparation of (S,S)-XII
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To a solution of (S,S)-XI (6.90 g, 10.4 mmol) in THF (100 mL) was added dropwise
TBAF (1.0M in THF, 10.4 mL). The solution was stirred at room temperature for 16 h.
Water (35 mL) was added and the mixture was extracted with CH2Cl2 (3 x 60 mL). The
combined organic extracts were dried (MgSO4), filtered, and concentrated. Flash
chromatography on silica gel (7:93 methanol:CH2Cl2) affords (S,S)-XII (3.91 g, 88%) as
a sticky white foam. TLC: Rf 0.4 (6:94 methanol:dichloromethane); Optical rotation:
[]D20 = -21.6o (c 0.5, CH3Cl); 1H NMR (400 MHz, d-CHCl3)  7.35-7.21 (10H, m),
7.23-7.21 (2H, m), 7.01-6.99 (2H, m), 5.21 and 5.19 (2H, overlapping t, J =8.40, 7.92
Hz), 4.71-4.63 (4H, m), 4.18 (1H, t, J = 8.24 Hz), 4.11-4.04 (2H, m), 3.48-3.39 (2H, m);
C NMR (100 MHz, d-CHCl3)  165.52, 165.50, 141.93, 141.87, 139.71, 137.09,
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129.25, 128.71, 128.63, 127.65, 127.58, 127.23, 126.69, 126.68, 75.43, 75.23, 69.49,
64.80, 41.41, 35.53; IR (neat) 3243, 1658, 1555-1148, 1019 cm-1; HRMS (ESI): Calcd.
For C27H26N2O3 (M+H): 449.1841, found 449.1833 m/z.

Preparation of BINOL tether (S,S)-5I and BINOL tether (R,R)-5C

PCl3 (3.66 mL, 41.9 mmol) was added dropwise to (R)-BINOL (500 mg, 1.75 mmol) at
room temperature, followed by the dropwise addition of a catalytic amount of N-methyl
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pyrrolidine (4 drops). The reaction mixture was heated to 74oC for 1.0 h. (Careful
monitoring of the temperature was done to ensure no racemization). The crude reaction
mixture was concentrated. Toluene was added (3x20 mL) and subsequently removed
under reduced pressure to remove excess PCl3 affording BINOL-PCl without further
purification. The freshly prepared BINOL-PCl was dissolved in THF(10 mL) and added
to a solution of (S,S)-XII (596 mg, 1.40 mmol), catalytic DMAP (8.53 mg, 6.99 x 10-2
mmol), and TEA (2.42 mL, 17.5 mmol) in THF (15 mL). The reaction mixture was
stirred overnight at room temperature. The crude mixture was filtered through celite, and
the precipitate was washed with THF (3 x 5 mL). The filtrate was concentrated, and flash
chromatography on silica gel (33:33:33 ethyl acetate: dichloromethane: hexanes) affords
(S,S)-5I (758 mg, 73%) as a white foam. Optical rotation: []D20 = -164o (c 0.5, CH3Cl);
1

H NMR (400 MHz, d-CHCl3)  7.91-7.81 (4H, m), 7.44-7.08 (20 H, m), 6.90-6.88 (2H,

m), 5.12 and 5.10 (2H, overlapping t, J = 10.1 Hz and 9.92 Hz), 4.87 and 4.62 (2H, ddd,
J1 = 7.72, 12.32 Hz, J2 = 7.92, 12.32 Hz), 4.59-4.54 (2H, m), 4.06 (1H, t, J = 8.16 Hz),
3.99-3.91 (2H, m), 3.36 and 3.30 (2H, ddd, J1 = 7.80, 13.9 Hz, J2 = 8.56, 13.89 Hz); 13C
NMR (100 MHz, d-CHCl3)  165.34 (JC,P = 8.44 Hz), 153.91, 148.82, 147.45, 141.98
(JC,P = 5.82 Hz), 138.23, 137.83, 133.34, 132.91, 132.83, 131.82, 131.63, 131.32,
130.46, 130.18, 128.81, 128. 73, 128.68, 128.63, 128.39, 128.26, 127.57, 127.51, 127.01,
126.66, 126.62, 126.29, 125.93, 125.09, 124.93,122.78, 121.88, 121.56, 117.90, 75.36,
75.14, 69.60, 69.58, 66.82, 62.34, 41.41, 35.78; 31P NMR (162 MHz, d-CHCl3)  139.0
ppm ; IR (neat) 3040, 1653, 1589-1328, 1021, 939 cm-1; HRMS (ESI): Calcd. For
C47H37N2O5P (M+H): 741.2513, found 741.2540 m/z.
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(R,R)-5C was prepared in the same manner starting with (R,R)-XIII (702 mg, 1.40
mmol) affording (R,R)-5C (879 mg, 78%) as a white foam. Optical rotation: []D20 = 78o (c 0.5, CH3Cl); 1H NMR 7.95-7.49 (4H, m),  7.47-7.02 (26 H, m), 5.19 and 5.17
(2H, overlapping t, J = 10.5, 10.4 Hz), 4.67-4.58 (2H, m), 4.14-4.04 (3H, m), 3.52-3.49
(2H, m);

C NMR (100 MHz, d-CHCl3)  165.52 (JC,P = 11.04 Hz), 152.94, 148.77,
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148.66, 147.72, 147.66, 147.00, 142.00, 138.03, 137.86, 133.90, 133.85, 133.62, 132.80,
132.46, 131.62, 131.37, 131.19, 130.99, 130.54, 130.41, 130.12, 129.87, 129.35, 128.64,
128.54, 128.41, 128.37, 128.34, 128.13, 127.53, 127.49, 127.25, 127.06, 126.93, 126.68,
126.65, 126.56, 126.47, 126.32, 126.11, 124.93, 124.70, 124.42, 123.82, 122.64, 121.78,
121.68, 121.13, 120.99, 118.14, 74.26 (JC,P = 17.9 Hz), 69.57, 41.33, 35.89; 31P NMR
(162 MHz, d-CHCl3)  144.8 ppm; IR (neat) 3028, 1646, 1585-1348, 1197, 956 cm-1;
HRMS (ESI): Calcd. For C52H39N2O5 (M+H): 803.2675, found 803.2709 m/z.

Characterization of (BINOL)SAL Zn(IC)
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Optical rotation: []D20 = -92° (c 0.5, CH3Cl); 1H NMR  8.00-7.89 (9H, m), 7.56-6.96
(47 H, m), 5.10-5.05 (1H, m), 4.87-4.82 (1H, m), 4.05-3.96 (4H, m), 3.83-3.78 (6H, m),
3.67 (2H, s), 3.32-3.24 (4H, m);

13

C NMR (100 MHz, d-CHCl3)  169.85, 169.69,

152.91, 148.83, 147.90, 147.23, 145.33, 144.14, 137.14, 130.43, 130.08, 129.92, 128.40,
128.83, 127.94, 127.55, 127.18, 127.06, 126.92, 126.29, 126.21, 124.89, 121.97, 121.91,
121.72, 118.91, 72.92, 65.39; 31P NMR (162 MHz, d-CHCl3)  147.5 and 144.0 ppm; IR
(neat) 3028, 2933, 1646, 1197 cm-1; HRMS (ESI): Calcd. For C99H74N4O10P2Zn (M+H):
1605.4250, found 1605.4299 m/z.

BINOL-OPh (L5)

TLC: Rf = 0.80 (10:90 EtOAc:hexanes); melting point: 95-100 °C (decomposition);
Optical rotation: []D20 = -142.4° (c 0.5, CH3Cl); 1H NMR  8.02-

-

109

7.23 (12H, m); 13C NMR (100 MHz, d-CHCl3)  151.18, 147.22, 147.10, 132.78, 132.47,
131.76, 131.31, 130.61, 129.97, 129.89, 128.46, 128.40, 126.79, 126.69, 126.46, 126.36,
125.32, 125.16, 124.48, 121.64, 120.41, 120.31; 31P NMR (162 MHz, d-CHCl3)  145.1;
IR (neat) 2909, 2894, 1388-1201, 1069 cm-1.

BINOL-POBn (L6)

TLC: Rf = 0.75 (8:92 EtOAc:hexanes); melting point: 125-130 °C (decomposition);
Optical rotation: []D20 = -440° (c 0.5, CH3Cl); 1H NMR  8.08-7.96 (4H, m), 7.61-7.284
(12 H, m), 5.04 and 4.82 (2H, dd, J1 = 12.19 Hz, 8.01 Hz, J2 = 12.19 Hz, 8.31 Hz); 13C
NMR (100 MHz, d-CHCl3)  148.7, 148.6, 147.5, 137.4, 137.3, 132.8, 132.5, 131.6,
131.1, 130.5, 130.2, 128.5, 128.4, 128.4, 128.1, 127.6, 126.7, 126.3, 126.3, 125.1, 125.0,
124.0, 124.0, 122.6, 121.8, 121.8, 121.5, 64.7, 66.7; 31P NMR (162 MHz, d-CHCl3) 
140.8 ppm; IR (neat) 3044, 1589-1319, 939 cm-1.

Preparation of BINOL(n-alkyl series) L4a–L4d
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PCl3 (3.66 mL, 41.9 mmol) was added dropwise to (R)-BINOL (500 mg, 1.75 mmol) at
room temperature followed by the dropwise addition of a catalytic amount of N-methyl
pyrrolidine (4 drops). The reaction mixture was heated to 74oC for 1.0 h. (Careful
monitoring of the temperature was done to ensure no racemization). The crude reaction
mixture was concentrated. Toluene was added (3x20 mL) and subsequently removed
under reduced pressure to remove excess PCl3 affording BINOL-PCl without further
purification. 1,3-propanediol (86.4 mg, , 1.14 mmol) in THF (15 mL) was added TEA
(0.728 mL, 3.41 mmol). The solution was stirred for 15 minutes and the freshly prepared
BINOL-PCl was dissolved in THF (10 mL) and added slowly to the reaction flask at
room temperature. The reaction mixture was stirred overnight at room temperature. The
crude mixture was filtered through celite, and the precipitate was washed with THF (3 x 5
mL). The filtrate was concentrated under reduced pressure. Flash chromatography on
silica gel (5:95 ethyl acetate : hexanes) affords alkyl n3BINOL ligand L7 (419 mg,
52.4%) as a white foam. Melting point: 92-95°C (decomposition); Optical rotation:
[]D20 = -4.6o (c 0.5, CH3Cl); 1H NMR (400 MHz, d-CHCl3)  8.01-7.88 (8H, m), 7.537.27 (16H, m), 4.06 and 3.90 (4H, m), 1.85 (2H, m) ppm; 13C NMR (100 MHz, d-CHCl3)
 148.76 (JC,P = 5.08 Hz), 147.52, 132.85, 132.61, 131.55, 131.02, 130.43, 130.12,
128.39, 128.35, 127.03, 126.29, 126.24, 125.07, 124.90, 122.61, 121.87, 121.56, 61.18
(JC,P = 6.07), 32.21 ppm; 31P NMR (162 MHz, d-CHCl3)  140.42 ppm; IR (neat) 3049,
1589-1319, 927 cm-1; HRMS (ESI): Calcd. For C43H30O6P2(M+H): 705.1596, found
705.1609 m/z.
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n4-alkyl BINOL L8 was prepared according to the general procedure starting with 1,4butane diol (102 mg, 1.14 mmol) affording the product (489 mg, 59.9%) as a white foam.
Melting point: 95-98°C (decomposition); Optical rotation: []D20 = -4.0o (c 0.5, CH3Cl);
1

H NMR (400 MHz, d-CHCl3)  8.03-7.92 (8H, m), 7.57-7.28 (16H, m), 4.01 and 3.81

(4H, m), 1.70 (4H, m) ppm; 13C NMR (100 MHz, d-CHCl3)  148.75 (JC,P = 5.1 Hz),
147.59, 132.87, 132.66, 131.57, 131.03, 130.45, 130.07, 128.41, 128.36, 127.03, 126.30,
126.27, 125.08, 124.92, 124.15, 124.10, 122.73, 122.71, 121.90, 121.59, 64.63 (JC,P =
6.07), 27.30 ppm; 31P NMR (162 MHz, d-CHCl3)  141.06 ppm; IR (neat) 3050, 15921322, 940 cm-1; HRMS (ESI): Calcd. For C44H32O6P2(M+H): 719.1752, found 719.1772
m/z.

n5-alkyl BINOL L9 was prepared according to the general procedure starting with 1,5pentane diol (118 mg, 1.14 mmol) affording the product (502 mg, 60.31%) as a white
foam. Melting point: 102-109°C (decomposition); Optical rotation: []D20 = -3.4o (c 0.5,
CH3Cl); 1H NMR (400 MHz, d-CHCl3)  8.01-7.89 (8H, m), 7.54-7.26 (16H, m), 3.96
and 3.77 (4H, m), 1.63-1.54 (4H, m), 1.46-1.40 (2H, m) ppm; 13C NMR (100 MHz, dCHCl3)  148.7 (JC,P = 5.1 Hz), 132.8, 132.6, 131.5, 131. 0, 130.4, 130.0, 128.4, 128.3,
127.0, 126.3, 126.2, 125.0, 124.9, 124.1, 122.7, 121.9, 121.6, 65.0 (JC,P = 6.13), 30.5 (JC,P
= 4.1 Hz), 21.9 ppm; 31P NMR (162 MHz, d-CHCl3) 141.4; IR (neat) 3043, 1585-1319,
944 cm-1; HRMS (ESI): Calcd. For C45H34O6P2(M+H): 733.1909, found 733.1909 m/z.
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n6-alkyl BINOL L10 was prepared according to the general procedure starting with 1,6hexane diol (134 mg, 1.14 mmol) affording the product (528 mg, 62.3%) as a white foam.
Melting point: 104-110°C (decomposition); Optical rotation: []D20 = -2.6o (c 0.5,
CH3Cl); 1H NMR (400 MHz, d-CHCl3)  8.01-7.90 (8H, m), 7.55-7.26 (16H, m), 3.95
and 3.77 (4H, m), 1.65 (4H, m), 1.32 (4H, m); 13C NMR (100 MHz, d-CHCl3)  148.92,
147.61 (JC,P = 2.08 Hz), 132.9, 132.7, 131.5, 131.0, 130.4, 13.0, 128.4, 128.3, 127.0,
126.3, 126.2, 125.0, 124.9, 124.2, 122.8, 121. 9, 121.6, 65.1 (JC,P = 6.6 Hz), 30.9, (JC,P =
4.0 Hz), 25.20 ppm; 31P NMR (162 MHz, d-CHCl3)  141.9; IR (neat) 3039, 1584-1319,
940 cm-1; HRMS (ESI): Calcd. For C46H36O6P2(M+H): 747.2065, found 747.2043 m/z.
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CHAPTER THREE: UNEXPECTED REACTION PATHWAYS IN THE OXIMEDIRECTED RHODIUM-CATALYZED ASYMMETRIC HYDROBORATION

3.1 Introduction
The asymmetric hydroboration reaction, the net addition of B-H to a prochiral alkene,
is a valuable synthetic transformation due in large measure to the versatile nature of the
organoborane product’s carbon-boron bond; chiral organoboranes undergo an expanding
number of stereospecific functional group transformations converting the C-B bond to CO, C-C, C-N, C-X (X = halide), or C-H (Figure 1).1-6 Recent studies on the formation of
carbon-carbon bonds is of particular note. Ohmura, Awano, and Suginome reported the
coupling of -(acylamino)benzyl boronic esters with aryl bromides with inversion of
configuration.3 The high degree of enantiospecificity is attributed to the coordination of
amide to boron hindering the approach of palladium from one of the faces. In a
complementary strategy, Crudden and co-workers showed that cross-couplings of
secondary boronate esters precede with retention of configuration.4 Other recently
reported transformations are also quite impressive. For example, Aggarwal and coworkers found that C-B bonds could be transformed selectively to carbon-halide bonds
with inversion of configuration.5 Several of the substrates examined in this study
retained 99-100% of their enantiomeric purity. Miura and co-workers recently reported
an in situ conversion of an aminoboronate to a diamine with retention of configuration.6
These transformations illustrate the value in selective approaches chiral organoboronates.
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Figure 1 Representative bond transformations for the versatile C-B bond

Below are several methods for preparation of chiral organoboranes. (Figure 2). The
oldest preparative method is the asymmetric hydroboration of an alkene with a
stoichiometric equivalent of chiral borane; this will be discussed in detail in section 3.2
(vide infra). Alternatively, the catalytic asymmetric hydroboration (CAHB) is a powerful
method to induce asymmetry from a chiral catalyst rather than the borane itself.7-12
CAHB has a long history, and after a period of relative dormancy, recent results, obtained
for new classes of substrates and simple chiral catalysts, have reinvigorated the field.
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Takacs and co-workers found that simple TADDOL-derived monophosphites and
phosphoramidites were effective ligands for the Rh-CAHB of a series of para-substituted
styrene derivatives affording 90-95% ee; while the yields of the branched isomer (6279%) were moderate due to formation of the competing linear isomer, it was significant
that, in contrast to prior dogma, both electron-donating and electron-withdrawing
substituents were sucessful.13 The low regioselectivity problem was later solved by using
TADDOL-derived supramolecular catalysts to give greater than 90% yields of chiral
branched isomers in high enantiomeric excess.14,15 Alternative strategies began to
emerge. For example, chiral organoboranes can be prepared in high enantiomeric purity
by copper-catalyzed borylative conjugate additions to ,-unsaturated esters using
diboranes.16 Hall and co-workers presented an alternative approach with a coppercatalyzed hydride addition to -boronyl--alkyl-,-unsaturated esters.17 In a related
approach, the asymmetric hydrogenation of vinyl boronates has proven to be quite
effective with rhodium18 and iridium19,20 catalysts.
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Figure 2 Representative methods for formation of chiral C-B bond

3.2 The challenging hydroboration of 1,1-disubstituted alkenes
The stoichiometric asymmetric hydroboration reaction was first reported by Brown
and Zweifel for the selective hydroboration of cis-alkenes (99% ee) with
diisopinocampheylborane (Ipc2BH) (Figure 2).21-23 This landmark achievement proved
for the first time chiral reagents could achieve such high enantioselectivity. The
limitations of using Ipc2BH include limited substrate generality (low enantioselectivity
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for trans-, tri-, and 1,1-disubstituted alkenes) and problematic reagent stability due to the
competing dehydroboration. Substrate generality was improved with the development of
monoisopinocampheylborane (IPcBH2); this reagent increased the enantioselectivity to
more useful values for trans-disubstituted (73% ee) and trisubstituted alkenes (53%
ee).24,25 Masamune and co-workers developed a C2-symmetric borolane (DMB) giving
excellent selectivity for cis- or trans-disubstittued and trisubstituted alkenes (97-99%
ee).26 However, DMB is both relatively unstable and its synthesis of DMB requires
seven steps decreasing its practicality. Nonetheless, the one class of disubstituted alkenes
for which there was no effective asymmetric hydroboration reagent was the 1,1disubstituted series (i.e., methylidene substrates); this is attributed to difficulty in
differentiation between the prochiral enantiotopic faces.27 Recently, Soderquist reported
a novel chiral borane derived from 10-substituted-9-borabicyclo[3.3.2]decanes which
afforded quite good selectivity for some 1,1-disubstituted alkenes; however, there are two
significant drawbacks with this reagent.28 (1) Synthesis of the chiral borane requires four
linear steps from -methoxy-9-BBN including a chiral resolution. (2) Good selectivity
for 1,1-disubstituted alkenes was achieved only when the was a significant difference in
steric demand between the alkene substituents, for example, methyl versus tert-butyl.
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Figure 3 Chiral boranes for the asymmetric hydroboration reaction. A) The first
generation of chiral boranes were effective for all but the 1,1-disubstituted series. B)
Soderquist developed a series of bicyclic boranes giving high selectivity for
hydroboration of 1,1-disubstitued alkenes that possess sterically-biased olefin
substituents.

Thus while significant progress has been made, problems remain when using
stoichiometric chiral boranes to achieve high selectivity. Chiral boranes may require
multiple difficult steps for preparation and do not have long shelf lives. CAHB using a
chiral metal catalyst with a racemic or achiral borane is, in principle, a more practical
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approach, especially if it is feasible to design a library of catalysts screened against
simple to prepare boranes for the various classes of alkenes.7-12 .
The discovery of catalyzed hydroboration originated from the observation by Kono
and Ito that 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH) or catecholborane (catBH)
readily undergoes oxidative addition to Rh(PPh3)3Cl (Wilkinson’s Catalyst) at room
temperature (Figure 4).29 Subsequently, it was found tmdBH30 and catBH31 only react
with alkenes at elevated temperatures with little to no reaction at room temperature. The
metal-catalyzed variant was first realized by Männig and Nöth with their report of the
rhodium catalyzed hydroboration of alkenes with Wilkinson’s catalyst and catBH at room
temperature.32 They showed that the rhodium-catalyzed hydroboration preferred alkenes
over ketones, which suggested this approach could be tolerant of other functional groups.
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Figure 4 Discovery of oxidative addition of borane to Wilkinson’s catalyst led to
development of metal catalyzed hydroboration

The generally accepted mechanism for the Rh-catalyzed hydroboration was proposed
by Mannig and Noth with a representative mechanism shown (Figure 5).32 Rh(PPh3)3Cl
must first disassociate a ligand to open a coordination site affording intermediate A,
which upon alkene coordination forms intermediate B. Oxidative addition of borane
(intermediate C) followed by migratory insertion may form either a branched alkyl-Rh
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intermediate (D) or a linear alkyl-Rh species (D’). Reductive elimination affords the
corresponding alkyl-borane product while regenerating the active catalytic species A.

Figure 5 Proposed mechanism for Rh-catalyzed hydroboration with Wilkinson's catalyst

It has been a challenge to achieve high selectivity from the catalyzed asymmetric
hydroboration reaction (CAHB) of 1,1-disubstitued alkenes (Figure 6). Sato, Miyaura,
and Suzuki reported a cationic Rh-BINAP catalyst and catecholborane afforded moderate
selectivity in the Rh-CAHB of α-methyl styrene.33 Mazet and Gérard reported an iridium
P,N-ligated catalyst which gave excellent selectivity using pinacolborane (92% ee).34
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Pinacolborane was selected over catecholborane, because the corresponding
pinacolboronate esters are easier to isolate. To highlight the impact of ligand choice,
when BINAP is substituted for the optimized chiral P,N-ligand, no reaction occurs.
Hoveyda recently reported the hydroboration of α-methyl styrene (87% ee) using a
copper catalyst ligated with a chiral N-heterocyclic carbene (NHC) and dipinacolborane
(B2(pin)2).35 In this example, the B2(pin)2 reacts with (NHC)Cu-alkoxide forming
(NHC)Cu-BPin. Enantioselective Cu-B addition to the 1,1-disubstituted alkene forms an
organocopper intermediate. Protonolysis regenerates the copper alkoxide forming
hydroboration products. Aside from the directed examples discussed in section 3.3, a
major limitation in the CAHB of 1,1-disubstiuted alkenes is the lack of substrate scope’
In the recent examples cited above, for example, only α-methyl substituted vinylarene
derivatives are reported. This is perhaps not surprising; the difference in size between the
aryl and the methyl substituents likely helps differentiate the enantiotopic faces of the pisystem.
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Figure 6 CAHB of α-methyl styrene

3.3 Directed hydroboration
An alternative strategy that proves useful in expanding the substrate scope beyond
simple sterics uses a coordinating functional group to direct the catalytically-active metal
to the prochiral alkene. A cationic metal with an open coordination site is able to bind to
the directing group and the alkene; two-point binding has long been proven effective for
the Rh-catalyzed asymmetric hydrogenation (Rh-CAH) and a wide variety of other
directed reactions.36 Evans, Fu, and Hoveyda pioneered the field of amide-directed
hydroboration of ,-unsaturated acyclic alkenes catalyzed by achiral rhodium and
iridium complexes (Figure 7).37,38 Excellent regioselectivity was observed when two
considerations were met: (1) A secondary amide is required to prevent reduction of the
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amide in the presence of catBH. (2) Excess catBH is required since the borane
decomposes under the reaction conditions.39 (This will be discussed furthermore in
section 3.4).

Entry

Catalyst

yield (%)

Regioselectivity
()

1

[Rh(nbd)(dppb)]BF4

74

20:1

2

[Ir(cod)(Pcy3)(py)]PF6

73

99:1

Figure 7 First example of a directed catalytic hydroboration

A simple modification of the catalyzed hydroboration mechanism adapted for twopoint binding substrates is shown below. Starting with a disolvated Rh(I) complex A,
coordination of a substrate with a directing group (DG) and alkene affords Rh(I) complex
B. Oxidative addition of borane (X2B-H where X = a diol derivative such as pinacol,
catechol, etc.) gives Rh(III) complex C. Migratory insertion of the alkene gives the
Rh(III)-alkyl complex D which undergoes reductive elimination expelling the alkyl
borane and regenerating active catalyst A. One can consider possible deviations from
this simplified catalytic mechanism at several stages during the cycle. For example,
oxidative addition of X2B-H can place either the H or the boron in the apical position in
the perspective drawn below potentially leading to diastereomeric intermediates. Which
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diastereomer is formed may dictate whether the alkene migratory insertion occurs into the
Rh-H or Rh-BX2bond. Secondly, if reductive elimination step is slow or disfavored, a
competing -hydride elimination pathway can give undesired byproducts.40-43 Our group
has recently submitted a publication (now accepted) on a collaborative computational
study evaluating the different reaction pathways for the amide-directed Rh-catalyzed
hydroboration.

Figure 8 Proposed mechanism for 2-point binding hydroboration. DG = directing group,
L = ligating group, (R)2B-H = borane

Takacs et al envisaged that a chiral rhodium catalyst could potentially be effective for
the directed CAHB of ,-unsaturated amides. Previously, Takacs and co-workers found
TADDOL-based phosphites and phosphoramidites gave high enantioselectivity in the
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CAHB of styrene derivatives with pinacolborane (Figure 2).44 While the reactions went
to near completion, the desired yields were only moderate due to formation of the
undesired linear isomer. It was proposed that the amide’s directing ability should negate
this regioselectivity problem. They found that Rh-CAHB of acyclic ,-unsaturated
substrates using chiral TADDOL and BINOL-derived monophosphite and
phosphoramidite ligands were effective for certain ,-unsaturated di- or trisubstituted
alkenes directed by amides45,46 including published work not reported in this thesis which
I carried out, as well as Weinreb amides.47 The successful results from directed
hydroboration of di- and trisubstituted alkenes prompted exploration of the challenging
class of 1,1-disubstituted alkenes (i.e., methylidene substrates). Aniline-derived amides
and tert-butyl esters were quite effective in the Rh-CAHB of 1,1-disubstituted ,unsaturated methylidene substrates.48 Regioselectivity favored gamma- over betasubstitution ranged from 5:1 to 20:1 with good yields for gamma-borylated product
(53%-78%) and excellent enantioselectivity (91-94% ee).
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Figure 9 Directed CAHB of 1,1-disubstituted alkenes
Studies into the CAHB of Oxime Ethers: Results and Discussion
A note to the readers: the following portion of this chapter outlines our findings into
an unexpected and unusually facile C-H insertion and its role in the oxime-directed Rhcatalyzed hydroboration. Our current understanding of the reaction is as follows:


Reduced products are not formed directly from H2 and Rh(I). The Rh-catalyzed
hydroboration is susceptible to influence of H2 on the reaction mechanism.



Ortho-metallation is only detected with a proximal alkene that reacts. Saturated
substrates do not readily ortho-metallate under standard reaction conditions.
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Substitution of the alkene for alternate directing groups does not facilitate C-H
insertion.


The mechanism by which oxime-directed hydroboration products are formed is
dependent upon the nature of the borane. With catecholborane, the reaction
pathway is oxidative addition, migratory insertion, and reductive elimination.
With tmdBH, the hydroboration products are likely formed from a
dehydrogenative borylation followed by reduction.



The source of the “H-H” addition in the reduced products is not straightforward.
During Rh-catalyzed hydroboration, isotopically-labelled boranes (>90% D
incorporation) lose deuterium before transfer to the reacting alkene; the B-D is
exchanged for B-H, presumably from the THF solvent.

3.4 Oxime-directed hydroboration

Amides are relatively stable and often require relatively harsh reactions conditions
to refunctionalize in the presence of other sensitive functionalities; this makes their
presence less synthetically useful. Oximes are more labile than amides and have the
benefit of an extra heteroatom for further functionalization (Figure 10); in addition,
oximes are much less common, and a route to their enantioselective synthesis may
offer new possibilities for synthesis. For example, the nitrogen protecting group may
be removed forming hydroxylamines or the labile O-N bond may be cleaved giving
alcohols. Together with the possibilities for subsequent functionalization of the C-B
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bond, investigating their CAHB chemistry seemed to be a potentially useful
endeavor.

Figure 10 Hydroboration of , unsaturated oximes provide access to wide variety of
products
Oxime-directed catalysis to ,-unsaturated alkenes can be effective. Recently,
Sanford and co-workers reported an oxime-directed Pd-catalyzed dihydroxylation of
a ,-unsaturated alkene (Figure 11).49 Using chiral aliphatic oximes, the Pdcatalyzed diastereoselective dihydroxylation of ,-unsaturated alkenes gave up to
80% diastereomeric excess.
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Figure 11 Oxime-directed dioxygenation of ,-unsaturated alkenes

While the hydroboration of 1,1-disubstituted-,-unsaturated phenyl amide
derivatives precedes smoothly affording the -isomer as the major product (53%
yield), a significant amount of reduction product (22%) was also isolated (Figure 9).48
It was presumed that this reduced product was the result of a competing side reaction
wherein a Rh(III) dihydride catalyst was formed; it is believed the H2 is its source
having been formed by catalyzed borane decomposition or through spontaneous
disproportionation (Scheme 1)39 or a nucleophile-promoted pathway.50 Typically,
these pathways can be avoided if the alkene is more reactive than the borane
decomposition, but for slow-reacting or coordinating substrates these pathways
become more of a concern. With two-point directing substrates, an excess of borane
is required to get complete conversion of starting materials suggesting the directing
groups may promote borane disproportionation.
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Scheme 1 Spontaneous disproportionation of catecholborane. Adapted with
permission from Inorg. Chem. 1962, 1, 744-748 ©2014 American Chemical Society

3.5 The initial reactions of a simple oxime substrate were patterned after the
amide substrates examined previously and initially seemed promising.
1,1-disubstituted-,-unsaturated oxime 1, originally prepared and investigated
preliminarily by Mr. Andrew Geis, was subjected to Rh-CAHB under the identical
reaction conditions used for the structurally similar 1,1-disubstituted-,-unsaturated
N-phenyl amide discussed previously with Rh[(xTaddol)POPh]2BF4 as the catalyst
(Figure 12). Starting material was consumed after 16 h, but -alcohol 4 was isolated
in only 6% yield. Preliminary studies had indicated by chiral HPLC that oxime 1
underwent CAHB with high enantioselectivity; however that turned out to be wrong.
I confirmed that the enantiomers did not resolve upon chiral HPLC or chiral GC with
the columns available. Fortunately, derivatizing with Mosher’s acid chloride, (S)methoxy--(trifluomethyl)phenylacetyl chloride, gave diastereomeric esters that
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could be used to determine the diastereomeric excess by 19F NMR; unfortunately, it
was low (12% de).51,52 Two products in which the alkene had been reduced
accounted for about 90% of the mass recovered in the reaction; these two products
were formed in a 1:2 ratio and were isolated and characterized. The minor of the two
reduced product was the typical reduced product seen from net H2 reduction of the
alkene; the major reduced product was missing an aromatic proton and an unusual
singlet accounting for one exchangeable hydrogen at  11.2 ppm was seen. NMR and
high-resolution mass spectrometry analysis helped me to determine the product is the
ortho-hydroxylated product 3. We hypothesized this occurred through directed C-H
activation followed by boryl substitution. Under oxidative workup conditions,
borylated product was converted to the ortho-hydroxy derivative. [Readers note that
the terms ortho-metallation and ortho-borylation will be used in the discussion below
based on the observed formation of the ortho-hydroxy product.] Attempts to isolate
the borylated product for further characterization were unsuccessful; the orthoborylated and gamma-borylated products co-eluted and were inseparable. Changing
the catalyst to one using a phosphoramidite ligand (XTADDOL)PN(Me)Ph afforded
the -alcohol as the major product (57%), but the enantioselectivity, although
improved, was still low (33% ee by MTPA-derivatization) and the undesired reduced
material was obtained in 41% yield.
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Figure 12 Hydroboration of ,-unsaturated oximes afford gamma-hydroxylated and
reduced products
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Since the often (annoying) competing reduction is now a major competing
pathway with oxime substrates, it was postulated that ortho-metallation could be
responsible for the increased yields of reduced material. However, a simpler
explanation is that borane decomposition forms H2 which is scavenged by Rh(I) to
promote the Rh-catalyzed hydrogenation. The stoichiometry of the reagents used in
the reaction indicates that the borane could in principle provide enough H2 to account
for the reduced products (Figure 13). For example, the -borylated product requires
consumption of one equivalent of borane. H2 can be formed from 2 sources: (1)
decomposition of two equivalents of borane gives one equivalent diborane and one
equivalent H2; and/or (2) the ortho-borylated material arises from H/B exchange with
liberation of one H2.

Figure 13 Possible sources of H2 from borane decomposition and ortho-borylation

3.6 Proof of the structure of the ortho-hydroxylated material 3 by alternative
synthesis
To confirm the structure of ortho-hydroxylated product 3, an alternate synthetic
scheme was developed (Figure 14). Starting from commercially available 2-
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hydroxybenzophenone, the oxime was formed in good yield. Alkylation with 1bromo-2-methyl propane afforded ortho-hydroxylated ether 3 whose spectral
characterization proved identical to that isolated from the hydroboration reaction.
The intramolecular hydrogen bonding of the ortho-hydroxy group suppresses
intermolecular hydrogen exchange giving a sharp concentration independent singlet
in the HNMR spectrum with an unusually far downfield chemical shift ( 11.2 ppm).

Figure 14 Synthetic proof of ortho-hydroxylated product

3.7 The observed ortho-hydroxylation to form 3 occurs at room temperature, but
such mild conditions for C-H activation are not common in the literature.
The field of C-H activation chemistry has expanded rapidly over the past 10 years and
continues to grow with an ever increasing number of new organometallic catalysts 53-63
and organocatalysts.64 Nonetheless, metal-catalyzed C-H activation is rarely observed to
be facile at room temperature; heating is usually required for efficient orthometallation.63 There are only a few reports of Rh(III) catalyzed C-H activation at room
temperature; out of over 150 reports, only 5 were accomplished at room temperature
(Figure 15).65-69 A survey of the directing groups reported for C-H activation found Nphenyl amides directed the rhodium-catalyzed C-H activation captured by an alkene,
imine, or halide at 60-130 oC.65,70-72 If elevated temperatures are required, then it is
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perhaps not surprising, that we did not observe the potential corresponding orthometallation/borylation in our prior studies of amide-directed CAHB using N-phenyl
amide substrates. Relevant to the chemistry described in this chapter, oximes have been
used as directing groups for C-H activation with Pd73,74 and Rh75,76, but all of these
reports required harsh conditions (>60 °C) to effect reaction.

Figure 15 Examples of Rh-catalyzed C-H activation at room temperature. A)
Carboxylation of arenes; B) Indoline and Pyrrole Synthesis; C) Using a self-oxidizing
directing group
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3.8 The reduced product is not formed simply by rhodium-catalyzed alkene
hydrogenation
The simplest way to account for the formation of reduced alkene products is that Rh(I)
scavenges adventitious H2 that is formed from borane decomposition, and the alkene
simply undergoes rhodium-catalyzed hydrogenation; this is the generally assumed origin
of reduced products in CAHB. If this is the case for the oxime substrate, then the orthoborylation occurs via an independent pathway (vide infra). In testing the rhodiumcatalyzed hydrogen, we were surprised to find that running the reaction under a hydrogen
atmosphere (H2 balloon) with the rhodium catalyst but no borane present did not reduce
the alkene (Table 1, entry 1). While this result doesn’t rule out the possibility that a
Rh(III)-dihydride is responsible for alkene reduction, it does suggest the dihydride is not
formed directly from Rh(I) and H2.
tmdBH is needed to effect alkene hydrogenation. The reaction was again run under a
hydrogen atmosphere, but this time limiting amounts of tmdBH were present. With as
little as 0.4 equivalents of tmdBH, exclusive formation of the reduced product 2 was
found; neither hydroxylated product (i.e., 3 or 4) were formed in appreciable amounts
(Table 1, entry 3). With 2.0 equivalents of tmdBH (i.e., the normal reaction conditions
except under a hydrogen atmosphere), both 3 and 4 were present, but in amounts
substantially below that seen in the absence of the hydrogen atmosphere (Table 1, entry
4). Surprisingly, similar effects are not seen for the analogous CAHBs using
catecholborane (catBH) under a H2 atmosphere (Table 1, entries 5-7). This result is
confirmed when CAHBs using catBH afforded similar yields under H2 atmosphere or N2
atmosphere (Table 1, entry 8 vs 9).
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Table 1: Borane as an additive influences the hydrogenation reaction

Entry
1
2
3
4
5
6
7
8a
a

Borane (equivalent)
0 equiv
tmdBH (0.2 equiv)
tmdBH (0.4 equiv)
tmdBH (2.0 equiv)
catBH (0.2 equiv)
catBH (0.4 equiv)
catBH (2.0 equiv)
catBH (2.0 equiv)

Starting Material
Remaining (%)
100
50
5
0
94
92
0
0

H2 product (%)
0
50
95
61
1
2
8
6

-OH (%)
0
0
0
21
0
3
58
63

Reaction under a N2 atmosphere without added H2.
A proposed mechanism to account for the formation of the hydrogenation product is

described below (Figure 16A). Oxidative addition of a borane (X2BH) to to
Rh(I)(Ligand)2 (intermediate B) produces Rh(III)H(Ligand)2BR2 (intermediate C). As
H2 is introduced, -bond metathesis between the Rh-B and H-H would regenerate X2BH
(the borane is effectively a co-catalyst) and form Rh-dihydride D. (A more detailed
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explanation of the possible mechanism is in Section 3.15.) Migratory insertion followed
by reductive elimination forms the reduced product. Perira and Srebnik exploit a similar
“crossover” strategy in the Rh-catalyzed addition of CCl4 to alkenes using a substoichiometric amount of pinBH (Figure 16B) to promote the reaction pathway.77

Figure 16: A) Proposed mechanism for role of borane activation for active reduction of
alkenes B) Crossover occurs readily with Wilkinson's catalyst and pinBH in CCl4
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3.9 The choice of borane has a large effect on the product distribution obtained in
the Rh-CAHB of ,-unsaturated oximes
,-unsaturated oxime 1 was screened with boranes differing only in diol backbone.
tmdBH and pinBH are similar electronically and sterically, yet give substantially
different product ratios in the Rh-CAHB of 1 (Table 2). The new complication arises in
that pinBH gives poor regioselectivity for hydroboration of the alkene; that is, competing
formation of the -alcohol 6 lowers the yield of desired -alcohol 4. CatBH affords only
7% total reduced material, and less than 1% of ortho-hydroxlation 3; the latter suggests
that C-H activation is disfavored by catBH. Overall, the desired -alcohol is the
predominant product with catBH (63% yield), but the enantioselectivity is poor (ca 6%
ee).
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Table 2 Nature of borane affects the hydroboration greatly

Entry Borane
tmdBH
1
B1
pinBH
2
B3
catBH
3
B2

Starting
Material
Remaining
1(%)

H2 product 2
(%)

o-OH / H2 3
(%)

-OH 6
(%)

-OH 4
(%)

0

10

31

0

58 (33% ee)

14

24

8

16

30 (11% ee)

0

6

1

7

63 (6% ee)

3.10 Are the reduced products formed via the same pathway as chiral -products?
If a short-lived catalytic species is responsible for the formation of reduced product 2,
its rate of formation would likely differ from that of the other products over the course of
the reaction; that is what is found (Figure 16). After completion of borane addition at 0
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°C, the reaction mixture was stirred at 0 °C for 30 minutes and then allowed to warm to
room temperature. Aliquots were removed and quenched by oxidative workup. The
crude products were extracted and purified by flash chromatography. Their isolated
yields are shown below (Figure 17). The majority of reduced product 2 is formed within
the first 30 minutes at 0 °C. Meanwhile, the ortho-borylated product 3 and -borylated
product 4 were formed, roughly in parallel, over the remaining course of the reaction.
This result suggests reduced product 2 may be formed from a pathway independent of the
ortho-borylated and gamma borylated products. It is not clear how the proposed
mechanism in Figure 15 accommodates this conclusion since the reduction stops shortly
into the reaction; one possibility is that a limited amount of hydrogen remains or is
generated after the initial phase of the reaction.
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reduced

ortho-hydroxylated / reduced

gamma alcohol

50

% yield

40
30
20
10
0
0

50

100

150
time (minutes)

200

250

Figure 17 Rate reaction for oxime directed hydroboration indicates ortho-hydroxylated
product and gamma-hydroxy product are formed concurrently

3.11 The size of the vinyl substituent has only a small effect on the product
distribution, but improves the selectivity.
Previous studies in the amide-directed CAHB of methylidene substrates found that
substrates in which the vinyl methyl substituent is replaced by a larger, more stericallydemanding substituent gave increased yields of -borylated product with decreased
formation of reduced products.48 To probe this, two substrates were prepared, one
bearing an isobutyl substituent and another with a cyclohexyl group. Unfortunately, the
substituents had little impact on the observed product distributions (Table 3). However,
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there was one significant benefit, the level of enantioselectivity increased as high as 70%
ee giving some hope that a superior catalyst could ultimately be obtained. Perhaps
increasing the size of the substituent helps to further differentiate the enantiotopic faces
of the alkene.

Table 3 Changing the vinyl substituent increases the enantioselectivity but total reduced
products remain relatively unaffected

Entry Borane
1
tmdBH
2
catBH
3
tmdBH
4
catBH

R = substituent
Isobutyl
Isobutyl
Cyclohexyl
cyclohexyl

H2 product (%)
16
0
28
5

o-OH / H2 (%)
29
0
11
2

-OH (%)
0
0
0
7

-OH (%)
/ (% ee)
52 (60)
16 (0)
60 (40)
52 (70)
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3.12 The alkene is essential for efficient ortho-metallation/borylation and the
formation of 3.
Having gathered some information on the formation of reduced product 2, we turned
our attention to the formation of the ortho-borylated and reduced product 3. The C-H
insertion could occur either before, during, or after reaction with the alkene. As the
ortho-borylated material with the alkene intact has never been observed, it is presumed
that C-H insertion must occur during the hydroboration reaction. To test this, the reduced
product 2 was synthesized and subjected to hydroboration conditions. Only 3% of the
ortho-hydroxylated product 3 was isolated after workup. While not conclusive evidence
that ortho-metallation requires the alkene be present, for example, one could imagine that
ortho-metallation occurs but hydrogen is delivered back to its original position, the
results obtained starting from 2 coupled with the evidence presented for its formation by
an independent pathway is strongly suggestive that 2 is not converted to 3 under the
reaction conditions (Figure 18).

Figure 18 Ortho-borylation not promoted in saturated oxime

Is norbornadiene involved in the catalytic cycle? Norbornadiene (nbd) is a common
diene ligand used with metal precursors in catalysis; due to the strain in the pi-systems,
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the diene ligand is thought to rapidly react via CAHB and thus be an innocuous bystander
in the hydroboration reaction of interest. However, olefin ligands have the ability to
participate in catalytic reactions;78,79 for example, norbornene has a substantial role in
catalysis in the palladium-catalyzed Catellani reaction.80-82 In the Catellani reaction,
norbornene is thought to form a palladacycle intermediate which upon reductive
elimination and depalladation reforms norbornene. Hence, norbornene is part of the
catalytic cycle or at the very least serves as a co-catalyst in that reaction. In a similar
vein, Hua, Nguyen, Scaggs, and Jeon found phosphorus ligating groups and norbornene
cooperatively participated in the diastereoselective rhodium-catalyzed intramolecular
alkene hydrosilyation reaction (Figure 19).83 When norbornene was used as a substoichiometric additive, excellent yield and diastereoselectivity were observed. The
proposed mechanistic cycle involves norbornene acting as a hydride shuttle.
If norbornadiene were responsible for C-H activation and subsequent formation of
ortho-borylated product 3, replacement with an alternative diene ligand should result in a
change in yield. When Rh(1,5-cyclooctadiene)2BF4 was used, there was no change in
reduced or borylated yields. Furthermore, norbornene rapidly undergoes CAHB.84 This
suggests that while norbornadiene is expected to undergo CAHB, it should otherwise not
interfere in the reaction of 1.
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Figure 19 Norbornene-mediated rhodium-catalyzed intramolecular alkene
hydrosilylation reactions

Is an active catalyst, not just the catalyst precursor and tmdBH, needed for orthoborylation of 2? C-H activation using rhodium catalysts may proceed through either a
rhodium(I) intermediate, which oxidatively adds to the ortho-C-H bond, or a Rh(III)
intermediate via transmetallation or some variant of sigma-bond metathesis.57 While
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reduced product 2 is not efficiently converted to ortho-borylated product 3 under the
typical reaction conditions, it is possible the some rhodium intermediate along the
reaction pathway can more efficiently effect the reaction. To explore whether generation
of a Rh(III)-alkyl species in the presence of saturated oxime 2 could facilitate orthometallation, a fast-reacting sacrificial substrate was added. Norbornene was used in
previous studies as a sacrificial substrate to consume a non-selective catalyst during the
Rh-CAHB reaction.84 Adding 0.3 equivalents of norbornene to the attempted reaction of
2 did not increase the yield of the ortho-hydroxylated product 3 (Figure 20).

Figure 20 Formation of Rh(III) through sacrificial substrate does not increase yield of
ortho-borylated material

Alternative weak directing groups do not promote ortho-borylation suggesting that an
intermediate along the pathway in which the alkene reacts leads to the attendant orthometallation. If the alkene substituent is required to promote ortho-metallation/borylation,
then one can consider two possible modes; either ortho-C-H insertion occurs from an
intermediate formed during hydroboration of the alkene, or the alkene simply serves as a
weak directing group to promote ortho-C-H insertion. To explore the latter possibility,
the analogous ester and alkyne substrates were prepared (Figure 21). When treated under
the standard catalytic conditions, no ortho-borylated products were obtained from these
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substrates. This suggests an intermediate along the pathway in which the alkene reacts to
form a Rh(III)-alkyl intermediate, leads to the attendant ortho-metallation.

Figure 21 Determination whether alkene could act as directing group for agostic C-H
interaction

The 1,1-,-unsaturated derivative was used to determine the effect of distancing the
alkene by one carbon from the directing group. Evans, Fu, and Hoveyda saw a reduction
in reaction rate as the amide-directing groups were extended farther from the alkenes.85
We observed a similar decrease in reactivity with only 31% -OH product isolated after
16 hours (Figure 22). Ortho-borylated product was not observed under these reaction
conditions, although a substantial quantity of reduced product was isolated.
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Figure 22 ,-unsaturated oxime affords -alcohol in high regioselectivity with no orthoborylation

3.13 The proximal aryl group is necessary for effective hydroboration.
The oxime ether derived from benzophenone was initially chosen for these
investigations because it (1) provided a convenient chromophore for UV-Vis detection,
and (2) it was thought that the sterically demanding aryl substituents might enhance the
facial bias of the alkene pi-system. However, since ortho-borylation was a problem, it
seemed reasonable to keep the chromophore, but move it away from the metal center
(Figure 23). Two 2-phenylisobutyraldehye oxime derivatives were therefore prepared. It
was expected that the phenyl substituent would be oriented away from the alkene to avoid
unfavorable steric interactions, and the methyl groups would reside in a staggered
confirmation relative to the nitrogen lone pair. Unfortunately, these substrates proved
inactive to hydroboration under conditions previously optimized for the benzophenone
derived oximes. Only starting material was recovered with no sign of reduction or
hydroboration.
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Figure 23 Moving the problematic phenyl group eliminates ortho C-H from borylation

3.14 Deuterium-labeling reveals near quantitative ortho-metallation during tmdBHpromoted rhodium-catalyzed reduction of 1 to 2 under a H2 atmosphere.
At this point we decided to look at the reactions of deuterium-labeled substrate 1,
first focusing on reaction conditions that exclusively promote reduction of the alkene
(i.e., reaction under a hydrogen atmosphere). The preparation of benzophenone-d10 was
straightforward (Scheme 2). Bromobenzene-d5 was converted to the aryl Grignard.
Addition to 1,1’-carbonyldiimimidazole (CDI) affords benzophenone-d10 upon aqueous
workup. Benzophenone-d10 was used to prepare the ,-unsaturated substrate 16-d10 (the
labeled version of 1) and a saturated analogue 18-d10 (a labeled version of 2) for further
mechanistic studies.
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Scheme 2 Preparation of deuterated analogues for mechanistic studies. a) NaH, 3-Cl-2Me-1-propene, TBAI; b) NaH, 1-Br-2-Me-propane, TBAI.

Unexpected deuterium scrambling is observed for the reaction run under a hydrogen
atmosphere. ,-Unsaturated substrate 16-d10 was subjected to the tmdBH-promoted
hydrogenation conditions described above for substrate 1 (2 mol%
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4, 0.4 equivalents tmdBH, 1 atm H2) (Figure 24).
The crude product was filtered through a short plug of silica gel to remove trace metals.
1

H NMR analysis showed a newly formed singlet at  7.52 ppm which was tentatively

assigned the ortho-H shown in Figure 24. The two hydrogens  to the oxime, a doublet
at  4.00 pm, were used as the internal standard to quantitate deuterium incorporation in
the reduced product 17. Based on this standard, one ortho-deuterium was exchanged for
hydrogen to the extent of 83% in the 17; ortho-metallation is occurring much more
frequently than initially thought. Most of the deuterium liberated by H/D-exchange is
transferred to the alkene. Approximately 57% is transferred from the phenyl ring to the carbon of what was the alkene; a smaller amount of deuterium (approximately 12%) was
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transferred to what was the -carbon of the alkene. Only ca 14% of deuterium originally
on the phenyl ring is missing, presumably lost as H-D under these reaction conditions.

Figure 24 Rh-catalyzed hydrogenation of ,-Unsaturated substrate 16-d10

The reduced product is stable under the reaction conditions; labelled reduction
product 18-d10 does not undergo H/D-exchange. The role of the alkene in the H/D-
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exchange was explored next. In an atmosphere of with a large excess H2, exchange of
H/D should occur frequently for an ortho-metallated intermediate if oxidative addition
were occurring without alkene participation (Figure 25). Saturated analogue 18-d10 was
added to a H2 atmosphere, but no H/D exchange was observed. This result suggests for
C-H (or C-D) activation to occur, a , unsaturated alkene, borane, and an ortho C-H (or
C-D) must be present.

Figure 25 Ortho-metallation not observed with labeled saturated substrate under H2
atmosphere
Chelation-assisted oxidative addition could explain the C-D/C-H exchange and
deuterium scrambling in a pathway independent from hydroboration (Figure 25), but this
proposed mechanism is not supported by experiment. Chelation-assisted C-H activation
has frequently been proposed in unrelated C-H metallation chemistry using rhodium(I)
catalysts 57,86,87 This could in principle explain the observed deuterium scrambling in 17
as follows. Two-point coordination of the substrate to Rh(I) species followed by
oxidative addition of the ortho C-D would generate a Rh(III) intermediate. Migratory
insertion of the coordinated alkene into the Rh-D bond delivers deuterium generating an
Rh(III)-alkyl intermediate. -Hydride elimination leaves deuterium on either the alkene
or the methyl substituent scrambling deuterium in the starting 16-d10. Reductive
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elimination generates an aryl C-H while regenerating the rhodium(I) catalyst.

Figure 26 Ortho-metallation is not observed without the addition of borane.
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Deuterium is not scrambled in the starting material, 16-d10. To test the possible
mechanism shown in Figure 26, ,-unsaturated analogue 16-d10 was treated in separate
experiments with 2 mol% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and with 2 mol%
[(nbd)Rh((XTADDOL)POPh)2]BF4; the mixtures were stirred under N2 for 16 hours. No
deuterium/hydrogen exchange was observed for 16-d10. Increasing the catalyst loading to
20 mol% showed no evidence for deuterium scrambling. In addition, a small amount
(8%) of 16-d10 was observed from the reaction mixture described in Figure 24. Analyzing
its 1H NMR spectrum showed no deuterium exchange or loss (NMR data:  4.98 (1H),
4.93 (1H), 4.65 (2H), 1.78(3H) ppm). From the experiments described above, we
conclude that neither the starting material nor the reduced product undergo H/Dscrambling to account for 17; furthermore, the mechanism for facile ortho-metallation
H/D-exchange requires tmdBH and does not proceed independent of alkene reduction.

3.15 Even in the absence of added hydrogen, ortho-metallation is virtually
quantitative during concomitant Rh-CAHB
The results obtained in the reaction of 16-d10. Having first focused on the reaction of
,-unsaturated substrate 16-d10 under conditions that promote exclusive reduction of the
alkene (i.e., reaction under a hydrogen atmosphere), we now return to reaction conditions
that promote Rh-CAHB. 16-d10 was reacted under an inert atmosphere as described
above for substrate 1 (2 mol% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and 2 eq
tmdBH). Ignoring the isotope distribution, the labeled and unlabeled substrates give
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virtually identical product distributions (Figure 27). Surprisingly, we find evidence for
ortho-metallation and H/D-exchange, not only for the reduced product as was found for
reaction under a hydrogen atmosphere, but for all three products! The isotope
distribution for the reduced product 19 differs in small, but perhaps important ways, from
17 described above. One ortho-deuterium is replaced by hydrogen virtually
quantitatively, and the deuterium is cleanly incorporated into a methyl group in 19. The
ortho-borylated and alkene reduced product 20 similarly shows clean redistribution of
one ortho-deuterium to a methyl group, but with incorporation of boron in the orthoposition. In this case, a second ortho-deuterium is partially exchanged for hydrogen. We
will consider the distribution of the deuterium for the major product, the expected
hydroboration product 21 later, but note here that one ortho-deuterium is replaced by
hydrogen virtually quantitatively.

Figure 27 Hydroboration of ,-Unsaturated substrate 16-d10 reveals D-transfer A)
Reaction conditions: 2 mol% Rh(nbd)2BF4, 4.1 mol% (XTADDOL)PN(Me)Ph, 2.0
equiv tmdBH, THF, rt, 16 h. Oxidative workup: NaBO3, THF/H2O
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Proposed mechanisms to account for the redistribution of deuterium in 16-d10 are
discussed below. Deuterium exchange of the ortho-C-D/C-H must be associated with
hydroboration of ,-unsaturated alkene. We propose the pathways diverge as the stage
where X2B-H undergoes oxidative addition to the rhodium-substrate complex (Figure 28,
steps A and A’). Step A ultimately leads to formation of ortho-borylated product, while
the diastereomeric pathway through the step labeled A’ leads to -borylated product; this
is based on the proximity of the pi-system to the Rh-H bond. In pathway A, migratory
insertion of hydride to the -position leads to an intermediate with rhodium bound to the
-carbon. In pathway A’, migratory insertion forms a -Rh intermediate. Two pathways
can help explain the deuterium incorporation on the -borylated products as will be
discussed in further detail below.

Figure 28 Proposed mechanism for formation of ortho-borylated 3 and -borylated 4
accounting for deuterium scrambling to substituent

164

Formation of ortho-borylated product 3. The details for a proposed mechanism to
rationalize the formation of ortho-borylated product 3 is shown below (Figure 29).
Coordination of substrate is followed by oxidative addition of tmdBH (Figure 29, steps A
and B). After migratory insertion, the rhodium bound to the -carbon may be situated
such that it has an agostic interaction with the ortho C-D predisposing it towards -bond
metathesis (Figure 29, steps C and D).88 -bond metathesis substitutes the boron for
deuterium on the ortho-carbon; reductive elimination can then account for deuterium
incorporation on the -carbon (Figure 29, step E).

165

Figure 29 Proposed mechanism for borylated/reduced products

The proposed mechanism seems to account for several of the unusual observations
made for this reaction. It accounts for the reduction of the alkene as well as the orthoborylation and the fact that experimentally, no ortho-borylated product with the alkene
intact has been found. It suggests that the mild C-H activation may be due to the unique
electronics of the rhodium-alkyl intermediate, an intermediate that is unlike those in the
vast majority rhodium-catalyzed C-H activation reactions. The need for a rhodium-alkyl
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intermediate might explain the ineffectiveness of alternative directing groups. It may
also account for why the nature of the borane is critical; recall, catBH does not promote
ortho-metallation. Similarly, why substrates in which the aryl C-H is more distal or the
alkene is more remote might not favor a structure having a strong agostic interaction with
the ortho C-D predisposing it toward -bond metathesis.
Precedence for increased reactivity from an ortho-metallated hydrogenation catalyst
species has recently been described. Pfaltz and co-workers demonstrated an orthometallated iridium catalyst was efficient in the asymmetric hydrogenation of aliphatic
imines (Figure 30).88 Iridium P,N-ligated catalyst Pfaltz-L1 rapidly converted to the
metallocycle Pfaltz-L2 at 0 °C in the presence of phenyl methyl ketimine under a H2
atmosphere (1 bar). The ortho-metallocycle was observed by NMR; attempts to isolate
failed due to decomposition. Generally, alkyl ketimines suffer from low reactivity to
hydrogenation relative to aryl ketimines; Pfaltz speculated the poor reactivity from
aliphatic ketimines could be due to inability to form catalytically active orthometallocycle complexes. Ir-catalyzed asymmetric hydrogenation of cyclohexyl methyl
ketimine with Pfaltz-L2 did indeed give higher reactivity than the parent catalyst PfaltzL1.
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Figure 30 Pfaltz’s discovery of an ortho-iridacycle with improved catalyst efficiency in
the iridium-catalyzed asymmetric hydrogenation of dialkyl ketimines.

The Rh-BX2/C-D -bond metathesis is a particularly interesting aspect of the proposed
mechanism. Whether rhodium is formally oxidized to the Rh(V) oxidation state or
whether the Rh(III) intermediate reacts through a -bond metathesis has been the subject
of recent debate.89,90 For example, hydride exchange in the rhodium-catalyzed
hydrosilyation reaction has been studied by Vyboishchikov and Nikonov.91 Rh(V)-silyl
hydride complexes were isolated and characterized.92-97 DFT calculations on a series of
silyl hydride complexes formally assigned as Rh(V) complexes were found to have
varying degrees of interligand Si-H interactions (Figure 31). This finding led the authors
to eliminate a classical oxidative addition as the mechanism; instead the interaction was
considered “sophisticated” and “multicentral.”
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Figure 31 Four-centered intermediates may be a better description than discrete Rh(V)
complexes in Rh-H/Si-H exchange reactions

Recently, an alternative to traditional -bond metathesis, -complex assisted
metathesis (-CAM), has been suggested.89 While -bond metathesis occurs in a single
concerted step, -CAM is said to proceeds through multiple rearrangements of -ligands
leading to bond metathesis. Hall and Hartwig proposed catalytic cycles supported by
DFT calculations that involve -CAM for the borylation of alkanes; this was supported
by experimental observation of key intermediates associated with multiple ligand
exchanges (Figure 32A).98 Adapting this to the oxime-directed hydroboration would
involve formation of a tmdB-D intermediate that subsequently reacts to form the orthoborylated -Rh species (Figure 32B).

Figure 32 -CAM mechanism for ortho-borylation and deuterium exchange. A)
Hartwig observed formation of tris-borated Rh complexes likely formed from -CAM.
B) Proposed mechanism for -CAM in oxime-directed CAHB.
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Returning to the redistribution of deuterium for the major product in the expected
hydroboration product 21. -alcohol 21 also showed quantitative replacement of
deuterium at the ortho-position of the aromatic ring by hydrogen and complete transfer of
deuterium to the propenyl moiety. Curiously, the deuterium incorporation added to two
positions on what was the propenyl moiety in a 50:50 ratio. This seems indicative of a
pseudo symmetric intermediate or an isomerization reaction. The latter seems more
reasonable and a proposed mechanism accounting for the observed redistribution of
deuterium is described below (Figure 33).
Formation of ortho-borylated product 21. The proposed mechanism for the formation
of 21 is more difficult to formulate than that accounting for the formation of 3. As
suggested in the previous mechanism, the catalytic cycle is initiated by oxidative addition
of tmdBH to the rhodium-complexed substrate (Figure 33, steps A and B). This cycle
differs from that described in Figure 29 in that we propose migratory insertion of the
alkene into the Rh-BX2 bond affording a -rhodium(III)-alkyl intermediate. We need to
once again, suppose a strong agostic interaction, in this case involving the ortho-C-D and
Rh(III)-D bond (Figure 33, steps C and D). After -bond metathesis (or -CAM),
competing -hydride elimination is apparently preferred over reductive elimination. This
gives either the ,-unsaturated vinyl boronate or alkene and a rhodium dihydride (i.e., HRh-D). Stepwise readdition of H and D to the two isomeric alkenes could afford the
observed products with deuterium placed appropriately.
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Figure 33 Proposed mechanism for deuterium transfer to both gamma carbons in
formation of gamma alcohols

Dehydrogenative borylations. Figure 33 suggests that the -borylated products do not
come from the envisaged mechanism for two-point binding hydroboration, but instead via
a dehydrogenative borylation/reduction; the latter pathway has precedence in the
literature. Dehydrogenative borylation has been reported for directed and non-directed

171

systems.40-43 For example, Westcott and co-workers found the hydroboration of
enamides proceeds through a dehydrogenative borylation followed by hydrogenation
(Figure 34).43 The vinyl boronate (the product from dehydrogenative borylation) was
isolated in 15% yield along with the net hydroboration product (i.e., 70% of the reduced
boronate ester). To distinguish between a classical hydroboration mechanism and the
two-step dehydrogenative borylation/hydrogenation mechanism, a trisubstituted enamine
resistant to hydrogenation was used; hydroboration of 1-pyrrolidino-1-cyclopentene gave
80% conversion to the vinyl boronate (observed by NMR).

Figure 34 Dehydrogenative borylation and subsequent reduction reported by Westcott
and co-workers

The dehydrogenative borylation/hydrogenation mechanism is admittedly not a perfect
fit for the oxime-directed Rh-CAHB. We have not found the signature vinyl boronate (or
the corresponding aldehyde upon oxidation) in crude reaction mixtures.

11

B NMR

analysis of the crude product mixtures before oxidative workup show peaks
corresponding to trace amounts of unreacted tmdBH, the ortho- and gamma-borylated
products, and borane degradation products (tris-tmdB);39 there are no peaks
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corresponding to what one would expect for a vinyl boronate. Finally, there isn’t a
compelling explanation at this stage for the facile reduction of the presumed vinyl
boranate with hydrogen.
The nature of the borane had a significant impact on the propensity to orthometallate. Treating ,-unsaturated substrate 16-d10 with 2 mol%
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and 2 equivalents catBH (in place of tmdBH)
gives -alcohol 22 in low yield (20%), but no H/D exchange is not observed in 22 or the
recovered starting material (Figure 35). This suggests either a very different mechanism
(perhaps the standard two-point binding CAHB mechanism) as a consequence of a
lowered tendency for -bond metathesis as a function of borane. To explore whether
lack of ortho-H/D exchange is due to the non-catalyzed hydroboration by catBH,
attempted hydroboration using only catBH resulted in 1-2% -alcohol

Figure 17 Catecholborane produces products with no H/D exchange

To summarize, tmdBH and catBH both form the -alcohol in comparable yields but
labeling studies suggest different mechanisms account for unlabeled product formation
(58% and 63%). From the deuterium distribution, tmdBH may form the product through
a dehydrogenative borylation followed by H2 (or HD) reduction; catBH affords the
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product through the expected oxidative addition / reductive elimination pathway (Figure
36).

Figure 18 The nature of the borane determines how the -borylated products are formed.

3.16 Competition and double labeling experiments indicate little or no crossover
The deuterium transfer observed in 21 seems to suggest that the deuterium is
transferred intramolecularly, although it must be noted that there is a net loss of
deuterium in 20, so there must be intermolecular pathways as well. To further probe the
question of whether deuterium is mostly transferred inter- or intramolecularly, a series of
competition and double labeling experiments were carried out. First, ,-unsaturated
substrate 6 and saturated analogue 2 were combined under the standard Rh-CAHB
conditions with tmdBH (Figure 37). It was possible to isolate most of the reactions
products via flash chromatography, but unfortunately, the oxidized isobutyl derivative
and the reduced starting material 2 proved inseparable. However, 1H NMR analysis of
the inseparable mixture indicates that saturated substrate 2 remains unchanged. We
therefore conclude that presence of the saturated substrate does not affect the yield of alcohol formation (52%).
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Figure 19 Competition reaction between a saturated and unsaturated substrate produces
no crossover in hydroboration products

The next series of experiments are double labeling experiments looking for deuterium
crossover from isotopically labeled to unlabeled substrates; this would confirm whether
the ortho-metallation liberated some undetermined, as of yet, deuterated intermediate.
Chromatographic conditions were found to separate the hydroboration products derived
from 1 (vinyl methyl substitutent) and 10 (cyclohexyl substituent). For comparison
purposes, ,-unsaturated substrates 16-d10 and 10 were individually reacted under the
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standard standard Rh-CAHB conditions with 2 mol%
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and 2 equivalents tmdBH; each giving a
mixture of reduced product, ortho-borylated and reduced product, and the expected alcohol hydroboration product (Figure 38). A 1:1 mixture of 16-d10 and 10 were
similarly reacted and the products separated after oxidation. While some differences can
be noted, the mixture of substrates gave results that were overall quite similar to the
individual experiments. First and foremost, the yields of -alcohol (i.e., 21 and 13) were
unchanged in the competition reaction compared to the individual reactions, and most
importantly, no deuterium crossover was found between labeled and unlabeled substrates.
The ortho-borylated/reducted products 12 and 20 were also essentially unchanged in
yield, the distribution of deuterium was unchaged in 20, and 12 did not pick up any
deuterium via crossover. The reduced products 19 and 11 behaved quite differently. The
isotopically labeled 19 was obtained in somewhat lower yield under the completion
conditions (i.e., 3% versus 10%), although given the complex mixture obtain, it is not
clear how significant that difference is; its deuterium distribution is, however, unchanged.
Reduced product 11 (7% yield compared to 28% performed in the individual reaction)
surprisingly incorporates one deuterium via aryl H/D-exchange. In addition, recovered
10 (7%) is now doubly deuterated on the alkene; note that the latter could not be
separated from the starting material so its assignment is tentative but might be taken as
evidence of the previously described dehydrogenative borylation/reduction pathway. The
source of the deuterium which transfers to the unlabeled material is likely from orthoborylated product 20 since, as in its individual experiment, a total of 1.6 deuterium atoms
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undergo H/D-exchange, of which 1 is transferred intramolecularly. It seems remarkable,
but totaling the deuterated crossover products accounts for essentially all of the 0.6
deuterium atoms lost in forming 20.
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Figure 20 Competition experiment with labeled and unlabeled substrates reveal no
crossover in gamma-alcohol formation - only reduced. Reaction conditions A: 2 mol%
Rh(nbd)2BF4, 4.1 mol% (XTADDOL)PN(Me)Ph, 2.0 equiv tmdBH, THF, rt, 16 h.
Oxidative workup: NaBO3, THF/H2O
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One possible explanation for presence of deuterium on the alkene in recovered 10 is a
decreased rate of hydrogenation; recall no recovered starting material had shown the
wash in of deuterium into substrate 1. Experimentally, this indeed seems to be the case.
Attempted rhodium-catalyzed hydrogenation of 10 using the standard reaction conditions
with 0.4 equivalents tmdBH and a hydrogen atmosphere, 10 affords only 54% of the
reduced product 11; in contrast, 1 gives the reduced product quantitatively under these
conditions (Figure 39).

Figure 21 Hydrogenation with cyclohexyl substituent has reduced reactivity compared to
methyl substituent

Due to the slow reduction of 10, we wondered whether a labeled oxime derivative
with a cyclohexyl alkene substituent would also show exchange of the vinyl hydrogens.
,-Unsaturated substrate 23-d10 was synthesized and treated under Rh/tmdBH/H2hydrogenation conditions using 2% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4, 0.4
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equivalents tmdBH under a H2 atmosphere (Figure 40). The reduced product was
isolated with 82% ortho-D substitution; this is comparable to the 83% ortho-D exchange
from ,-unsaturated substrate 10-d10 under identical reaction conditions in a H2
atmosphere (Figure 24). The 1H NMR spectrum is shown below with deuterium
incorporation at the -methyl ( 0.87 ppm) (Figure 40).

Figure 40 Hydrogenation ,-unsaturated substrate 23-d10 incorporates deuterium into
the products. H NMR of portion of isolated reduced product

Rh-CAHB of ,-unsaturated substrate 23-d10 affords a product distribution not too
dissimilar from its unlabeled isomer 10 (Figure 41) and all reaction products show
quantitative ortho-H/D exchange. There are some subtle differences in the redistribution
of that deuterium. The reduced products incorporated one deuterium on the -methyl as
before, but the -alcohol 25 incorporates only 50% deuterium on the methyl substituent
and no deuterium is incorporated on the -carbon or the cyclohexyl ring; this differs from
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16-d10 for which there was complete deuterium transfer to two positions in the product.
Whether this has significance to the mechanism is not clear

Figure 41 Hydroboration of d10-labeled benzophenone oxime with cyclohexyl substituent
gives deuterium incorporation onto the product

3.17 Synthesis of deuterium-labeled boranes and the unusual loss of label in the
oxime-directed Rh-CAHB.
Deuterated boranes are commonly used for exploring the mechanism of the
hydroboration reaction, and we sought to carry out studies with tmdBD to compare to
those described above; however, this proved to be problematic. While there are several
reports of the preparation of deuterated borane reagents, many authors using such
reagents do not isotopic purity of the borane used. The most common methods for
preparing deuterated boranes is via the reaction of BD3-THF or PhN(Et)2-BD399,100 with
the diol backbone of choice. In our hands reacting with the 2-methyl-2,4-pentadiol, we
find up to 20% tmdBH contaminates the tmdBD after distillation. Since BD3 is prepared
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from 99% D-incorporated NaBD4, we attribute the source of hydrogen to exchange from
the diol.
To address this problem, two routes were recently reported to facilitate H/D exchange
using iridium catalysts and D2 (Figure 42). Hartwig and co-workers reported an iridium
catalyst reported to reduce dipinacolborane (B2pin2) to pinBD in 80% yield.101
Alternatively, Nolan and co-workers reported low catalyst loadings (0.1 mol% Ir catalyst)
for the deuteration of boranes under relatively mild conditions 10 atm D2.102 Nolan’s
approach was reported for a series of boranes structurally similar to those used in our
research, so this approach was attempted first.

Figure 42 Preparation of tmdB-D with a high degree of isotopic purity

Nolan’s iridium-NHC catalyst was prepared as described in Figure 43.103 The
catalyst is labile, so only small quantities of catalyst (<100 mg) were prepared used fresh.
Repeating Nolan’s deuteration conditions (0.1 mol% catalyst loading with 10 psi D2)
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afforded tmdBD with approximately 86% deuterium incorporation as determined by 1H
NMR analysis. Fortunately, increasing the catalyst loading to 0.3 mol% and the D2
pressure to 30 psi improved the H/D-exchange; isotopic incorporation of greater than
90% D was achieved as estimated from 1H NMR and 11B NMR (Figure 43).

Figure 43 Ir-NHC catalyst affords deuterated tmdBD
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The reaction of ,-unsaturated substrate 1 with 2 equivalents of freshly prepared
tmdBD under the standard reaction conditions (2 mol%
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 catalyst in THF) gave quite unexpected results
(Figure 44). While the yields of the now expected reduced, ortho-hydroxylated and
reduced, and -alcohol hydroboration products were comparable to those obtained with
tmdBH, there is little to no deuterium incorporation on the  or -substituents. Only the
ortho-hydroxylated and reduced product has a low percentage (ca. 35%) of deuterium
incorporation at the -position of the reduced material. In contrast, neither the reduced
product nor the -alcohol had deuterium incorporated at the  or -positions.
Furthermore, aryl H/D-exchange was also low; only about 50% deuterium incorporation
was observed for the reduced and hydroboration products.

Figure 44 CAHB with labeled borane reveals a loss of deuterium label in the
hydroboration products.
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The source of the hydrogen to account for lost deuterium is puzzling and currently a
topic under investigation in the Takacs labs. Finding the source of the hydrogen is
important. The competing formation of reduced products compromises the efficiency of
our CAHB reactions, and not only ours, those of other researchers, too. Thus far, it has
been assumed that the reduced products arise from H2 produced in the decomposition of
the borane. The decomposition of tmdBD should generate D2, but we find no deuterium
incorporation into the reduced product and the regioselective incorporation of 35%
deuterium in the ortho-borylated and reduced product above is not consistent with
hydrogenation by D2. Why would the latter reaction be regioselective, if the deuterium
comes from D2? The source of reduction seems in reality be more complicated than a
simple scavenging of available H2 or D2; it is time to get that story sorted out.
As for potential sources of hydrogen, we know is that the mass balance accounts for
ca 90% of the material, largely eliminating substrate decomposition as a viable source of
hydrogen. Hydrogen involved in reduction must come from a source previously believed
to be innocuous; the likely sources are ligand, diene (i.e., norbornadiene or 1,5cylooctadiene), or solvent (tetrahydrofuran). The substoichiometric amounts of ligand
and diene available do not seem to be a viable source of hydrogen, but there is some
precedent suggesting that THF could be an option. Yi and Leung reported that a
rhodium(III)-alkyl complex catalyzed the H/D-exchange of THF from D2O, albeit at high
temperature and long reaction times (135 °C, 40 h) (Figure 45).104 For the oximedirected CAHB, experiments in deuterated solvents are currently underway to investigate
whether THF is the source of H.
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Figure 45 Deuteration of THF with a Rh(III) catalyst. Adapted from Ref 104 with
permission from John Wiley and Sons.

Others in the Takacs lab have picked up the study of oxime ethers at this point. To
prevent aryl-H/D exchange, acetone-, cyclohexyl, and cyclopentyl-derived oxime ethers
are currently under investigation (Figure 46).

Figure 46 Next generation of functionalized oximes for the directed CAHB.

3.18 Conclusions and Future Directions
At this point in the studies, the mechanistic understanding of oxime-directed RhCAHB is still not complete. However, many important observations have been found for
planning future studies. Isolation of the ortho-hydroylated material proved Rh-catalyzed
ortho-metallation transpired. Had the C-H not been functionalized, this reaction pathway
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may have gone unnoticed. The proximity of the alkene to the ortho-H was key for orthometallation to occur. ,-unsaturated alkenes were required for ortho-metallation to
occur suggesting a Rh(III)-alkyl intermediate is likely involved. Subsequent labelling
studies of the benzophenone oximes revealed metallation to be selective. Deuterium
transfer to the reacting alkene was observed in both reduction and hydroboration
products. In contrast, deuterium-labeled borane afforded hydroboration products missing
deuterium incorporation suggesting the borane-D(H) was lost before migratory insertion
of the alkene. More importantly, this loss of deuterium gives mechanistic evidence for
the source of reduced product formation; Reduction during Rh-CAHB may turn out to be
more sophisticated than a simple H2 reduction. This has broad implications not only to
future labeling studies, but to sequestering the troublesome reduction step encountered in
various organic transformations.
For future studies, either the hydroboration or the C-H activation could be further
optimized. To exploit the hydroboration reaction, varying the borane or the ligating
groups could lead to higher yields of desired hydroboration products. Takacs et al
previously reported that the influence of the borane has a substantial role in selectivity
and reactivity for Rh-CAHB.47

Exploration of boranes may provide a catalyst system

capable of avoiding C-H activation as was found with Rh-CAHB with catecholborane.
Screening monodentate and bidentate ligands with various electronic and steric properties
may dissuade the reaction from progressing through the undesired C-H activation
pathway.
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A more interesting approach is taking advantage of the C-H activation. Additives
could be used to trap the ortho-metalated species for further product functionalization.
For example, reactions run under a carbon monoxide atmosphere could form aldehydes.
Furthermore, ortho-D was transferred quantitatively to the -substituents in the RhCAHB of deuterium-labeled oximes. If fluorine were substituted for deuterium, fluorine
transfer generates a new stereocenter with a net addition of H-F to the alkene (Figure 47).

Figure 47 Rh-CAHB of flourinated benzaldehydes may reveal valuable transformations

In conclusion, this ongoing study has demonstrated the complexity of the Rh-CAHB.
The mechanism may vary from depending on the choice of directing group, catalyst,
borane, and proximity of directing group to the alkene. While selectivity and yields
obtained in these studies were modest, the ortho-metallation under mild conditions may
be further exploited in future studies. The largest contribution from this challenging
study was observation of reduction products being formed through an indirect
hydrogenation or hydroboration. Further insight into the reduction mechanism and
source of H2 could prove generally beneficial to organometallic catalysis.

3.19 Experimental
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Reactions were carried out under a dry nitrogen atmosphere. Tetrahydrofuran (THF)
was freshly distilled from sodium metal and benzophenone. Dichloromethane (DCM),
methanol (MeOH), benzene, and toluene were dried with 4Å molecular sieves. All
synthesized compounds were purified using flash chromatography with the indicated
solvents on Silica Gel 60 Geduran®. Thin layer chromatography analyses were
performed on Silica Gel HLF (250 microns) precoated analytical plates and visualized
with use of handheld short wavelength UV light, vanillin stain (ethanol, H2SO4, and
vanillin), or ninhydrin stain (ethanol, acetic acid, and ninhydrin). NMR spectra were
recorded on a 400 MHz spectrometer using CHCl3 ( 7.27 ppm), CDCl3 ( 77.0 ppm),
DMSO ( 2.54 ppm), or d6-DMSO ( 40.45 ppm). Peaks are expressed as m (unresolved
multiplet), q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet). IR spectra
were recorded by FT-IR using the ATR technique (ZnSe). Optical rotations were
measured in solutions, 1.0 g/100 mL CHCl3 unless indicated otherwise and recorded
using a Rudolph Autopol III automatic polarimeter. HRMS analyses were performed by
the Nebraska Center for Mass Spectrometry.

A mixture of benzophenone (5.00 g, 27.4 mmol), hydroxylamine hydrochloride (2.48 g,
35.7 mmol), and sodium acetate (2.92 g, 35.7 mmol) in MeOH (100 mL) was placed in
250 mL round-bottomed flask with a reflux condensor. The reaction mixture was heated
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to reflux for 4 hours. The reaction mixture was cooled to room temperature. The crude
reaction mixture was concentrated under reduced pressure. The remaining solid was redissolved in EtOAc (100 mL) and washed with water (3 x 30 mL). The organic extract
was dried with Na2SO4, filtered, and concentrated yielding a white solid. The solid was
recrystallized from ethyl acetate/hexanes and dried under white vacuum affording 27
(4.87 g, 90%) as a white powder-like solid (mp 138-140 °C). TLC analysis (30:70 ethyl
acetate/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3)  9.29 (1H, s),
7.54-7.36 (10H, m); 13C NMR (100 MHz, CDCl3)  158.0, 136.2, 132.7, 129. 6, 129.3,
129.2, 128.4, 128.3, 127.9; IR (neat) 3419 (N=OH), 3074 (Aromatic C-H) cm-1

2-hydroxy-benzophenone (1 g, 5.04 mmol) was converted to 2-hydroxybenzophenone
oxime 28 using the procedure for benzophenone oxime 27 affording 28 (989 mg, 92%) as
a white powder. TLC analysis (70:30 ethyl acetate/hexanes) showed a spot at Rf 0.2; 1H
NMR (400 MHz, CDCl3)  11.24 (1H, s), 7.57-7.52 (3 H, m), 7.38-7.35 (2H, m), 7.317.30 (2H, m), 7.28-7.25 (2H, m), 7.06-7.03 (1H, m), 6.91-6.85 (1H, m), 6.78 (1H, t, J =
7. 9 Hz); 13C NMR (100 MHz, CDCl3)  162.3, 126.1, 157.9, 139.4, 131.1, 131.0, 131.0,
130.8, 130.8, 130.7, 129.3, 126.2, 128.5, 128.5, 128.5, 128.4, 127.9, 119.1, 119.1, 118.7,
118.6, 117.1, 117.1 IR (neat) 3377 (N-OH), 3311 (ArOH), 3031 (Aromatic C-H) cm-1
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D10-benzophenone (5.29 g, 27.5 mmol) was converted to D10-benzophenone oxime 29
using the procedure for benzophenone oxime 27 affording 29 (5.23 g, 92%) as a white
powder. TLC analysis (30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 1H NMR
(400 MHz, CDCl3)  9.44 (1H, s), 7.52-7.34 (.06 H, m); 13C NMR (100 MHz, CDCl3) 
157.9, 136.1, 132.5, 129.3, 129.2, 129.1, 128.9, 128.7, 128.1, 128.0, 127.9, 127.8, 127.7,
127.5, 127.3; IR (neat) 3233 (N-OH) cm-1; HRMS (EI): Calcd. For C13HD10NO (M):
207.1468, found 207.1464 m/z.
Preparation of allylic alcohols

A mixture of magnesium (14.3 g, 589 mmol) and iodine (catalytic) in THF (10 mL) was
placed in a 500 mL 3-neck round-bottomed flask with a reflux condenser and addition
funnel. 2-methyl-1-bromo-propane (80.6 g, 589 mmol) in 200 mL THF was added to the
addition funnel and slowly added to magnesium solution with applied heat until reaction
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initation. Rate of addition was adjusted to safely maintain reflux. To a separate 1 L
round bottomed flask was added propargyl alcohol (10.0 g, 178 mmol) and copper iodide
(34.0 g, 178 mmol). The reaction mixture was purged with N2 three times. A 1:1
mixture of THF/benzene (400 mL) was added to the copper iodide flask and the reaction
mixture was cooled to -78 °C. The solution of isopropenylmagnesium bromide was
added dropwise. The reaction was allowed to warm to room temperature and stirred
overnight. The crude reaction mixture was washed with NH4Cl (satd) (100 mL) and
extracted with EtOAc (3 x 100 mL). The organic extracts were combined and washed
with brine (1 x 50 mL). The organic extract was dried with MgSO4, filtered,
concentrated yielding an orange oil. Flash chromatography on silica gel (30:70
EtOAc/hexanes) afforded 30 (12.8 g, 62%) as a clear oil. TLC analysis (25:75 ethyl
acetate/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3)  5.07 (1H, s),
4.87 (1 H, s), 4.07 (2H, d, J = 6.0 Hz), 1.97-1.73 (1H, m), 0.91 (3H, d, J = 6.6 Hz); 13C
NMR (100 MHz, CDCl3)  147.9, 110.3, 65.9, 42.8, 26.3, 22.5; IR (neat) 3376 (OH),
3051 (alkene C-H),2961 (C-H), 1773 (C=C), 976 (C-O) cm-1

Cyclohexyl bromide (102 g, 743 mmol) was converted to cyclohexyl substituted allylic
alcohol 31 using the procedure for 30 affording 31 (15.5 g, 56%) as a clear oil. TLC
analysis (30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz,
CDCl3)  9.44 (1H, s), 7.52-7.34 (.06 H, m); 13C NMR (100 MHz, CDCl3)  157.9,
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136.1, 132.5, 129.3, 129.2, 129.1, 128.9, 128.7, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5,
127.3; IR (neat) 3300 (OH), 2921 (alkene C-H), 2838 (C-H), 1639 (C=C), 1010 (C-O)
cm-1

Preparation of Allylic Carbonates

To a cooled solution (0 °C) of isobutyl allylic alcohol 30 (10.0 g, 87.6 mmol) and DMAP
(535 mg, 4.38 mmol) in DCM (150 mL) was slowly added pyridine (13.9 g, 175 mmol).
Ethyl chloroformate (11.4 g, 105 mmol) was added dropwise over the course of 15
minutes. The reaction mixture was allowed to warm to room temperature overnight. The
reaction mixture was washed with water (3 x 25 mL). The organic extracts were dried
with Na2SO4, filtered, and concentrated yielding a faint yellow oil. The crude reaction
mixture was purified via flash chromatography on silica gel (30:70 DCM/hexanes)
afforded 32 (15.0 g, 92%) as a clear oil. TLC analysis (30:70 DCM/hexanes) showed a
spot at Rf 0.5; 1H NMR (400 MHz, CDCl3)  5.11 (1H, s), 4.95 (1 H, s), 4.22 (2H, q, J =
7.2 Hz), 1.98 (2H, d, J = 7.2 Hz), 1.82-1.76 (1H, m), 1.33 (3H, t, J = 7.1 Hz), 0.89 (6H, d,
J = 9.8 Hz); 13C NMR (100 MHz, CDCl3)  155.1, 142.3, 113.8, 69.9, 64.0, 42.8, 26.2,
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22.4, 14.3; IR (neat) 2954 (C-H stretch), 1739 (C=O stretch), 1649 (C=C stretch), 1250
(C-O stretch) cm-1

Cyclohexyl allylic alcohol 31 (13.6 g, 88.2 mmol) was converted to cyclohexyl
substituted ethyl carbonate 31 using the procedure for 32 affording 33 (17.8 g, 95%) as a
clear oil. TLC analysis (30:70 DCM/hexanes) showed a spot at Rf 0.6; 1H NMR (400
MHz, CDCl3)  5.06 (1H, s), 4.97 (1 H, s), 4.62 (2H, s), 4.23 (2H, q, J = 6.4 Hz), 1.98
(1H, t, J = 11.5 Hz), 1.84-1.69 (5H, m), 1.35-1.17 (8H, m); 13C NMR (100 MHz, CDCl3)
 155.1, 148.7, 111.1, 69.4, 64.0, 41.2, 32.1, 26.6, 26.2, 14.3; IR (neat) 2928 (C-H
stretch), 1744 (C=O stretch), 1721 (C=C stretch), 1237 (C-O stretch)cm-1

Preparation of unsaturated and saturated substrates
Substrates were alkylated with oximes via 2 methods: Method A (Alkylation) or Method
B (Pd-catalyzed substitution)
Method A: Alkylation
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To a cooled solution of benzophenone oxime (2.00g, 10.1 mmol) and catalytic t-butyl
ammonium iodide (187 mg, 0.51 mmol) in a mixture of 1:1 DMF/THF (100 mL) was
added dry NaH (316 mg, 13.2 mmol). 3-chloro-2-methyl-1-propene (1.19g, 13.2 mmol)
was added dropwise. The reaction mixture was stirred for 30 minutes at 0 °C. The
septum was removed and an oven-dried reflux condenser flushed with N2 was added to
the round bottom flask. The reaction mixture was heated at 70 °C for 4 hours. The
reaction mixture was cooled to 0 °C and water was added dropwise (2 mL). A 3:1
Et2O/water was added to the reaction mixture. The organic extracts were dried with
Na2SO4, filtered, and concentrated affording a yellow oil. The crude reaction mixture
was purified via flash chromatography on silica gel (30:70 DCM/hexanes) afforded 1
(2.14 g, 84%) TLC analysis (30:70 DCM/hexanes) showed a spot at Rf 0.6; 1H NMR
(400 MHz, CDCl3)  7.52-7.32 (10H, m), 4.97 (1H, s), 4.92 (1H, s), 4.64 (1H, s), 1.77
(3H, s); 13C NMR (100 MHz, CDCl3)  156.7, 142.1, 136.6, 133.5, 129.2, 128.8, 128.2,
128.1, 127.9, 112.2, 78.24, 19.7; IR (neat) 3054 (C-H aromatic stretch), 2908 (C-H
aliphatic), 1652 (C=C stretch), 1501 (C=N stretch), 1441 (N-O stretch), 979 (C-O stretch)
cm-1

D10-benzophenone oxime 29 (2 g, 9.65 mmol) was converted to isotopically labeled
benzophenone oxime 16 using the procedure for 1 affording 16 (2.02 g, 80%) as a white
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powder. TLC analysis (70:30 DCM/hexanes) showed a spot at Rf 0.5; 1H NMR (400
MHz, CDCl3)  4.97 (1H, s), 4.92 (1H, s), 4.64 (2H, s), 1.77 (3H, s); 13C NMR (100
MHz, CDCl3)  142.11, 112.24, 78.24, 19.66; IR (neat) 2910 (C-H aliphatic), 1659 (C=C
stretch), 1438 (N-O stretch), 982 (C-O stretch) cm-1

To a cooled solution of benzophenone oxime 27 (2.00g, 10.1 mmol) and catalytic t-butyl
ammonium iodide (187 mg, 0.51 mmol) in a mixture of 1:1 DMF/THF (100 mL) was
added dry NaH (316 mg, 13.2 mmol). 1-bromo-2-methylpropane (1.72 g, 13.2 mmol)
was added dropwise. The reaction mixture was stirred for 30 minutes at 0 °C. The
septum was removed and an oven-dried reflux condenser flushed with N2 was added to
the round bottom flask. The reaction mixture was heated at 70 °C for 4 hours. The
reaction mixture was cooled to 0 °C and water was added dropwise (2 mL). A 3:1
Et2O/water was added to the reaction mixture. The organic extracts were dried with
Na2SO4, filtered, and concentrated affording a yellow oil. The crude reaction mixture
was purified via flash chromatography on silica gel (30:70 DCM/hexanes) afforded 2
(2.24 g, 92%) as a clear oil. TLC analysis (30:70 DCM/hexanes) showed a spot at Rf
0.6; 1H NMR (400 MHz, CDCl3)  7.51-7.31 (10H, m), 3.98 (2H, d, J = 6.8 Hz), 2.122.02 (1H, m), 0.93 (6H, d, J = 6.7 Hz); 13C NMR (100 MHz, CDCl3)  156.1, 136.44,
135.6, 129.3, 129.1, 128.6, 128.2, 128.0, 127.8, 81.2, 28.1, 19.2; IR (neat) 3054 (C-H
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aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (CO stretch) cm-1

2-hydroxylbenzophenone oxime 28 (500 mg, 2.34 mmol) was converted to orthohydroxylated oxime 3 using the procedure for 2 affording 3 (126m g, 20%) as a clear oil.
TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.7; 1H NMR (400 MHz,
CDCl3)  11.2 (1H, s), 7.52-7.47 (3H, m), 7.32-7.24 (3H, m), 7.03 (1H, d, J = 8.9 Hz),
6.84-6.77 (1H, m), 6.73 (1H, t, J = 8.0 Hz), 3.94 (2H, d, J = 6.9 Hz), 2.10-2.00 (1H, m),
0.90 (2H, d, J = 6.72 Hz); 13C NMR (100 MHz, CDCl3)  160.3, 158.2, 132.0, 130.7,
130.5, 128.9, 128.4, 128.3, 118.8, 118.8, 117.1, 81.5, 27.9, 19.0; IR (neat) 3055 (C-H
aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (CO stretch) cm-1

Methyl-2-(((diphenylmethylene)amino)oxy) acetate (methyl ester analogue 14) Methyl
bromoacetate (814 mg, 5.3 mmol) and benzophenone oxime 27 (1.0 g, 5.1 mmol) were
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converted to methyl ester 14 (784 mg, 61%) as a colorless oil using the procedure for
benzophenone alkylation for 2. TLC analysis (30:70 EtOAc/hexanes) showed a spot at
Rf 0.7; 1H NMR (400 MHz, CDCl3)  7.51-7.32 (10H, m), 4.76 (2H, s), 3.80 (3H, s); 13C
NMR (100 MHz, CDCl3)  170.6, 158.5, 136.02, 133.0, 129.6, 129.4, 129.1, 128.2,
128.2, 128.1, 71.0, 51.9; IR (neat) 3070(C-H aromatic stretch), 2945 (C-H aliphatic), ,
1747 (C=O), 1435 (N-O stretch), 1084 (C-O stretch) cm-1

Benzophenone O-prop-2-yn-1-yl-oxime (alkyne analogue 15) Propargyl bromide (633
mg, 5.32 mmol) and benzophenone oxime 27 (1.0 g, 5.1 mmol) were converted to ,alkyne 15 (924 mg, 77%) as a colorless oil using the procedure for benzophenone
alkylation for 2. TLC analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR
(400 MHz, CDCl3)  7.55-7.34 (10H, m), 4.80 (2H, d, J = 2.4 Hz), 2.49 (1H, t, J = 2.3
Hz); 13C NMR (100 MHz, CDCl3)  158.3, 136.2, 133.0, 129.6, 129.4, 129.0, 128.3,
128.2, 128.1, 80.0, 74.4, 62.0; IR (neat) 3280 (sp C-H stretch), 2910 (C-H aliphatic),
1446 (N-O stretch), 1011 (C-O stretch) cm-1
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D10-benzophenone oxime 29 (500 mg, 2.41 mmol) was converted to isotopically labeled
benzophenone oxime 18 using the procedure for 2 affording 18 (604 mg, 95%) as a
colorless oil. TLC analysis (70:30 DCM/hexanes) showed a spot at Rf 0.5; 1H NMR
(400 MHz, CDCl3)  3.98 (2H, d, J = 6.8 Hz), 2.11-2.02 (1H, m), 0.93 (6H, d, J = 6.7
Hz); 13C NMR (100 MHz, CDCl3)  81.2, 28.1, 19.2

Method B: Pd-catalyzed substitution

To a mixture of benzophenone oxime 27 (2.00 g, 10.1 mmol), Pd2(dba)3 (194 mg, 0.21
mmol), and dppb (216 mg, 0.51 mmol) in THF (40 mL) was added isobutyl carbonate 32
(1.58 g, 8.47 mmol). The reaction mixture was stirred overnight at room temperature.
The reaction mixture was concentrated in vacuo and purified via flash chromatography
on silica gel (20:80 DCM/hexanes) affording 6 (2.33 g, 94%) as a clear oil. TLC analysis
(10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR (400 MHz, CDCl3)  7.52-7.32
(10H, m), 5.03 (1H, s), 4.89 (1H, s), 4.65 (2H, s), 1.96-1.84 (2H, m), 1.83-1.74 (1H, m),
0.88 (6H, d, J = 6.5 Hz); 13C NMR (100 MHz, CDCl3)  156.7, 144.8, 136.6, 133.5,
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129.2, 128.7, 128.2, 128.0, 127.9, 112.9, 77.3, 43.3, 26.0, 22.5; IR (neat) 3058 (C-H
aromatic stretch), 2951 (C-H aliphatic), 1655 (C=C stretch), 1488 (C=N stretch), 1437
(N-O stretch), 969 (C-O stretch) cm-1

Cyclohexyl carbonate 33 (1.80 g, 8.46 mmol) was converted to ,-unsaturated
cyclohexyl substrate 10 using the procedure for 6 affording 10 (2.48 g, 92%) as a clear
oil. TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR (400 MHz,
CDCl3)  7.49-7.31 (10H, m), 4.97 (1H, s), 4.89 (1H, s), 4.71 (1H, s), 1.95 (1H, t, J =
11.3 Hz), 1.80-1.67 (5H, m), 1.32-1.11 (5H, m); 13C NMR (100 MHz, CDCl3)  156.7,
151.0, 136.6, 133.6, 129.2, 128.7, 128.2, 128.0, 127.9, 109.9, 76.9, 41.4, 32.2, 26.8, 26.3;
IR (neat) 3084 (C-H aromatic stretch), 2925 (C-H aliphatic), 1642 (C=C stretch), 1441
(N-O stretch), 976 (C-O stretch) cm-1

200

Typical reduction reaction procedure with sub-stoichiometric tmdBH addition

To a vial containing Rh(nbd)2BF4 (3.0 mg, 7.93 μmol) was added L2 (11.4 mg, 16.0
μmol) in THF (1 mL) and stirred for 1 hour for complexation (solution changes from
colorless to yellow instantaneously). A 1 mL aliquot of the resulting Rh[(L2)2(nbd)]BF4
solution was added to a 50 mL round bottom flask with stir bar. The resulting yellow
solution was added ,-unsaturated oxime 1 (66.3 mg, 0.11 mmol) as a solution in THF
(2 mL). The reaction mixture was stirred for 30 minutes at RT and then cooled in an ice
bath. To the cooled solution (0 °C) was added dropwise (over the course of 2 minutes) a
solution of 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH, B1, 13.5 mg, 0.53 mmol) in
THF (1 mL). The reaction vessel was evacuated and added a H2 balloon. The mixture
was allowed to warm to room temperature and stirred for 16 hours. The reaction mixture
was added a 1:3 water/THF mixture (4 mL). NaBO3-monohydrate (300 mg, 300 mmol)
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was added and the reaction mixture was stirred vigorously. After a 6 hour stir, the
resultant mixture was extracted with EtOAc (3 x 15 mL) and the combined organic
extracts were dried with Na2SO4, filtered, and concentrated under reduced pressure. The
crude reaction mixture was purified via flash chromatography on silica gel (30:70
DCM/hexanes) afforded 2 as a colorless oil.

Benzophenone O-isobutyl oxime (Reduced product 2) TLC analysis (10:90
EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR (400 MHz, CDCl3)  7.51-7.31 (10H,
m), 3.98 (2H, d, J = 6.8 Hz), 2.12-2.02 (1H, m), 0.93 (6H, d, J = 6.7 Hz); 13C NMR (100
MHz, CDCl3)  156.1, 136.44, 135.6, 129.3, 129.1, 128.6, 128.2, 128.0, 127.8, 81.2,
28.1, 19.2; IR (neat) 3054 (C-H aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N
stretch), 1438 (N-O stretch), 996 (C-O stretch) cm-1
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Typical hydroboration reaction

To a vial containing Rh(nbd)2BF4 (3.0 mg, 7.93 μmol) was added L2 (11.4 mg, 16.0
μmol) in THF (1 mL) and stirred for 1 hour for complexation (solution changes from
colorless to yellow instantaneously). A 1 mL aliquot of the resulting Rh[(L2)2(nbd)]BF4
solution was added to a 50 mL round bottom flask with stir bar. The resulting yellow
solution was added ,-unsaturated oxime 1 (66.3 mg, 0.26 mmol) as a solution in THF
(2 mL). The reaction mixture was stirred for 30 minutes at RT and then cooled in an ice
bath. To the cooled solution (0 °C) was added dropwise (over the course of 20 minutes)
a solution of 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH, B1, 67.6 mg, 0.53 mmol) in
THF (1 mL). The mixture was allowed to warm to room temperature and stirred for 4
hours. Afterwards, the reaction mixture was concentrated and reduced product 2 was
separated via flash chromatography on silica gel (20:80 EtOAc/hexanes) as a clear oil.
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The inseparable ortho-borylated and -borylated products were concentrated and added a
1:3 water/THF mixture. NaBO3-monohydrate (300 mg, 300 mmol) was added and the
reaction mixture was stirred vigorously. After a 6 hour stir, the resultant mixture was
extracted with EtOAc (3 x 15 mL) and the combined organic extracts were dried with
Na2SO4, filtered, and concentrated under reduced pressure. The crude reaction mixture
was purified via flash chromatography on silica gel (20:80 EtOAc/hexanes) afforded 3
and 4 as colorless oils.

Benzophenone O-isobutyl oxime (Reduced product 2) ,-unsaturated substrate 1 (66.3
mg, 0.24 mmol) was converted to reduced product 2 (6.8 mg, 10%) as a colorless oil.
TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR (400 MHz,
CDCl3)  7.51-7.31 (10H, m), 3.98 (2H, d, J = 6.8 Hz), 2.12-2.02 (1H, m), 0.93 (6H, d, J
= 6.7 Hz); 13C NMR (100 MHz, CDCl3)  156.1, 136.44, 135.6, 129.3, 129.1, 128.6,
128.2, 128.0, 127.8, 81.2, 28.1, 19.2; IR (neat) 3054 (C-H aromatic stretch), 2958 (C-H
aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-O stretch) cm-1

204

(2-hydroxyphenyl)(phenyl methanone O-isobutyl oxime (Ortho-hydroxylated and
reduced product 3) ,-unsaturated substrate 1 (66.3 mg, 0.24 mmol) was converted to
ortho-hydroxylated / reduced product 3 (22.3 mg, 31%) as a colorless oil. TLC analysis
(10:90 EtOAc/hexanes) showed a spot at Rf 0.8; 1H NMR (400 MHz, CDCl3)  11.2 (1H,
s), 7.52-7.47 (3H, m), 7.32-7.24 (3H, m), 7.03 (1H, d, J = 8.9 Hz), 6.84-6.77 (1H, m),
6.73 (1H, t, J = 8.0 Hz), 3.94 (2H, d, J = 6.9 Hz), 2.10-2.00 (1H, m), 0.90 (2H, d, J = 6.7
Hz); 13C NMR (100 MHz, CDCl3)  160.3, 158.2, 132.0, 130.7, 130.5, 128.9, 128.4,
128.3, 118.8, 118.8, 117.1, 81.5, 27.9, 19.0; IR (neat) 3055 (C-H aromatic stretch), 2958
(C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-O stretch) cm-1

Benzophenone O-(3-hydroxy-2-methylpropyl) oxime (gamma-hydroxyl product 4)
,-unsaturated substrate 1 (66.3 mg, 0.24 mmol) was converted to gamma-hydroxylated
product 3 (40.7 mg, 57%) as a colorless oil. TLC analysis (30:70 EtOAc/hexanes)
showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3)  7.50-7.33 (10H, m), 4.29 and
4.13 (2H, ddd, J1 = 4.6= Hz, J2 = 7.5 Hz), 3.64-3.52 (2H, m), 2.18-2.11 (1H, m), 2.01
(1H, t, J = 5.5 Hz), 0.94 (3H, d, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3)  157.2, 136.1,
133.3, 129.5, 128.9, 128.9, 128.3, 128.2, 127.8, 77.9, 66.3, 35.8, 13.5; IR (neat) 3360 (OH stretch), 3041 (C-H aromatic stretch), 2924 (C-H aliphatic), 1585 (C=N stretch), 1434
(N-O stretch), 989 (C-O stretch) cm-1
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Benzophenone O-2-cyclohexylpropyl oxime (reduced product 11) ,-unsaturated
substrate 10 (84.4 mg, 0.24 mmol) was converted to reduced product 11 (25.0 mg, 28%)
as a colorless oil using the procedure for typical Rh-CAHB described for 1. TLC
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR (400 MHz, CDCl3) 
7.52-7.33 (10H, m), 4.20 and 4.02 (2H, dd, J1 = 6.0 Hz, J2 = 10.2 Hz), 1.80-1.62 (6H, m),
1.30-1.08 (6H, m), 0.88 (3H, d, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3)  156.2, 136.7,
133.6, 129.3, 129.1, 128.9, 128.6, 128.2, 127.9, 127.8, 78.3, 40.0, 37.8, 30.8, 28.9, 26.9,
26.8, 26.7, 13.7; IR (neat) 3058 (C-H aromatic stretch), 2921 (C-H aliphatic), 1588 (C=N
stretch), 1443 (N-O stretch), 980 (C-O stretch) cm-1

Benzophenone O-2-cyclohexyl-3-hydroxypropyl oxime (gamma-hydroxyl product 13)
,-unsaturated substrate 10 (84.4 mg, 0.24 mmol) was converted to gammahydroxylated product 13 (53.5 mg, 60%) as a colorless oil using the procedure for typical
Rh-CAHB described for 1. Chiral HPLC analysis (Chiralcel OD, 70:30
hexanes:isopropanol) showed peaks at 7.82 min and 8.47 min; TLC analysis (30:70
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EtOAc/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3)  7.51-7.33 (10H,
m), 4.44-4.31 (2H, unresolved ddd), 3.68 (2H, t, J = 6.4 Hz), 2.01 (1H, t, J = 5.5 Hz),
0.94 (3H, d, J = 7.0 Hz), 2.07-2.03 (1H, m), 1.75-1.00 (13 H, m);

13

C NMR (100 MHz,

CDCl3)  157.4, 136.0, 133.3, 129.5, 129.0, 128.8, 128.3, 128.3, 127.8, 75.7, 63.5, 46.0,
36.9, 30.7, 30.5, 26.7, 26.6, 26.5; IR (neat) 3360 (O-H stretch), 3058 (C-H aromatic
stretch), 2917 (C-H aliphatic), 1490 (C=N stretch), 1441 (N-O stretch), 981 (C-O stretch)
cm-1

Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime (gamma hydroxylated
product 9) ,-unsaturated substrate 6 (77.5 mg, 0.24 mmol) was converted to gammahydroxylated product 3 (40.7 mg, 57%) as a colorless oil. Chiral HPLC analysis
(Chiralcel OD, 70:30 hexanes:isopropanol) showed peaks at 9:01 min and 9:55; min TLC
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3) 
7.51-7.34 (10H, m), 4.35 and 4.14 (2H, ddd, J1 = 4.0 Hz, J2 = 10.8 Hz), 3.64-3.63 (1H,
m), 3.57-3.51 (1H, m), 2.12(1H, t, J = 5.5 Hz,), 2.04-2.02 (1H, m), 1.71-1.64 (1H, m),
1.21-1.11 (2H, m), 0.97-0.93 (6H, m); 13C NMR (100 MHz, CDCl3)  157.3, 136.0,
133.2, 129.5, 129.0, 128.9, 128.3, 128.3, 127.8, 77.0, 65.1, 38.5, 37.2, 25.3, 22.9, 22.8;
IR (neat) 3376 (O-H stretch), 3081 (C-H aromatic stretch), 2961 (C-H aliphatic), 1595
(C=N stretch), 1448 (N-O stretch), 976 (C-O stretch) cm-1
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MTPA characterization of gamma alcohol for enantiomeric excess assignment
Determination of enantiomeric excess of 4 could not be determined with with chiral
HPLC columns. Synthesis of the corresponding diastereomers from (S)-(+)--Methoxyα-trilfluoromethylphenylacetyl chloride (S)-MTPA-Cl allows for NMR determination of
the diastereomeric excess.

(2R)-3-(((diphenylmethylene)amino)oxy)-2-methylpropyl-3,3,3-trifluoro-2-methoxy2-phenylpropanoate (4-(R)-MTPA. To a vial containing gamma-hydroxylated product
4 (5.0 mg, 18.6 μmol) and excess triethylamine (3 drops) was added DCM (3 mL). (S)MTPA-Cl (25.0 μmol, 0.25 mL of a freshly prepared 0.1 M solution in toluene) was
added dropwise under N2. DMAP (1.86 mmol, 0.1 mL from a freshly prepared 0.1 M
stock solution in DCM) was added and the resulting reaction mixture was stirred at room
temperature for 4 hours. The salt was filtered with a small silica plug which was
subsequently flushed with EtOAc (2 x 1 mL). The combined organic filtrates were
concentrated in vacuo. The crude reaction mixture was purified via flash
chromatography on silica gel (10:90 EtOAc/hexanes) which afforded 4-(R)-MTPA (8.8
mg, 98 %) as a colorless oil. TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf
0.8; 1H NMR (400 MHz, CDCl3)  7.48-7.28 (15H, m), 4.35-4.23 (2H, m), 4.17-4.02
(2H, m) 3.55 (3H, s), 2.42-2.36 (1H, bs), 0.99 (3H, t, J = 7.6 Hz); 13C NMR (100 MHz,
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CDCl3)  166.6, 157.2, 157.1, 136.3, 133.3, 132.3, 129.6, 129.4, 129.1, 129.0, 128.8,
128.4, 128.3, 128.1, 128.1, 127.8, 127.4, 124.8, 121.9, 84.6, 75.4, 68.1, 55.4, 32.8, 13.8;
19

F NMR (357.5 MHz, CDCl3)  -71.56, -71.64 ; IR (neat) 3038 (C-H aromatic stretch),

2924 (C-H aliphatic), 1742 (C=O), 1451 (N-O stretch), 1000 (C-O stretch) cm-1

Rh-CAHB of deuterated benzophenone derivatives with tmdB-H
Using a procedure for typical Rh-CAHB with deuterium-labeled substrate 16 and tmdBH,
the products isolated as described below.
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(D9H)-Benzophenone O-isobutyl oxime (reduced product 19) ,-unsaturated substrate
16 (69.1 mg, 0.24 mmol) was converted to reduced product 19 (6.82 mg, 10%) as a
colorless oil. TLC analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 1H NMR
(400 MHz, CDCl3)  7.50 (1H, s), 3.98 (2H, d, J = 6.7 Hz), 2.11-2.02 (1H, m), 0.94-0.90
(5H, m); 13C NMR (100 MHz, CDCl3)  127.7, 81.2, 28.0, 19.2

(2-hydroxyphenyl)(phenyl methanone O-isobutyl oxime (ortho-hydroxylated and
reduced product 19) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was converted to
ortho-hydroxylated product 20 (22.2 mg, 30%) as a colorless oil. TLC analysis (30:70
EtOAc/hexanes) showed a spot at Rf 0.85; 1H NMR (400 MHz, CDCl3)  11.2 (1H, s),
6.83 (0.6H, s), 3.94 (2H, d, J = 6.9 Hz), 2.09-1.99 (1H, m), 0.91-0.88 (4.7H, m); 13C
NMR (100 MHz, CDCl3)  160.3, 158.2, 131.8, 130.4, 128.3, 128.0, 127.8, 127.5, 118.8,
118.7, 81.5, 27.9, 27.8, 19.0, 18.9, 18.7, 18.5; IR (neat) 3085 (O-H phenol), 2920 (C-H
aliphatic), 1585 (C=N stretch), 1441 (N-O stretch), 1025 (C-O stretch) cm-1
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Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime(gamma-hydroxylated
product 21) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was converted to gammahydroxylated product 21 (38.7 mg, 52%) as a colorless oil. TLC analysis (30:70
EtOAc/hexanes) showed a spot at Rf 0.5; 1H NMR (400 MHz, CDCl3)  7.49 (1H, s),
4.30 and 4.13 (2H, ddd, J1 = 4.5 Hz, J2 = 10.9 Hz), 3.62-3.53 (1.5H, m), 2.17-2.10 (1H,
m), 2.04 (1H, bs), 0.95-0.92 (2.5H, m); 13C NMR (100 MHz, CDCl3)  127.7, 77.9, 66.3,
35.8, 13.5; IR (neat) 3339 (O-H stretch), 2924 (C-H aliphatic), 1595 (C=N stretch), 1454
(N-O stretch), 972 (C-O stretch) cm-1
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D10-Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime(gammahydroxylated product 21) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was
converted to gamma-hydroxylated product 22 (15.1 mg, 20%) as a colorless oil. TLC
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.5; 1H NMR (400 MHz, CDCl3) 
4.30 and 4.13 (2H, ddd, J1 = 4.6 Hz, J2 = 10.9 Hz), 2.18-2.10 (1H, m), 2.03 (1H, bs), 0.94
(3H, d, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3)  157.1, 136.0, 133.0, 77.9, 66.3, 35.8,
13.5. ; IR (neat) 3342 (O-H stretch), 2931 (C-H aliphatic), 1588 (C=N stretch), 1451 (NO stretch), 969 (C-O stretch) cm-1
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(D9H)Benzophenone O-2-cyclohexylpropyl oxime (reduced product 26) ,unsaturated substrate 23 (87.0 mg, 0.24 mmol) was converted to reduced product 19
(4.60 mg, 5%) as a colorless oil. TLC analysis (30:70 EtOAc/hexanes) showed a spot at
Rf 0.9; 1H NMR (400 MHz, CDCl3)  7.50 (1H, s), 4.11 (2H, dd, J1 = 5.8 Hz, J2 = 10.3
Hz), 1.81-1.57 (6H, m), 1.31-0.97 (7H, m), 0.88-0.85 (2H, m); 13C NMR (100 MHz,
CDCl3)  127.7, 78.3, 33.9, 37.8, 37.8, 30.7, 28.8, 26.9, 26.8, 26.7, 13.7, 13.6; IR (neat)
2914 (C-H aliphatic), 1587 (C=N stretch), 1428 (N-O stretch), 972 (C-O stretch) cm-1
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(D9H)Benzophenone O-2-cyclohexyl-3-hydroxypropyl oxime (gamma hydroxylated
product 25) ,-unsaturated substrate 23 (87.0 mg, 0.24 mmol) was converted to gammahydroxylated product 19 (40.2 mg, 44%) as a colorless oil. TLC analysis (30:70
EtOAc/hexanes) showed a spot at Rf 0.5; 1H NMR (400 MHz, CDCl3)  7.50 (1H, s),
4.20 and 4.02 (2H, ddd, J1 = 3.8 Hz, J2 = 10.6 Hz), 3.70-3.66 (1.4H, m), 2.29-2.22 (0.5H,
m), 2.06-2.02 (1H, m), 1.75-1.58 (6H, m), 1.44-1.40 (1H, m), 1.28-1.02 (5.5 H, m); 13C
NMR (100 MHz, CDCl3)  157.4, 133.0, 127.7, 75.7, 63.5, 46.0, 36.9, 30.7, 30.5, 26.4,
26.6, 26.5; IR (neat) 3358 (O-H stretch), 3062 (aromatic C-H), 2926 (C-H aliphatic),
1575 (C=N stretch), 1450 (N-O stretch), 972 (C-O stretch) cm-1
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Synthesis of tmdB-D
Labeled-boranes prepared with an iridium catalyst and D2 were reported by Nolan et
al.103 The catalyst was readily prepared from commercially available tBu NHC and
[Ir(coe)2Cl]2.

Ten open-faced vials, each with several glass beads to aid in stirring, were each added
tmdBH (0.19 g, 1.48 mmol) in DCM (0.2 mL). A stock solution of Ir[t-BuNHC] catalyst
was prepared by dissolving catalyst (28.8 mg, 49.0 μmol) in DCM (2.2 mL) creating a
.022 M solution. To each open-faced reaction vial was added freshly prepared Ir[tBuNHC] stock solution (0.2 mL, 4.4 μmol). The reaction vials were loaded into a high
pressure chamber. The chamber was charged with D2 (30 psi) and lightly shaken (ca 100
revolutions/min) at ambient temperature for 24 h, at which point the deuterium pressure
was released. The reaction mixtures were combined into one vial and carefully
concentrated under reduced pressure at 0 °C. Bulb-to-bulb distillation (1 atm, 180 °C)
afforded tmdB-D (1.1 g, 58%) as a colorless oil. 1H NMR (400 MHz, CDCl3)  4.21
(1H), 1.82 (1H, d, J = 14 Hz), 1.56 (1H, t, J = 12.4 Hz), 1.32-1.26 (9H, m); 13C NMR
(100 MHz, CDCl3)  71.0, 64.7, 46.2, 31.0, 28.2, 23.0; 11B NMR (128 MHz, CDCl3) 
25.1 (s)
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CHAPTER FOUR: SYNTHESIS OF D-CYCLOSERINE AND 13C-LABELED DCYCLOSERINE

4.1 Tuberculosis - A constantly evolving worldwide threat
In 1993, the World Health Organization (WHO) declared tuberculosis (TB) a global
public health emergency with 7-8 million reported cases resulting in a staggering 1.3-1.6
million deaths.1 TB is caused by bacillus Mycobacterium tuberculosis. Current drug
treatment from TB has led to a mortality rate reduction of 41% since 1990. Two
obstacles slowing the WHO’s target of 50% reduction by 2015 are (1) the co-infection
with HIV makes treatment more difficult and (2) effective treatment to multidrugresistant (MDR-TB) and extensively drug-resistant (EDR-TB) strains remains elusive. In
2011, one in five reported TB cases was classified as MDR-TB. With the numbers of
drug-resistant strains increasing, the demand for new drug treatments will remain.
D-Cycloserine (DCS) is a second-line drug for the treatment of TB. While the
mechanism of action is not fully understood, it is believed to serve as a D-alanine mimic,
which competitively inhibits the D-alanine pathway of peptidoglycan biosynthesis.2
Finding therapeutic targets that inhibit the D-alanine pathway is believed to be
important,3 because M. tuberculosis is comprised of a lipid rich structure comprised of a
D-alanine cross-linked peptidoglycan backbone.4

This backbone gives the cell wall its

tensile strength, and thus inhibition of the cross-linking leads to less virulent strains.
In a collaboration with Professors Robert Powers (UNL-Chemistry) and Raul Barletta
(UNL Veterinary and Biomedical Sciences) experiments were proposed to elucidate on
the mechanism of action for DCS. To carry out these experiments, an effective route for

226

an isotopically labeled derivative was needed to prepare sufficient quantities for
metabolic experiments. The synthesis of DCS has been reported in both the unlabeled5,6
and labeled7,8 forms. However, these routes were not suitable for producing 13C-labeled
DCS starting from commercially available 13C-labeled serine, the latter is typically sold
only in milligram quantities.

During the preparation of our manuscript, several other

synthetic routes were published on the synthesis of D-cycloserine from D-serine.9,10
While these methods may have been effective, several considerations argued against their
use. (1) The isotopically labeled racemic serine is much less expensive than the
enantiomerically pure form. (2) When using isotopically labeled D-serine as the starting
material, the -stereocenter must be carefully monitored throughout the synthesis for
unwanted racemization. Additionally, our route employed a late stage resolution that
allowed access to both enantiomers of the labeled cycloserine for subsequent
experiments. Herein, the synthetic route that will be described was used to produce both
unlabeled and 13C-labeled DCS starting from 250 mg of the corresponding DL-serine.
4.2 Synthesis of DL-Cycloserine

Scheme 1 Synthesis of DL-cycloserine
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DL-serine was converted to the corresponding methyl ester upon treatment with
SOCl2 in MeOH. The Mitsunobu reaction with serine derivatives can be challenging due
to a competing elimination reaction. Cherney and Wang reported that a bulky aminoprotecting group is required for sufficient conversion.11 A trityl group was chosen due to
its relative ease of installation and removal; the latter effected by either H2 or acid. The
diisopropyl azodicarboxylate (DIAD) promoted Mitsunobu reaction with trityl-protected
serine methyl ester proceeded smoothly affording the desired hydroxy succinimide
derivative 3 in 80% yield.
Two common methods for succinimide deprotection use either hydrazine12,13 in protic
solvents or methyl hydrazine14 in polar solvents at elevated temperatures. Treatment of 3
with hydrazine in refluxing EtOH led to hydrazine attack on the methyl ester.
Conversely, deprotection in EtOH at room temperature afforded hydroxyl amine 4 in
only 35% yield with trityl-protected cycloserine being the major product formed.
Originally optimistic that this could be an entry into the DCS synthesis, attempts at trityl
deprotection by acid or hydrogenation catalyzed by Pd/C only led to decomposition of
the cycloserine – likely resulting from N-O bond cleavage.15 Fortunately, treating 3 with
hydrazine in CH2Cl2 affords the deprotected hydroxylamine derivative 4 in near
quantitative yield. Addition of dry HCl (3M in Et2O) affords the doubly-protonated salt
5, a similar intermediate to that used in the original DCS synthesis reported by
Stammer.5,6 Using the reaction conditions, with respect to concentration and equivalents
base, Stammer’s report gave a low yield of (DL)-cycloserine in our hands. This is likely
the result of the high solubility of cycloserine in H2O. Optimization of reaction
conditions found a 2:1 mixture of MeOH / H2O with 3 equivalents base gave (DL)-
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cycloserine 6 in moderate yields (51%). The high solubility of cycloserine in water can
be explained by its zwitterionic nature. The IR spectra of 6 has a strong C-O stretch at
1527 cm-1, while the C=O stretch is absent in the spectrum.

Figure 1 Equilibrium favors zwitterionic form of cycloserine

4.3 Corrected resolution of DCS with L-tartaric acid
The first synthesis of DCS reported addition of L-tartaric acid to DL-cycloserine
facilitated precipitation of the desired DCS/D-tartrate salt. However, when the salt
formation was practiced with commercially available DCS, no precipitation occurred
upon addition of D-tartaric acid (Figure 2). Conversely, addition of one equivalent of Ltartaric acid to DCS led to spontaneous precipitation of a fine white crystalline powder.
After filtration, this powder was identified to be the DCS/L-Tartrate salt 7. The optical
rotation of the isolated DCS/L-Tartrate salt 7 ([a]D20 = +43.2) is identical to that
previously reported for the DCS/D-tartrate salt.6 We conclude that the literature report
was made in error. Additionally, when one equivalent of L-tartaric acid was added to the
water soluble DCS/D-tartrate salt, compound 7 slowly precipitated from the solution.
This latter observation suggested that both enantiomers of the cycloserine could be
resolved through sequential salt formation, crystallization, and filtration.
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Figure 2 Resolution of D-cycloserine with L-tartaric acid

Given the literature, we were somewhat surprised by the solubility of the
cycloserine/tartrate salts; it proved to be somewhat problematic and required careful
optimization of the reaction conditions. As expected, addition of D-tartaric acid to DCS
does not precipitate a salt either at 0.78 M or 2.61 M (Figure 3, entries A and C).
However, when L-tartaric acid is added to duplicate aqueous solutions of DCS/D-tartrate
salt, DCS-L-tartrate salt spontaneously precipitates out of solution at higher
concentrations but not at the more dilute conditions (Figure 3, entry B and D); even after
stirring for 24 h, no salt precipitation was observed for the dilute sample at 0.78 M.
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Figure 3 Resolution of DCS is concentration dependent in water. A) DCS, D-tartaric acid
(0.78 M) ; B) DCS, D-tartaric acid, L-tartaric acid (0.78 M); C) DCS, D-tartaric acid
(2.61 M); D) DCS, D-tartaric acid, L-tartaric acid (2.61 M)

4.4 Resolution of (DL)-cycloserine

Figure 4 Sequential resolution of DL-cycloserine

After addition of L-tartaric acid to DL-cycloserine 6, the DCS/L-tartrate salt 7
precipitated and was separated by filtration and then dried under vacuum. To the filtrate
was added D-tartaric acid and the resulting solid precipitate was filtered affording
LCS/D-tartrate salt 8. The two salts have nearly identical but opposite optical rotations
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([a]D20 = +43.2 and -42.8, c = 0.7 H2O respectively) as to be expected for an effective
resolution. Ion exchange chromatography on Amberlite® IR-120 PLUS resin followed
by lyophlization of the eluents afforded DCS and L-cycloserine (LCS) with a minimal
amount of unidentified impurities. Careful recrystallization of the resolved cycloserine
affords DCS 9 and L-cycloserine 10 in 64-65% yield. The moderate yields are likely the
resulting from the high solubility of cycloserine in water during the recrystallization. The
degree of optical rotation of synthesized 9 matches that of commercially purchased DCS
([a]D20 = +120.3° (c = 1.0, H2O)).

Figure 5 Ion exchange resin effectively removes tartrate
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4.5 Synthesis of isotopically labeled DCS

Scheme 2 Synthesis of D-cycloserine-1-13C

Starting from isotopically labeled DL-serine-1-13C, D-cycloserine-1-13C 16 was
synthesized in 16.4% overall yield. Yields for each step were comparable to that of the
unlabeled material. 1H NMR, 13C NMR, and high-resolution mass spectrometry were
used to characterize the isotopically-labeled material.

233

Figure 6 High resolution mass spectrometry finds peaks for unlabeled DCS (9) and 13Clabeled DCS (16)

4.6 Experimental

Reactions were carried out under a dry nitrogen atmosphere. Dichloromethane (DCM),
tetrahydrofuran (THF), and methanol (MeOH) were freshly distilled under the following
conditions: DCM from calcium hydride, THF from sodium metal and benzophenone,
and MeOH from Mg. All synthesized compounds were purified using flash
chromatography with the indicated solvents using EMD Silica Gel 60 Geduran®. Thin
layer chromatography analyses were performed on Analtech Silica Gel HLF (250
microns) precoated analytical plates and visualized with use of handheld short
wavelength UV light, vanillin stain (ethanol, H2SO4, and vanillin), or ninhydrin stain
(ethanol, acetic acid, and ninhydrin). NMR spectra were recorded on a 400 MHz Bruker
Advance NMR spectrometer using CHCl3 ( 7.27 ppm), CDCl3 ( 77.0 ppm), DMSO (
2.54 ppm), or d6-DMSO ( 40.45 ppm). Peaks are expressed as m (unresolved multiplet),
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q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet). IR spectra were recorded
using an Avatar 360 FT-IR. Optical rotations were measured in solutions, 1.0 g/100 mL
H2O unless indicated otherwise, and recorded using an Autopol III automatic polarimeter.
HRMS analyses were performed by the Nebraska Center for Mass Spectrometry.

Synthesis of D-cycloserine
DL-Serine methyl ester hydrochloride (1). To a cooled (0 °C) solution of DL-serine
(250 mg, 2.38 mmol) in MeOH (2 mL) was added dropwise SOCl2 (0.17 mL, 2.4 mmol).
The solution was stirred for 16 h at room temperature, at which point it was concentrated
with rotary evaporation. To the resulting oil, hexanes were added (3 mL), and the
solution was concentrated. The resulting solid was then recrystallized from MeOH/Et2O
to afford 1 (352 mg, 95%) as a white crystalline solid (mp 124–126 °C (decomp.)). 1H
NMR (400 MHz, d6-DMSO) d 8.64 (3H, bs), 5.64 (1H, s), 4.08 (1H, t, J = 7 Hz), 3.83
(2H, s), 3.74 (3H, s); 13C NMR (100 MHz, d6-DMSO) d 168.93, 59.89, 54.84, 53.18; IR
(ATR) 3381 (OH stretch), 3023 (N-H stretch), 1736 (CO2CH3 stretch), 1499 (C-H bend),
1245 (C-N stretch) cm-1.

DL-Methyl 3-hydroxy-2-(tritylamino)propanoate (2). To a cooled (0 °C) solution of 1
(350 mg, 2.25 mmol) in DCM (10 mL) was added dropwise triethylamine (0.69 mL, 4.9
mmol) over the course of 5 minutes. Triphenylmethyl chloride (659 mg, 2.36 mmol) in
DCM (2.5 mL) was then added over the course of 15 minutes. The resulting cold
reaction mixture was stirred (2 h), and then warmed to room temperature overnight. The
reaction mixture was washed (1 x 10 mL NaHCO3) and extracted with DCM (3 x 15
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mL). The organic extracts were combined and washed with brine (1 x 5 mL). The
organic extract was dried with MgSO4, filtered, and concentrated yielding a white solid.
This solid was recrystallized from ethyl acetate/hexanes and dried under high vacuum
affording 2 (804 mg, 99%) as a white powder-like solid (mp 135–137 °C). TLC analysis
(30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 1H NMR (400 MHz, CDCl3) d
7.56–7.53 (6H, m), 7.34–7.25 (6H, m), 7.24–7.22 (3H, m), 3.79–3.75 (1H, m), 3.65–3.57
(2H, m), 3.33 (3H, s); 13C NMR (100 MHz, CDCl3) d 174.0, 145.7, 128.8, 128.0, 126.7,
71.0, 65.0, 57.9, 52.0; IR (ATR) 3465 (OH stretch), 3309 (N-H stretch), 1720 (CO2CH3
stretch), cm-1.

DL-O-(1,3-dihydro-2,5-dioxo-1-pyrolidinyl)-N-(triphenylmethyl) methyl ester (3).
A solution containing PPh3 (580 mg, 2.22 mmol), N-hydroxysuccinimide (255 mg, 2.22
mmol), and 2 (800 mg, 2.22 mmol) in THF (10 mL) was prepared. The reaction mixture
was purged with N2 three times. The reactants were stirred for 10 minutes to dissolve
most of the solid (some solid was not dissolved). The reaction was cooled to 0 °C, and
DIAD (0.46 mL, 2.22 mmol) was added dropwise over 3 minutes. The reaction was
allowed to warm to room temperature and stirred overnight. The crude reaction mixture
was concentrated under reduced pressure. Flash chromatography on silica gel (20:80
acetone/hexanes) afforded 3 (813 mg, 80%) as a white powder-like solid (mp 156–159
°C). TLC analysis (30:70 acetone/hexanes) showed a spot at Rf 0.30; 1H NMR (400
MHz, CDCl3) d 7.56–7.55 (6H, m), 7.31–7.27 (6H, m), 7.23–7.22 (3H, m), 4.42 and 4.01
(2H, dd, J1 = 9.1 Hz, 4.0 Hz, J2 = 9.1 Hz, 5.8 Hz), 3.70–3.65 (1H, m), 3.36 (3H, s), 3.12
(1H, d, J =10 Hz), 2.64 (4H, s); 13C NMR (100 MHz, CDCl3) d 172.5, 170.6, 145.6,
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128.8, 128.0, 126.6, 79.0, 71.2, 55.7, 52.2, 25.4; IR (ATR) 3658 (N-H stretch), 2977 (CH aromatic stretch), 1722 (CO2CH3 stretch), cm-1; HRMS (ESI) calcd. For C27H26N2O5
(M+H):459.1920, found 459.1914 m/z.

DL-Methyl--aminooxy-α-amino(triphenylmethyl)butyrate (4). To a cooled (0 °C)
solution of 3 (810 mg, 1.77 mmol) in DCM (5 mL) was slowly added hydrazine (0.16
mL, 5.09 mmol). The resulting solution was stirred at 0 °C for an additional 30 minutes
and then allowed to warm to room temperature overnight. The reaction mixture was
filtered through Celite® and concentrated. Flash chromatography on silica gel (3:97
methanol/dichloromethane) afforded 4 (664 mg, 98%) as a colorless oil. TLC analysis
(8:92 methanol/dichloromethane) showed a spot at Rf 0.35; 1H NMR (400 MHz, CDCl3)
d 7.64–7.62 (6H, m), 7.36–7.33 (6H, m), 7.27–7.24 (3H, m), 5.50 (2H, s), 4.11 (1H, dd, J
= 10.2 Hz, 4.8 Hz), 3.84–3.77 (1H, d overlapping with 1H), 3.29 (3H, s), 2.89 (1H, d, J =
10.1 Hz) ; 13C NMR (100 MHz, CDCl3) d 174.4, 146.0, 128. 9, 128.0, 126.7, 78.1, 71.0,
55.8, 51.8; IR (ATR) 3313 (N-H stretch), 3056 (C-H aromatic stretch), 1726 (CO2CH3
stretch) cm-1; HRMS (ESI) calcd. For C23H24N2O3 (M+Na):399.1685, found 399.1695
m/z.

DL--aminoxyalanine methyl ester dihydrochloride (5). To a cooled solution 0 °C of
4 (658 mg, 1.75 mmol) in THF (5 mL) was added dropwise 3.0 M HCl in diethyl ether
(2.62 mL, 7.87 mmol). The resulting mixture was allowed to warm to room temperature
and stirred overnight. The reaction mixture was filtered and the precipitate was washed

237

with THF (4 x 10 mL THF) and dried under vacuum affording 5 (358 mg, 99%) as a
white fluffy solid (mp 144–146 °C (decomp.)). 1H NMR (400 MHz, d6-DMSO) d 11.80–
7.80 (5H, bs), 4.61–4.59 (1H, m), 4.56–4.47 (2H, m), 3.76 (3H, s) 13C NMR (100 MHz,
d6-DMSO) d 164.3, 71.7, 53.7, 51.3; IR (ATR) 2848 (N-H stretch), 2639 (ON-H stretch),
1740 (CO2CH3 stretch) cm-1; HRMS (ESI) calcd. For C4H11N2O3 (M+H): 135.0770,
found 135.0769 m/z.

DL-Cycloserine (6). To a cooled (0 oC) solution of 5 (350 mg, 1.69 mmol) in
MeOH/water (0.5 mL/0.1 mL) was added KOH (332 mg, 5.92 mmol) in water (0.4 mL)
dropwise over a period of 10 minutes. The pH was carefully monitored and kept between
11-11.5. The solution was stirred for 30 minutes at 0 °C and 30 minutes at room
temperature. The reaction solution was cooled (0 °C) and 2 mL of a mixture of isopropyl
alcohol/ethanol (50:50) was added. The reaction mixture was then stirred for 10 minutes
and filtered. The solids were washed with 0.5 mL of a mixture of cold isopropyl
alcohol/ethanol (50:50). The filtrate was cooled (0 °C) and the pH of the solution was
adjusted to 6.0 with the addition of glacial acetic acid. The precipitation occurred over
30 minutes at 0 oC once the pH reached 6.0. The supernatant liquid was removed and
the remaining precipitate was washed (1 x 0.5 mL of isopropyl alcohol/ethanol (50:50))
and then diethyl ether (1 x 1 mL). The solid was dried under high vacuum yielding 6
(88.0 mg, 51%) as a white powder-like solid (mp 146–149 °C (decomp.)). 1H NMR (400
MHz, d6-DMSO) d 5.50–4.75 (3H, bs), 4.46–4.39 (1H, m), 3.79–3.72 (2H, m); 13C NMR
(100 MHz, d6-DMSO) d 174.9, 75.5, 54.1; IR (ATR) 3399 (NH3 stretch), 1536 (C-O
stretch) cm-1.

238

D-Cycloserine-L-Tartrate (7) and L-Cycloserine-D-Tartrate (9). To a cooled (0 °C)
solution of 6 (80.0 mg, 0.784 mmol) in H2O (0.3 mL) was added L-Tartaric Acid (118
mg, 0.784 mmol) in H2O (0.2 mL). A white solid precipitated immediately and the
reaction mixture was stirred for 30 minutes at 0 oC. The supernatant liquid was
transferred to a clean vial. The crystalline precipitate was washed with cold water (1 x 1
mL) and cooled acetone (1 x 1 mL). The solid was dried under high vacuum affording DCycloserine-L-Tartrate 7 (82.0 mg, 82%) as a white crystalline powder.

The

supernatant liquid was cooled (0 °C) and D-Tartaric acid (80.0 mg, 0.784 mmol) was
added. The reaction mixture was stirred for 30 minutes at 0 °C, and cold acetone (1 x 1
mL) was added. The supernatant liquid was decanted , and the white precipitate was
washed with cold water (1 x 1 mL). The water was decanted off. The solid was then
washed with cold acetone (0 °C, 1 x 1 mL) and dried under vacuum affording LCycloserine-D-Tartrate 8 (62.2 mg, 63%) as a white crystalline solid. 7: mp 158–160 °C
(decomp.); Optical rotation: [a]D20 = +43.2° (c 0.7, H2O); 1H NMR (400 MHz, d6DMSO) d 8.48–6.83 (7H, bs), 4.49 (1H, t, J = 8.08 Hz), 4.17 (1H, s), 3.99 and 3.90 (2H,
dd, J1 = 9.7 Hz, 7.9 Hz, J2 = 9.7 Hz, 8.3 Hz); 13C NMR (100 MHz, d6-DMSO) d 174.34,
170.95, 73.38, 52.73; IR (ATR) 3322 (N-H stretch), 3036 (OH stretch), 2786 (CO2H
stretch), 1683 (C=O stretch) cm-1. 9: mp 158–160 °C (decomp.); Optical rotation: [a]D20
= - 42.8° (c 0.7, H2O); 1H NMR (400 MHz, d6-DMSO) d 8.48–6.83 (7H, bs), 4.49 (1H, t,
J=8.08 Hz), 4.17 (1H, s), 3.99 and 3.90 (2H, dd, J1 = 9.7 Hz, 7.9 Hz, J2 = 9.7 Hz, 8.3
Hz); 13C NMR (100 MHz, d6-DMSO) d 174.3, 171.0, 73.4, 52.7; IR (ATR) 3322 (N-H
stretch), 3036 (OH stretch), 2786 (CO2H stretch), 1683 (C=O stretch) cm-1.
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D-Cycloserine (9). L-Tartrate salt 7 (75.0 mg, 0.297 mmol) was dissolved in water (0.5
mL) and added to a short plug of Amberlite® IR-120 PLUS ion exchange resin (ca 1.0 g,
sodium form). The column was washed with water (ca. 2.0 mL) until the effluent tested
negative to ninhydrin stain. D-Cycloserine 9 was then eluted with 2% aq. NH4OH (ca 10
mL) until the effluent test negative to ninhydrin stain. The latter eluent was lyophilized,
and the white flaky solid dissolved in 4% aq. NH4OH (0.1 mL) and a mixture of
ethanol/isopropanol (50:50, 1.0 mL). The solution was cooled (0 °C) and glacial acetic
acid added dropwise until the solution reached pH 6; a precipitate formed over the course
of ca. 30 minutes. The precipitate was washed with ether and dried affording DCycloserine (9) (19.7 mg, 65%) as a white powder-like solid (mp 146–149 °C
(decomp.)). [a]D20 = +120.3° (c 1.0, H2O); 1H NMR (400 MHz, d6-DMSO) d 5.50–4.75
(3H, bs), 4.46–4.39 (1H, m), 3.79–3.72 (2H, m); 13C NMR (100 MHz, d6-DMSO) d
174.9, 75.5, 54.1; IR (ATR) 3040 (NH3 stretch), 1528 (C-O stretch) cm-1.

L-Cycloserine (10). D-Tartrate salt 8 (58.0 mg, 0.23 mmol) was converted to LCyloserine (11) using the general procedure described for tartrate salt 9 giving 10 (15.3
mg, 64%) as a white powder-like solid (mp 146–149 °C (decomp.)). [a]D20 = -118.4° (c
1.0, H2O); 1H NMR (400 MHz, d6-DMSO) d 5.50–4.75 (3H, bs), 4.46–4.39 (1H, m),
3.79–3.72 (2H, m); 13C NMR (100 MHz, d6-DMSO) d 174.9, 75.5, and 54.1; IR (ATR)
1938 (NH3 stretch), 1528 (C-O stretch) cm-1.

Synthesis of labeled D-Cycloserine-1-13C
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DL-Methyl-3-hydroxy-2-(tritylamino)propanoate-1-13C (11). Commercially available
DL-Serine-1-13C (250 mg, 2.36 mmol) was converted to DL-Serine-1-13C methyl ester
hydrochloride using the procedure for unlabeled material (1). This material was used
immediately without subsequent purification. DL-Serine-1-13C methyl ester
hydrochloride was converted to DL-Methyl-3-hydroxy-2-(tritylamino)propanoate-1-13C
(11) using the procedure for unlabeled material (2) affording 11 (738 mg, 86% over 2
steps) as a white powder. 1H NMR (400 MHz, CDCl3) d 7.53–7.51 (6H, m), 7.32–7.28
(5H, m), 7.24–7.21 (3H, m), 3.78–3.72 (1H, m), 3.64–3.55 (2H, m), 3.32 (3H, d, J = 3.8
Hz), 3.05-2.96 (1H, m), 2.37 (1H, t, J = 12.56 Hz); 13C NMR (100 MHz, CDCl3) d 174.0;
HRMS (ESI) cald. For 13CC22H23NO3 (M+Na): 385.1609, found 385.1612 m/z.

DL-O-(1,3-Dihydro-2,5-dioxy-1-pyrolidinyl)-N-(triphenylmethyl)-1-13C methyl ester
(12). 11 (733 mg, 2.02 mmol) was converted to DL-O-(1,3-Dihydro-2,5-dioxy-1pyrolidinyl)-N-(triphenylmethyl)-1-13C methyl ester (12) using the procedure for
unlabeled material (3) affording 12 (660 mg, 71%) as a white powder. 1H NMR (400
MHz, CDCl3) d 7.56–7.53 (6H, m), 7.31–7.26 (6H, m), 7.23–7.18 (3H, m), 4.44–4.40
(1H, m), 4.03–3.98 (1H, m), 3.70–3.63 (1H, m), 3.35 (3H, d, J = 3.8 Hz), 3.10 (1H, dd, J1
= 10.0 Hz, J2 = 3.8 Hz), 2.69 (4H, s); 13C NMR (100 MHz, CDCl3) d 172.6; HRMS (ESI)
cald. For 13CC26H26N2O5 (M+Na): 482.1773, found 482.1781 m/z.

DL-Methyl--Aminooxy-α-amino(triphenylmethyl)butyrate-1-13C (13). 12 (653 mg,
1.42 mmol) was converted to DL-Methyl--Aminooxy-α-

241

amino(triphenylmethyl)butyrate-1-13C (13) using the procedure for unlabeled material (4)
affording 13 (526 mg, 98%) as a colorless oil. 1H NMR (400 MHz, CDCl3) d 7.55–7.52
(6H, m), 7.31–7.26 (6H, m), 7.23–7.18 (3H, m), 5.47 (2H, bs), 4.06–4.01 (1H, m), 3.77–
3.68 (2H, m), 3.24 (3H, d, J = 3.8 Hz), 3.78 (1H, bs); 13C NMR (100 MHz, CDCl3) d
174.3; HRMS (ESI) cald. For 13CC22H24N2O3 (M+Na): 400.1718, found 400.1727 m/z.

DL-Cycloserine-1-13C (14). 13 (520 mg, 1.38 mmol) was converted to the Di-HCl salt
using the procedure for unlabeled material (5) and used without further purification. DiHCl salt of 13 was then converted to DL-Cycloserine-1-13C (14) using the procedure for
unlabeled material (6) affording 14 (87.2 mg, 61% over 2 steps) as a white powder. 1H
NMR (400 MHz, d6-DMSO) d 4.44–4.36 (1H, m), 3.76–3.69 (2H, m); 13C NMR (100
MHz, d6-DMSO) d 175.0; HRMS (ESI) cald. For 13CC2H6N2O2 (M+H): 104.0541, found
104.0542 m/z.

D-Cycloserine-1-13C-L-Tartrate (15). 14 (80.3 mg, 0.787 mmol) was converted to DCycloserine-1-13C-L-Tartrate (15) using the procedure for unlabelled material (8)
affording 15 (76.7 mg, 77%) as a white crystalline powder. 1H NMR (400 MHz, d6DMSO) d 4.46 (1H, s), 4.05 (2H, s), 3.80 (2H, s); 13C NMR (100 MHz, d6-DMSO) d
174.2; HRMS (ESI) cald. For 13CC6H12N2O8 (M+H): 254.0705, found 254.0700 m/z.

D-Cycloserine-1-13C (16). 15 (73 mg, 0.288 mmol) was converted to D-Cycloserine-113

C (16) using the procedure for unlabelled material (9) affording 16 (16.9 mg, 57%) as a

white powder. 1H NMR (400 MHz, d6-DMSO) d 4.43–4.40 (1H, m), 3.76–3.71 (2H, m),
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3.60–3.10 (3H, bs); 13C NMR (100 MHz, d6-DMSO) d 175.0; HRMS (ESI) cald. For
13

CC2H6N2O2 (M+H): 104.0541, found 104.0543 m/z.
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